Section XI Financial Report
I. Auditor’s Report
Has the semi-annual report been audited □ Yes √ No The Company's semi-annual financial report has not been audited.
II. Financial statements
The unit of the figures in the statements in the notes to the financial statements: yuan
1 Consolidated balance sheet
Prepared by Meinian Onehealth Healthcare Holdings Co., Ltd. as at 30 June 2020 Expressed in Renminbi Yuan
Item 30 June 2020 31 December 2019 Current assets Cash at bank and on hand 2,514,532,837.26 4,759,517,528.74 Settlement funds Lendings to banks and other financial institutions Financial assets held for trading Derivative financial assets Bills receivable 1,339,476.00 1,960,000.00 Accounts receivable 2,130,943,760.87 2,292,574,441.06 Receivables under financing Prepayments 224,710,369.31 214,342,103.57 Premium receivable Reinsurance receivables Reinsurance contract provisions receivable Other receivables 499,351,220.08 384,677,621.78 Including: Interest receivable 615,073.84 738,823.84 Dividends receivable 39,725,570.73 25,339,452.03 Financial assets purchased under reverse sale agreements Inventories 119,878,893.35 129,615,381.32 Contract assets Assets held for sale Non-current assets due within one year 583,312,924.83 653,333,835.18 Other current assets 212,997,434.56 255,395,925.36 Total current assets 6,287,066,916.26 8,691,416,837.01 Non-current assets Loans and advances to customers Debt investments Other debt investments Long-term receivables 633,467,537.08 828,318,900.01
1 Long-term equity investments 157,013,371.17 162,090,985.54 Investments in other equity instruments Other non-current financial assets 1,271,876,037.72 1,226,749,518.89 Investment properties Fixed assets 2,472,855,083.89 2,608,356,009.29 Construction in progress 82,974,642.29 59,483,859.71 Bearer biological assets Oil and gas assets Right-of-use assets Intangible assets 166,328,353.26 163,907,170.30 Development costs Goodwill 4,206,110,762.59 4,104,391,143.02 Long-term deferred expenses 662,587,897.28 736,398,352.65 Deferred tax assets 343,919,454.73 100,159,632.69 Other non-current assets 558,947,952.32 237,348,067.10 Total non-current assets 10,556,081,092.33 10,227,203,639.20 Total assets 16,843,148,008.59 18,918,620,476.21 Current liabilities Short-term loans 2,041,260,631.04 2,309,069,932.12 Borrowings from the central bank Loans from banks and other financial institutions Financial liabilities held for trading Derivative financial liabilities Bills payable 16,050,200.00 636,592.00 Accounts payable 838,893,632.39 862,957,946.40 Advance payments received 1,447,485,391.71 Contract liabilities 1,393,741,279.29 Financial assets sold under repurchase agreements Accepted deposits and deposits from banks Securities brokerage Securities underwriting brokerage Employee benefits payable 416,098,437.48 457,112,710.77 Taxes payable 40,705,218.97 200,243,964.38 Other payables 340,386,828.45 389,436,292.94 Including: Interest payable Dividends payable 5,790,503.84 7,767,421.57 Fee and commission payable Reinsurance payables Liabilities held for sale Non-current liabilities due within one year 2,585,366,100.38 2,316,036,316.81 Other current liabilities Total current liabilities 7,672,502,328.00 7,982,979,147.13 Non-current liabilities Provisions for insurance contracts Long-term loans 1,547,887,089.36 1,182,789,431.02 Debentures payable 1,367,746,765.24 Including: Preference shares Perpetual bonds Lease liabilities Long-term payables 167,738,668.81 217,928,737.12
2 Long-term employee benefits payable Provisions Deferred income 15,836,502.03 8,183,333.33 Deferred tax liabilities 5,228,765.52 3,957,992.89 Other non-current liabilities 1,541,009.17 1,013,418.15 Total non-current liabilities 1,738,232,034.89 2,781,619,677.75 Total liabilities 9,410,734,362.89 10,764,598,824.88 Owners’ equity Share capital 3,919,920,974.00 3,919,920,974.00 Other equity instruments Including: Preference shares Perpetual bonds Capital reserve 2,511,924,578.99 2,439,936,041.00 Less: Treasury shares 300,055,044.16 300,055,044.16 Other comprehensive income -1,720,319.06 -379,371.01 Specific reserve Surplus reserve 71,934,339.69 71,934,339.69 General risk reserve Retained earnings 401,890,576.85 1,184,276,684.09 Total equity attributable to owners of the Company 6,603,895,106.31 7,315,633,623.61 Non-controlling interests 828,518,539.39 838,388,027.72 Total owners’ equity 7,432,413,645.70 8,154,021,651.33 Total liabilities and owners’ equity 16,843,148,008.59 18,918,620,476.21
Legal Representative: Yu Rong The person in charge of accounting The head of the accounting affairs: Ya Zhigao department: Ya Zhigao
2 Company balance sheet
Expressed in Renminbi Yuan
Item 30 June 2020 31 December 2019 Current assets Cash at bank and on hand 655,124,987.41 1,641,522,730.76 Financial assets held for trading Derivative financial assets Bills receivable Accounts receivable 10,100,000.00 41,100,000.00 Receivables under financing Prepayments 7,720,791.19 5,325,113.47 Other receivables 425,422,099.81 280,176,115.49 Including: Interest receivable Dividends receivable 39,725,570.73 125,339,452.03 Inventories 80,275.41 99,547.38 Contract assets Assets held for sale Non-current assets due within one year Other current assets 16,270,274.95 14,582,000.90 Total current assets 1,114,718,428.77 1,982,805,508.00 Non-current assets
3 Debt investments Other debt investments Long-term receivables Long-term equity investments 9,681,662,348.57 9,680,902,711.89 Investments in other equity instruments Other non-current financial assets 440,191,147.62 466,288,823.14 Investment properties Fixed assets 2,333,953.53 2,969,362.51 Construction in progress Bearer biological assets Oil and gas assets Right-of-use assets Intangible assets Development costs Goodwill Long-term deferred expenses 9,019,826.10 10,105,733.60 Deferred tax assets Other non-current assets 100,640,000.00 100,640,000.00 Total non-current assets 10,233,847,275.82 10,260,906,631.14 Total assets 11,348,565,704.59 12,243,712,139.14 Current liabilities Short-term loans Financial liabilities held for trading Derivative financial liabilities Bills payable Accounts payable 3,860,921.45 2,581,565.16 Advance payments received Contract liabilities Employee benefits payable 1,534,739.19 6,292,870.59 Taxes payable 349,775.30 795,932.88 Other payables 1,191,158,631.17 1,164,582,227.11 Including: Interest payable Dividends payable Liabilities held for sale Non-current liabilities due within one year 20,031,930.56 959,903,895.89 Other current liabilities Total current liabilities 1,216,935,997.67 2,134,156,491.63 Non-current liabilities Long-term loans Debentures payable Including: Preference shares Perpetual bonds Lease liabilities Long-term payables 688,300.00 Long-term employee benefits payable Provisions Deferred income Deferred tax liabilities Other non-current liabilities Total non-current liabilities 688,300.00
4 Total liabilities 1,217,624,297.67 2,134,156,491.63 Owners’ equity Share capital 3,919,920,974.00 3,919,920,974.00 Other equity instruments Including: Preference shares Perpetual bonds Capital reserve 6,326,571,718.36 6,254,583,180.37 Less: Treasury shares 300,055,044.16 300,055,044.16 Other comprehensive income Specific reserve Surplus reserve 136,626,800.32 136,626,800.32 Retained earnings 47,876,958.40 98,479,736.98 Total owners’ equity 10,130,941,406.92 10,109,555,647.51 Total liabilities and owners’ equity 11,348,565,704.59 12,243,712,139.14
3 Consolidated income statement
Expressed in Renminbi Yuan Six months of Six months of Item 2020 2019 I. Total operating income 1,814,450,825.76 3,641,060,666.52 Including: Operating income 1,814,450,825.76 3,641,060,666.52 Interest income Earned premium Fee and commission income II. Total operating costs 2,876,381,912.93 3,779,806,068.31 Including: Operating costs 1,732,974,753.43 2,344,165,299.69 Interest expense Fee and commission expenses Surrender value Net amount of compensation expenses Net amount of appropriation to insurance reserves Policy dividend payment Commissions for reinsurance Taxes and surcharges 2,247,622.21 6,223,834.77 Selling and distribution expenses 669,364,221.05 910,302,583.50 General and administrative expenses 245,100,703.39 308,565,538.54 Research and development expenses 17,647,421.12 22,964,101.21 Financial expenses 209,047,191.73 187,584,710.60 Including: Interest expenses 204,797,359.52 197,564,525.14 Interest income 19,911,737.88 12,710,587.25 Add: Other income 11,367,669.24 2,147,648.83 Investment income (“-” for losses) 69,637,371.28 41,037,273.03 Including: Income from investment in associates and joint ventures -5,385,777.78 -3,672,776.99 Income arising from derecognition of financial assets
measured at amortised cost Exchange gains (“-” for losses) Gains from the net exposure hedge (“-” for losses)
5 Gains from changes in fair value (“-” for losses) 7,355,571.02 183,835,590.00 Credit losses (“-” for losses) -59,220,725.12 -8,527,923.80 Impairment losses (“-” for losses) Gains from asset disposals (“-” for losses) -1,260,186.25 -497,308.27 III. Operating profit (“-” for loss) -1,034,051,387.00 79,249,878.00 Add: Non-operating income 5,086,116.65 4,380,772.02 Less: Non-operating expenses 21,222,357.56 7,607,870.32 IV. Profit before income tax (“-” for loss) -1,050,187,627.91 76,022,779.70 Less: Income tax expense -201,484,629.29 31,062,782.46 V. Net profit for the year (“-” for net loss) -848,702,998.62 44,959,997.24 (1) Net profit classified by continuity of operations (“-” for net loss): 1. Net profit from continuing operations (“-” for net loss) -848,702,998.62 44,959,997.24 2. Net profit from discontinued operations (“-” for net loss) (2) Net profit classified by ownership (“-” for net loss): 1. Owners of the Company -782,386,107.24 16,837,786.00 2. Non-controlling interests -66,316,891.38 28,122,211.24 VI. Other comprehensive income, net of tax -1,340,948.05 -229,729.53 Other comprehensive income (net of tax) attributable to owners of the -1,340,948.05 -229,729.53 Company (1) Items that will not be reclassified to profit or loss 1. Remeasurement of defined benefit plan 2. Other comprehensive income recognised under equity method 3. Changes in fair value of investments in other equity instruments 4. Changes in fair value of entity’s own credit risk 5. Others (2) Items that may be reclassified to profit or loss -1,340,948.05 -229,729.53 1. Other comprehensive income recognised under equity method 2. Changes in fair value of other debt investments 3. The amount of financial assets reclassified to other comprehensive
income 4. Credit losses of debt investments 5. Cash flow hedge reserve 6. Translation differences arising from translation of foreign currency -1,340,948.05 -229,729.53 financial statements 7. Others Other comprehensive income (net of tax) attributable to non-controlling
interests VII. Total comprehensive income for the year -850,043,946.67 44,730,267.71 Attributable to owners of the Company -783,727,055.29 16,608,056.47 Attributable to non-controlling interests -66,316,891.38 28,122,211.24 VIII. Earnings per share: (1) Basic earnings per share -0.22 0.0100 (2) Diluted earnings per share -0.22 0.0100 For a business combination involving entities under common control which occurred in the current period, the net profit of the absorbed business before being consolidated was RMB___. The net profit in the prior period was RMB___. Legal Representative: Yu Rong The person in charge of accounting The head of the accounting affairs: Ya Zhigao department: Ya Zhigao
6 4 Company income statement
Expressed in Renminbi Yuan Six months of Six months of Item 2020 2019 I. Operating income 0.00 38,915,094.34 Less: Operating costs 2,365,431.52 4,000,000.00 Taxes and surcharges 1,359.90 4,223.71 Selling and distribution expenses General and administrative expenses 32,228,665.38 49,307,908.24 Research and development expenses Financial expenses 28,464,199.63 27,189,907.20 Including: Interest expenses 19,300,386.09 31,305,763.90 Interest income 9,025,557.86 168,387.81 Add: Other income 210,043.53 96,349.54 Investment income (“-” for losses) 16,787,422.05 116,815,048.80 Including: Income from investment in associates and joint ventures -140,363.32 -153,746.32 Income arising from derecognition of financial assets measured at
amortised cost (“-” for losses) Gains from net exposure hedge (“-” for losses) Gains from changes in fair value (“-” for losses) Credit losses (“-” for losses) -487,754.40 Impairment losses (“-” for losses) Gains from asset disposals (“-” for losses) II. Operating profit (“-” for loss) -46,062,190.85 74,836,699.13 Add: Non-operating income 445,377.10 Less: Non-operating expenses 4,540,587.73 4,409,866.22 III. Profit before income tax (“-” for loss) -50,602,778.58 70,872,210.01 Less: Income tax expense IV. Net profit for the year (“-” for net loss) -50,602,778.58 70,872,210.01 (1) Net profit from continuing operations (“-” for net loss) -50,602,778.58 70,872,210.01 (2) Net profit from discontinued operations (“-” for net loss) V. Other comprehensive income, net of tax (1) Items that will not be reclassified to profit or loss: 1. Remeasurement of defined benefit plan 2. Other comprehensive income recognised under equity method 3. Changes in fair value of investments in other equity instruments 4. Changes in fair value of entity’s own credit risk 5. Others (2) Items that may be reclassified to profit or loss 1. Other comprehensive income recognised under equity method 2. Changes in fair value of other debt investments 3. The amount of financial assets reclassified to other
comprehensive income 4. Credit losses of debt investments 5. Cash flow hedge reserve 6. Translation differences arising from translation of foreign
7 currency financial statements 7. Others VI. Total comprehensive income for the year -50,602,778.58 70,872,210.01 VII. Earnings per share: (1) Basic earnings per share (2) Diluted earnings per share
5 Consolidated cash flow statement
Expressed in Renminbi Yuan Six months of Six months of Item 2020 2019 I. Cash flows from operating activities: Proceeds from sale of goods and rendering of services 1,938,602,106.68 2,950,391,800.81 Net increase in deposits from customers and other banks Net increase in borrowings from the central bank Net increase in loans from other financial institutions Proceeds from receiving the premiums of direct insurance contracts Net proceeds from reinsurance business Net increase in deposits of policyholders and investments Proceeds from interest, fee and commission Net increase in loans from banks and other financial institutions Net increase in funds of repo business Net proceeds from securities brokerage Refund of taxes 134,055.70 Proceeds from other operating activities 281,788,474.12 87,283,759.63 Sub-total of cash inflows 2,220,390,580.80 3,037,809,616.14 Payment for goods and services 873,918,286.62 1,177,312,138.73 Net increase in loans and advances to customers Net increase in deposits in the central bank and other banks Payment for the claims on direct insurance contracts Net increase in lendings to banks and other financial institutions Payment for interest, fee and commission Payment for policy dividends Payment to and for employees 1,242,126,399.04 1,771,443,962.32 Payment of various taxes 198,787,814.82 163,957,782.83 Payment for other operating activities 636,447,688.75 528,620,767.58 Sub-total of cash outflows 2,951,280,189.23 3,641,334,651.46 Net cash flow from operating activities -730,889,608.43 -603,525,035.32 II. Cash flows from investing activities: Proceeds from disposal of investments 0.00 11,054,478.50 Investment returns received 40,893,041.50 38,645,254.30 Net proceeds from disposal of fixed assets, intangible assets and other long- 14,598,688.83 1,512,163.12 term assets Net proceeds from disposal of subsidiaries and other business units Proceeds from other investing activities 244,119,589.74 258,126,022.31 Sub-total of cash inflows 299,611,320.07 309,337,918.23
8 Payment for acquisition of fixed assets, intangible assets and other long- 101,838,251.25 251,021,291.56 term assets Payment for acquisition of investments 394,342,816.34 195,811,054.28 Net increase in pledged loans Net payment for acquisition of subsidiaries and other business units 48,532,500.00 235,777,930.82 Payment for other investing activities 64,871,674.45 611,156,865.92 Sub-total of cash outflows 609,585,242.04 1,293,767,142.58 Net cash flow from investing activities -309,973,921.97 -984,429,224.35 III. Cash flows from financing activities: Proceeds from investors 96,141,000.00 1,151,000.00 Including: Proceeds from non-controlling shareholders of subsidiaries 96,141,000.00 1,151,000.00 Proceeds from borrowings 2,151,335,623.83 4,053,973,763.55 Proceeds from issuance of debentures 1,333,670,832.17 Proceeds from other financing activities 71,988,537.99 40,850,000.00 Sub-total of cash inflows 2,319,465,161.82 5,429,645,595.72 Repayments of borrowings 3,147,879,450.78 3,650,945,763.59 Payment for dividends, profit distributions or interest 338,631,720.11 245,072,185.25 Including: Dividends and profits paid to non-controlling shareholders of 46,367,360.81 46,779,766.05 subsidiaries Payment for other financing activities 38,763,788.47 349,084,797.85 Sub-total of cash outflows 3,525,274,959.36 4,245,102,746.69 Net cash flow from financing activities -1,205,809,797.54 1,184,542,849.03 IV. Effect of foreign exchange rate changes on cash and cash equivalents 1,688,636.46 -11,700,188.86 V. Net increase in cash and cash equivalents -2,244,984,691.48 -415,111,599.50 Add: Cash and cash equivalents at the beginning of the period 4,696,002,147.05 2,390,222,654.49 VI. Cash and cash equivalents at the end of the period 2,451,017,455.57 1,975,111,054.99
9 6 Company cash flow statement
Expressed in Renminbi Yuan Six months of Six months of Item 2020 2019 I. Cash flows from operating activities: Proceeds from sale of goods and rendering of services 31,004,886.43 7,350,000.00 Refund of taxes Proceeds from other operating activities 297,042,596.39 1,353,998,880.83 Sub-total of cash inflows 328,047,482.82 1,361,348,880.83 Payment for goods and services 2,924,203.59 149,600.00 Payment to and for employees 10,332,698.11 659,333.06 Payment of various taxes 1,359.90 13,928.10 Payment for other operating activities 541,713,569.44 533,857,410.38 Sub-total of cash outflows 554,971,831.04 534,680,271.54 Net cash flow from operating activities -226,924,348.22 826,668,609.29 II. Cash flows from investing activities: Proceeds from disposal of investments 26,097,675.52 Investment returns received 102,541,666.67 308,522,311.11 Net proceeds from disposal of fixed assets, intangible assets and other long-
term assets Net proceeds from disposal of subsidiaries and other business units Proceeds from other investing activities Sub-total of cash inflows 128,639,342.19 308,522,311.11 Payment for acquisition of fixed assets, intangible assets and other long- 717,223.89 1,859,980.54 term assets Payment for acquisition of investments 900,000.00 835,505,000.00 Net payment for acquisition of subsidiaries and other business units Payment for other investing activities Sub-total of cash outflows 1,617,223.89 837,364,980.54 Net cash flow from investing activities 127,022,118.30 -528,842,669.43 III. Cash flows from financing activities: Proceeds from investors Proceeds from borrowings Proceeds from other financing activities 72,676,837.99 Sub-total of cash inflows 72,676,837.99 Repayments of borrowings 900,000,000.00 Payment for dividends, profit distributions or interest 41,175,832.58 61,290,763.90 Payment for other financing activities 17,996,518.84 156,648,939.60 Sub-total of cash outflows 959,172,351.42 217,939,703.50 Net cash flow from financing activities -886,495,513.43 -217,939,703.50 IV. Effect of foreign exchange rate changes on cash and cash equivalents 9,139,920.25 V. Net increase in cash and cash equivalents -986,397,743.35 89,026,156.61 Add: Cash and cash equivalents at the beginning of the period 1,641,522,730.76 67,417,904.15 VI. Cash and cash equivalents at the end of the period 655,124,987.41 156,444,060.76
10 7 Consolidated statement of changes in owners’ equity
Current period Expressed in Renminbi Yuan
Six months of 2020 Non-controlling Attributable to owners of the Company Total interests Other equity instruments
Item
Other General
Less: Treasury Specific Surplus
Share capital Capital reserve comprehensive risk Retained earnings Others Sub-total shares reserve reserve
income reserve
shares Others
Preference Perpetualbonds
I. Balance at the end of the 3,919,920,974 2,439,936,041.00 300,055,044.16 -379,371.01 71,934,339.69 1,184,276,684.09 7,315,633,623.61 838,388,027.72 8,154,021,651.33 previous period Add: Changes in accounting
policies Corrections of prior period
errors Business combination involving entities under common control Others II. Balance at the beginning of the 3,919,920,974 2,439,936,041.00 300,055,044.16 -379,371.01 71,934,339.69 1,184,276,684.09 7,315,633,623.61 838,388,027.72 8,154,021,651.33 period III. Changes in equity during the 71,988,537.99 -1,340,948.05 -782,386,107.24 -711,738,517.30 -9,869,488.33 -721,608,005.63 period (“-” for decreases) 1. Total comprehensive income -1,340,948.05 -782,386,107.24 -783,727,055.29 -66,316,891.38 -850,043,946.67 2. Owners’ contributions and 71,988,537.99 71,988,537.99 102,814,763.85 174,803,301.84 decrease of capital (1) Ordinary shares contributed by 96,141,000.00 96,141,000.00 owners (2) Contribution by holders of other
equity instruments (3) Equity-settled share-based
payments (4) Others 71,988,537.99 71,988,537.99 6,673,763.85 78,662,301.84 3. Appropriation of profits -46,367,360.80 -46,367,360.80 (1) Appropriation for surplus
reserve
11 (2) Appropriation to general risk
reserve (3) Distributions to owners (or -46,367,360.80 -46,367,360.80 shareholders) (4) Others 4. Transfers within equity (1) Capital (or share capital) increased by capital reserve transfer (2) Capital (or share capital) increased by surplus reserve transfer (3) Transfer of surplus reserve to
offset losses (4) Changes arising from defined benefit plan transferred to retained earnings (5) Transfer of other comprehensive income to retained earnings (6) Others 5. Specific reserve (1) Appropriation during the period (2) Utilisation during the period 6. Others IV. Balance at the end of the period 3,919,920,974 2,511,924,578.99 300,055,044.16 -1,720,319.06 71,934,339.69 401,890,576.85 6,603,895,106.31 828,518,539.39 7,432,413,645.70
12 Prior period Expressed in Renminbi Yuan
Six months of 2019 Attributable to owners of the Company Other equity instruments
Item Other General Non-controlling
Less: Treasury Specific Surplus Total
Share capital Capital reserve comprehensiv risk Retained earnings Others Sub-total interests shares reserve reserve
e income reserve
shares Others
Preference Perpetualbonds
I. Balance at the end of the 3,121,566,956 1,331,871,192.64 83,515,021.33 518,850.52 71,934,339.69 2,123,783,947.53 6,566,160,265.05 729,506,976.46 7,295,667,241.51 previous period Add: Changes in accounting 7,557,690.00 7,557,690.00 147,055.00 7,704,745.00 policies Corrections of prior
period errors Business combination involving entities under common control Others II. Balance at the beginning 3,121,566,956 1,331,871,192.64 83,515,021.33 518,850.52 71,934,339.69 2,131,341,637.53 6,573,717,955.05 729,654,031.46 7,303,371,986.51 of the period III. Changes in equity during the period (“-” for -100,673,024.52 130,087,955.72 -229,729.53 -148,255,091.67 -379,245,801.44 26,950,897.56 -352,294,903.88 decreases) 1. Total comprehensive -229,729.53 16,837,786.00 16,608,056.47 28,122,211.24 44,730,267.71 income 2. Owners’ contributions and -100,673,024.52 130,087,955.72 -230,760,980.24 51,381,421.20 -179,379,559.04 decrease of capital (1) Ordinary shares 1,151,000.00 1,151,000.00 contributed by owners (2) Contribution by holders of
other equity instruments (3) Equity-settled share-based
payments (4) Others -100,673,024.52 130,087,955.72 -230,760,980.24 50,230,421.20 -180,530,559.04 3. Appropriation of profits -165,092,877.67 -165,092,877.67 -52,552,734.88 -217,645,612.55 (1) Appropriation for surplus
reserve
13 (2) Appropriation to general
risk reserve (3) Distributions to owners (or -165,092,877.67 -165,092,877.67 -52,552,734.88 -217,645,612.55 shareholders) (4) Others 4. Transfers within equity (1) Capital (or share capital) increased by capital reserve transfer (2) Capital (or share capital) increased by surplus reserve transfer (3) Transfer of surplus reserve
to offset losses (4) Changes arising from defined benefit plan
transferred to retained earnings (5) Transfer of other comprehensive income to retained earnings (6) Others 5. Specific reserve (1) Appropriation during the
period (2) Utilisation during the
period 6. Others IV. Balance at the end of the 3,121,566,956 1,231,198,168.12 213,602,977.05 289,120.99 71,934,339.69 1,983,086,545.86 6,194,472,153.61 756,604,929.02 6,951,077,082.63 period
14 8 Company statement of changes in owners’ equity
Current period Expressed in Renminbi Yuan
Six months of 2020
Other equity instruments
Item Less: Treasury Retained Share capital Capital reserve Surplus reserve Others Total shares earnings
Others Other
income
bonds
shares
Perpetual
Preference
comprehensive Specificreserve
I. Balance at the end of the previous period 3,919,920,974 6,254,583,180.37 300,055,044.16 136,626,800.32 98,479,736.98 10,109,555,647.51 Add: Changes in accounting policies Corrections of prior period errors Others II. Balance at the beginning of the period 3,919,920,974 6,254,583,180.37 300,055,044.16 136,626,800.32 98,479,736.98 10,109,555,647.51 III. Changes in equity during the period (“-” for 71,988,537.99 -50,602,778.58 21,385,759.41 decreases) 1. Total comprehensive income -50,602,778.58 -50,602,778.58 2. Owners’ contributions and decrease of capital 71,988,537.99 71,988,537.99 (1) Ordinary shares contributed by owners (2) Contribution by holders of other equity
instruments (3) Equity-settled share-based payments (4) Others 71,988,537.99 71,988,537.99 3. Appropriation of profits (1) Appropriation for surplus reserve (2) Distributions to owners (or shareholders) (3) Others 4. Transfers within equity (1) Capital (or share capital) increased by capital
reserve transfer (2) Capital (or share capital) increased by surplus
reserve transfer (3) Transfer of surplus reserve to offset losses
15 (4) Changes arising from defined benefit plan
transferred to retained earnings (5) Transfer of other comprehensive income to
retained earnings (6) Others 5. Specific reserve (1) Appropriation during the period (2) Utilisation during the period 6. Others IV. Balance at the end of the period 3,919,920,974 6,326,571,718.36 300,055,044.16 136,626,800.32 47,876,958.40 10,130,941,406.92 Prior period Expressed in Renminbi Yuan
Six months of 2019
Other equity instruments
Other
Item Less: Treasury compreh Retained Share capital Capital reserve Surplus reserve Others Total shares ensive earnings
bonds income
shares Others
Perpetual
Preference Specificreserve
I. Balance at the end of the previous period 3,121,566,956 5,047,465,527.61 83,515,021.33 136,626,800.32 252,638,671.77 8,474,782,934.37 Add: Changes in accounting policies Corrections of prior period errors Others II. Balance at the beginning of the period 3,121,566,956 5,047,465,527.61 83,515,021.33 136,626,800.32 252,638,671.77 8,474,782,934.37 III. Changes in equity during the period (“-” for 130,087,955.72 -94,666,044.76 -224,754,000.48 decreases) 1. Total comprehensive income 70,872,210.01 70,872,210.01 2. Owners’ contributions and decrease of capital 130,087,955.72 -130,087,955.72 (1) Ordinary shares contributed by owners (2) Contribution by holders of other equity
instruments (3) Equity-settled share-based payments (4) Others 130,087,955.72 -130,087,955.72 3. Appropriation of profits -165,092,877.67 -165,092,877.67 (1) Appropriation for surplus reserve
16 (2) Distributions to owners (or shareholders) -165,092,877.67 -165,092,877.67 (3) Others 4. Transfers within equity (1) Capital (or share capital) increased by capital
reserve transfer (2) Capital (or share capital) increased by surplus
reserve transfer (3) Transfer of surplus reserve to offset losses (4) Changes arising from defined benefit plan
transferred to retained earnings (5) Transfer of other comprehensive income to
retained earnings (6) Others 5. Specific reserve (1) Appropriation during the period (2) Utilisation during the period 6. Others -445,377.10 -445,377.10 IV. Balance at the end of the period 3,121,566,956 5,047,465,527.61 213,602,977.05 136,626,800.32 157,972,627.01 8,250,028,933.89
17 III. Company status
Meinian Onehealth Healthcare Holdings Co., Ltd. (“the Company”, “Company”, “the Group”, or "Meinian
Healthcare"), formerly known as Jiangsu Sanyou Group Co., Ltd., was incorporated by conducting the overall change based on the merger with Nantong Sanhe Fashion Co., Ltd. The Company was established on 22 January 1991. As at 31 December 2014, the registered capital and paid-in capital of the Company was RMB 224,250,000.
Pursuant to the profit distribution plan approved by the annual general meeting of shareholders for 2014 in its resolutions, the Company issued 2.4 bonus shares for every 10 shares to its shareholders based on its total share capital of 224,250,000 shares on 3 June 2015. After the profit distribution, the
Company’s total share capital was increased to RMB 278,070,000.
According to the Reply on Approving of Jiangsu Sanyou Group Co., Ltd. Conducting the Material Asset
Restructuring and Issuing Shares to Companies Including Shanghai Tianyi Investment (Group) Co.,
Ltd. for Acquiring Assets and Raising Supporting funds (CSRC Permits No.1718 [2015]), which was approved and issued by the China Securities Regulatory Commission (“CSRC”) on 20 July 2015,
Jiangsu Sanyou Group Co., Ltd. ("Jiangsu Sanyou") issued shares to the original shareholders of
Meinian Onehealth Healthcare (Group) Co., Ltd. (“Meinian Onehealth”), including 24 institutional shareholders such as Shanghai Tianyi Investment (Group) Co., Ltd. (“Tianyi Investment”) and 79 individual shareholders including Yu Rong and Xu Ke for acquisition of assets (“the material replacement of assets and issuance of shares for acquisition of assets"). As at 10 August 2015, the above original shareholders of Meinian Onehealth have completed equity transfer registration formalities for the equity transferred to the Company. After the material replacement of assets and issuance of shares for acquisition of assets, the share capital increased by RMB 919,342,463 and the
Company’s total share capital was increased to RMB 1,197,412,463.
As approved under the above document, CSRC Permits No.1718 [2015], the number of ordinary shares
(A shares) issued through private placement for raising supporting funds should not exceed
60,975,609. As at 25 August 2015, the Company has issued 13,328,890 Renminbi ordinary shares for raising supporting funds, and after the capital increase, the Company’s total share capital was increased to RMB 1,210,741,353.
18 Pursuant to the profit distribution plan approved by the annual general meeting of shareholders for 2015 in its resolutions, 10 shares were issued for every 10 shares to all shareholders by capital reserve transfer based on the total share capital of 121,074.1353 shares on 13 June 2016. After the capital increase by transfer, the Company’s total share capital was increased to RMB 2,421,482,706.
Pursuant to the resolution of its second extraordinary general meeting of shareholders for 2016 and the
Reply of the China Securities Regulatory Commission (“CSRC”) on Approving of Meinian Onehealth
Healthcare Holdings Co., Ltd. Issuing Shares to Companies Including Shanghai Weitu Investment
Centre (L.P.) for Acquiring Assets and Raising Supporting funds (CSRC Permits No.1764 [2017]), the
Company issued 86,677,923 shares to Shanghai Weitu Investment Centre (L.P.), 59,383,728 shares to Shanghai Tianyi Asset Management Co., Ltd. and 4,800,623 shares to Beijing Dongsheng Kangye
Investment Consulting Co., Ltd. for acquiring equity interests in Ciming Health Checkup Management
Group Co., Ltd. ("Ciming Checkup"). As at 11 October 2017, the share capital increased by RMB
150,862,274 due to the issuance of shares for acquisition of assets. After the capital increase, the
Company’s total share capital was increased to RMB 2,572,344,980.
As approved under the above document, CSRC Permits No.1764 [2017], the number of shares issued through private placement should not exceed 39,906,103 for raising supporting funds for issuance of shares and acquisition of assets. As at 6 November 2017, the Company has issued 28,960,817
Renminbi ordinary shares through private placement, and after the capital increase, the Company’s total share capital was increased to RMB 2,601,305,797.
Pursuant to the annual general meeting of shareholders for 2017 in its resolutions, 2 shares were issued for every 10 shares to all shareholders by capital reserve transfer based on the total share capital of 2,601,305,797 shares on 15 May 2018. After the capital increase by transfer, the Company’s total share capital was increased to RMB 3,121,566,956.
According to the profit distribution plan and the implementation plan of interest distribution approved at the annual general meeting of shareholders for 2018, on 17 May 2019, the Company declared and paid a cash dividend of RMB 0.53 (including tax) for every 10 shares to all of its shareholders and issued 2 shares for every 10 shares by capital reserve transfer on the distribution basis of its total share capital of 3,106,073,126 shares (which was calculated by deducting 15,493,830 repurchased shares in the special account of repurchase from the previous total share capital of 3,121,566,956 shares). After the capital increase by transfer, the Company’s total share capital was increased to RMB 3,742,781,581.
19 Pursuant to the resolution of its second extraordinary general meeting of shareholders for 2019 and the
Reply of the China Securities Regulatory Commission on Approving the Private Placement of Shares of
Meinian Onehealth Healthcare Holdings Co., Ltd. (CSRC Permits No.1556 [2019]), the Company issued 158,957,575 shares to Alibaba (China) Technology Co., Ltd. and 18,181,818 shares to Bosera
Asset Management Co., Ltd. for acquisition of equity interests in Meinian Onehealth Healthcare
Holdings Co., Ltd. ("Meinian Healthcare"). As at 28 October 2019, the Company has issued
177,139,393 Renminbi ordinary shares through private placement, and after the capital increase, the
Company’s total share capital was increased to RMB 3,919,920,974.
The unified social credit code of the Company is 91320600608304061J, and the registered address is
No. 218, Renmin East Road, Nantong, Jiangsu Province. The legal representative of the Company is
Yu Rong.
The business scope of the Company includes technological development, technology consulting, technical transformation and technical services within the professional field of medical technology; investment management; health management consulting (it should not be engaged in medical activities and psychological consulting), etc. (For business activities subject to approval in accordance with laws and regulations, operations may be conducted only with the approval of the relevant government authorities.)
The financial statements have been authorised for issuance by the Board of Directors of the Company on 27 August 2020.
The Company and its subsidiaries are mainly engaged in health examinations.
282 subsidiaries have been included in the consolidation scope of the Company from January to June
2020. For details, refer to Note IX - Interests in other entities. With respect to the consolidation scope of the Company, 7 new entities were included during the period. For details, refer to Note VIII - Change of consolidation scope.
20 IV. Basis of preparation
1 Basis of preparation
The consolidated financial statements of the Company and its subsidiaries (“the Group”) have been prepared on the going concern basis in accordance with the actual transactions and events, the basis of preparation, significant accounting policies and accounting estimates described below. Please refer to the relevant notes on accounting policies.
Since 1 January 2019, the Group has adopted the revised “Accounting Standard for Business
Enterprises No. 22 – Financial Instruments: Recognition and Measurement” and related new financial instruments standards issued by the Ministry of Finance (“MOF”) of the People’s Republic of China in
2017 (see Note V.10). Since 1 January 2020, the Group has adopted the revised “Accounting Standard for Business Enterprises No. 14 – Revenue” and related new revenue standards issued by the MOF in
2017 (see Note V.44(1)).
The Group has not adopted the revised “Accounting Standard for Business Enterprises No. 21 –
Leases” issued by the MOF in 2018.
2 Going concern
According to the Company’s assessment, the Company has a good ability to continue as a going concern within 12 months from the end of the current reporting period, and there are no factors that may cast significant doubt on the Company’s ability to continue as a going concern.
V. Significant accounting policies and accounting estimates
A reminder of specific accounting policies and accounting estimates:
The Company and its subsidiaries are engaged in technology development, consulting and technical services investment management, and health management consulting within the professional field of health examination and medical technology, and investment management, health management consulting, etc. Accounting policies for the recognition and measurement of provisions for receivables, depreciation of fixed assets and revenue recognition and measurement of the Group are adopted according to the specific characteristics of the Company’s operations. Please refer to the relevant notes on accounting policies.
21 1 Statement of compliance
The financial statements have been prepared in accordance with the requirements of Accounting
Standards for Business Enterprises or referred to as China Accounting Standards (“CAS”) issued by the
MOF. These financial statements present truly and completely the consolidated financial position and financial position of the Company as at 30 June 2020, and the consolidated financial performance and financial performance and the consolidated cash flows and cash flows of the Company for the six months ended 30 June 2020.
These financial statements also comply with the disclosure requirements of “Regulation on the
Preparation of Information Disclosures by Companies Issuing Securities, No. 15: General
Requirements for Financial Reports” as revised by the China Securities Regulatory Commission
(“CSRC”) in 2014.
2 Accounting period
The accounting period is from 1 January to 31 December.
3 Operating cycle
The operating cycle of the Company is 12 months.
4 Functional currency
The Company’s functional currency is Renminbi and these financial statements are presented in
Renminbi. Functional currency is determined by the Company and its subsidiaries on the basis of the currency in which major income and costs are denominated and settled. Some of the Company’s subsidiaries have functional currencies that are different from the Company’s functional currency. Their financial statements have been translated based on the accounting policy set out in Note V.9.
22 5 Accounting treatments for business combinations involving entities under common control and not under common control
(1) Business combinations involving entities under common control
A business combination involving entities under common control is a business combination in which all of the combining entities are ultimately controlled by the same party or parties both before and after the business combination, and that control is not transitory. The assets acquired and liabilities assumed are measured based on their carrying amounts in the consolidated financial statements of the ultimate controlling party at the combination date. The difference between the carrying amount of the net assets acquired and the consideration paid for the combination (or the total par value of shares issued) is adjusted against share premium in the capital reserve, with any excess adjusted against retained earnings. Any costs directly attributable to the combination is recognised in profit or loss when incurred.
The combination date is the date on which one combining enterprise obtains control of other combining entities.
(2) Business combinations involving entities not under common control
A business combination not involving entities under common control is a business combination in which all of the combining entities are not ultimately controlled by the same party or parties both before and after the business combination. Where (1) the aggregate of the acquisition-date fair value of assets transferred (including the acquirer’s previously held equity interest in the acquiree), liabilities incurred or assumed, and equity securities issued by the acquirer, in exchange for control of the acquiree, exceeds
(2) the acquirer’s interest in the acquisition-date fair value of the acquiree’s identifiable net assets, the difference is recognised as goodwill. If (1) is less than (2), the difference is recognised in profit or loss for the current period. The costs of issuing equity or debt securities as a part of the consideration for the acquisition are included in the carrying amounts of these equity or debt securities upon initial recognition. Other acquisition-related costs are expensed when incurred. Any difference between the fair value and the carrying amount of the assets transferred as consideration is recognised in profit or loss. The acquiree’s identifiable assets, liabilities and contingent liabilities, if the recognition criteria are met, are recognised by the Group at their acquisition-date fair value. The acquisition date is the date on which the acquirer obtains control of the acquiree.
23 For a business combination involving entities not under common control and achieved in stages, the
Group remeasures its previously-held equity interest in the acquiree to its acquisition-date fair value and recognises any resulting difference between the fair value and the carrying amount as investment income or other comprehensive income for the current period. In addition, any amount recognised in other comprehensive income and other changes in the owners’ equity under equity accounting in prior reporting periods relating to the previously-held equity interest that may be reclassified to profit or loss are transferred to investment income at the date of acquisition; Any previously-held equity interest that is designated as equity investment at fair value through other comprehensive income, the other comprehensive income recognised in prior reporting periods is transferred to retained earnings and surplus reserve at the date of acquisition.
6 Consolidated financial statements
(1) General principles
The scope of consolidated financial statements is based on control and the consolidated financial statements comprise the Company and the subsidiaries it controlled. Control exists when the investor has all of following: power over the investee; exposure, or rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. When assessing whether the Group has power, only substantive rights (held by the Group and other parties) are considered. The financial position, financial performance and cash flows of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.
Non-controlling interests are presented separately in the consolidated balance sheet within shareholders’ equity. Net profit or loss attributable to non-controlling shareholders is presented separately in the consolidated income statement below the net profit line item. Total comprehensive income attributable to non-controlling shareholders is presented separately in the consolidated income statement below the total comprehensive income line item.
When the amount of loss for the current period attributable to the non-controlling shareholders of a subsidiary exceeds the non-controlling shareholders’ share of the opening owners’ equity of the subsidiary, the excess is still allocated against the non-controlling interests.
24 When the accounting period or accounting policies of a subsidiary are different from those of the
Company, the Company makes necessary adjustments to the financial statements of the subsidiary based on the Company’s own accounting period or accounting policies. Intra-group balances and transactions, and any unrealised profit or loss arising from intra-group transactions, are eliminated when preparing the consolidated financial statements. Unrealised losses resulting from intra-group transactions are eliminated in the same way as unrealised gains, unless they represent impairment losses that are recognised in the financial statements.
(2) Subsidiaries acquired through a business combination
Where a subsidiary was acquired during the reporting period, through a business combination involving entities under common control, the financial statements of the subsidiary are included in the consolidated financial statements based on the carrying amounts of the assets and liabilities of the subsidiary in the financial statements of the ultimate controlling party as if the combination had occurred at the date that the ultimate controlling party first obtained control. The opening balances and the comparative figures of the consolidated financial statements are also restated.
Where a subsidiary was acquired during the reporting period, through a business combination not involving entities under common control, the identifiable assets and liabilities of the acquired subsidiaries are included in the scope of consolidation from the date that control commences, based on the fair value of those identifiable assets and liabilities at the acquisition date.
(3) Disposal of subsidiaries
When the Group loses control over a subsidiary, any resulting disposal gains or losses are recognised as investment income for the current period. The remaining equity investment is re-measured at its fair value at the date when control is lost, any resulting gains or losses are also recognised as investment income for the current period.
(4) Changes in non-controlling interests
Where the Company acquires a non-controlling interest from a subsidiary’s non-controlling shareholders or disposes of a portion of an interest in a subsidiary without a change in control, the difference between the proportion interests of the subsidiary’s net assets being acquired or disposed and the amount of the consideration paid or received is adjusted to the capital reserve (share premium) in the consolidated balance sheet, with any excess adjusted to retained earnings.
25 7 Classification of joint arrangements and accounting treatments for joint operation
8 Cash and cash equivalents
Cash and cash equivalents comprise cash on hand, deposits that can be readily withdrawn on demand, and short-term, highly liquid investments that are readily convertible into known amounts of cash and are subject to an insignificant risk of change in value.
9 Foreign currency transactions and translation of foreign currency financial statements
When the Group receives capital in foreign currencies from investors, the capital is translated to
Renminbi at the spot exchange rate at the date of the receipt. Other foreign currency transactions are, on initial recognition, translated to Renminbi at the spot exchange rates on the dates of the transactions.
Monetary items denominated in foreign currencies are translated to Renminbi at the spot exchange rate at the balance sheet date. The resulting exchange differences are generally recognised in profit or loss, unless they arise from the re-translation of the principal and interest of specific borrowings for the acquisition and construction of qualifying assets (see Note V.26). Non-monetary items that are measured at historical cost in foreign currencies are translated to Renminbi using the exchange rate at the transaction date. Non-monetary items that are measured at fair value in foreign currencies are translated using the exchange rate at the date the fair value is determined. The resulting exchange differences are recognised in profit or loss, except for the differences arising from the re-translation of equity investments at fair value through other comprehensive income, which are recognised in other comprehensive income.
In translating the financial statements of a foreign operation, assets and liabilities of foreign operation are translated to Renminbi at the spot exchange rate at the balance sheet date. Equity items, excluding retained earnings and translation differences arising from translation of foreign currency financial statements recognised in other comprehensive income, are translated to Renminbi at the spot exchange rates at the transaction dates. Income and expenses of foreign operation are translated to
Renminbi at the spot exchange rates at the transaction dates. The resulting translation differences are recognised in other comprehensive income. The translation differences accumulated in other comprehensive income with respect to a foreign operation are transferred to profit or loss in the period
26 when the foreign operation is disposed.
10 Financial instruments
Financial instruments include cash at bank and on hand, investments in equity securities other than those classified as long-term equity investments (see Note V.22), receivables, payables, loans and borrowings, debentures payable and share capital.
(1) Recognition and initial measurement of financial assets and financial liabilities
A financial asset or financial liability is recognised in the balance sheet when the Group becomes a party to the contractual provisions of a financial instrument.
A financial asset (unless it is a trade receivable without a significant financing component) and financial liabilities is measured initially at fair value. For financial assets and financial liabilities at fair value through profit or loss, any related directly attributable transaction costs are charged to profit or loss; for other categories of financial assets and financial liabilities, any related directly attributable transaction costs are included in their initial costs. A trade receivable without a significant financing component is initially measured at the transaction price according to Note
V.39.
(2) Classification and subsequent measurement of financial assets
(a) Classification of financial assets
The classification of financial assets is generally based on the business model in which a
financial asset is managed and its contractual cash flow characteristics. On initial recognition,
a financial asset is classified as measured at amortised cost, at fair value through other
comprehensive income (“FVOCI”), or at fair value through profit or loss (“FVTPL”).
Financial assets are not reclassified subsequent to their initial recognition unless the Group
changes its business model for managing financial assets in which case all affected financial
assets are reclassified on the first day of the first reporting period following the change in the
business model.
27 A financial asset is measured at amortised cost if it meets both of the following conditions and is not designated as at FVTPL:
- it is held within a business model whose objective is to hold assets to collect contractual
cash flows; and
- its contractual terms give rise on specified dates to cash flows that are solely payments
of principal and interest on the principal amount outstanding.
A debt investment is measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:
- it is held within a business model whose objective is achieved by both collecting
contractual cash flows and selling financial assets; and
- its contractual terms give rise on specified dates to cash flows that are solely payments
of principal and interest on the principal amount outstanding.
On initial recognition of an equity investment that is not held for trading, the Group may irrevocably elect to present subsequent changes in the investment’s fair value in other comprehensive income. This election is made on an investment-by-investment basis. The instrument meets the definition of equity from the perspective of the issuer.
All financial assets not classified as measured at amortised cost or FVOCI as described above are measured at FVTPL. On initial recognition, the Group may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortised cost or at
FVOCI as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.
The business model refers to how the Group manages its financial assets in order to generate cash flows. That is, the Group’s business model determines whether cash flows will result from collecting contractual cash flows, selling financial assets or both. The Group determines the business model for managing the financial assets according to the facts and based on the specific business objective for managing the financial assets determined by the
Group’s key management personnel.
28 In assessing whether the contractual cash flows are solely payments of principal and interest, the Group considers the contractual terms of the instrument. For the purposes of this assessment, ‘principal’ is defined as the fair value of the financial asset on initial recognition. ‘Interest’ is defined as consideration for the time value of money and for the credit risk associated with the principal amount outstanding during a particular period of time and for other basic lending risks and costs, as well as a profit margin. The Group also assesses whether the financial asset contains a contractual term that could change the timing or amount of contractual cash flows such that it would not meet this condition.
(b) Subsequent measurement of financial assets
- Financial assets at fair value through profit or loss
These financial assets are subsequently measured at fair value. Net gains and losses,
including any interest or dividend income, are recognised in profit or loss unless the
financial assets are part of a hedging relationship.
- Financial assets at amortised cost
These assets are subsequently measured at amortised cost using the effective interest
method. A gain or loss on a financial asset that is measured at amortised cost and is not
part of a hedging relationship shall be recognised in profit or loss when the financial asset
is derecognised, through the amortisation process or in order to recognise impairment
gains or losses.
- Debt investments at FVOCI
These assets are subsequently measured at fair value. Interest income calculated using
the effective interest method, impairment and foreign exchange gains and losses are
recognised in profit or loss. Other net gains and losses are recognised in other
comprehensive income. On derecognition, gains and losses accumulated in other
comprehensive income are reclassified to profit or loss.
- Equity investments at FVOCI
These assets are subsequently measured at fair value. Dividends are recognised as
income in profit or loss. Other net gains and losses are recognised in other
comprehensive income. On derecognition, gains and losses accumulated in other
comprehensive income are reclassified to retained earnings.
29 (3) Classification and subsequent measurement of financial liabilities
Financial liabilities are classified as measured at FVTPL or amortised cost by the Group.
- Financial liabilities at fair value through profit or loss
A financial liability is classified as at FVTPL if it is classified as held-for-trading (including
derivative financial liability) or it is designated as such on initial recognition.
Financial liabilities at FVTPL are subsequently measured at fair value and net gains and losses,
including any interest expense, are recognised in profit or loss, unless the financial liabilities are
part of a hedging relationship.
- Financial liabilities at amortised cost
These financial liabilities are subsequently measured at amortised cost using the effective
interest method.
(4) Offsetting
Financial assets and financial liabilities are generally presented separately in the balance sheet and are not offset. However, a financial asset and a financial liability are offset and the net amount is presented in the balance sheet when both of the following conditions are satisfied:
- the Group currently has a legally enforceable right to set off the recognised amounts; and
- the Group intends either to settle on a net basis, or to realise the financial asset and settle the
financial liability simultaneously.
(5) Derecognition of financial assets and financial liabilities
A financial asset is derecognised when one of the following conditions is met:
- the Group’s contractual rights to the cash flows from the financial asset expire;
- the financial asset has been transferred and the Group transfers substantially all of the risks
and rewards of ownership of the financial asset; or
- the financial asset has been transferred, although the Group neither transfers nor retains
substantially all of the risks and rewards of ownership of the financial asset, it does not retain
control over the transferred asset.
30 Where a transfer of a financial asset in its entirety meets the criteria for derecognition, the difference between the two amounts below is recognised in profit or loss:
- the carrying amount of the financial asset transferred measured at the date of derecognition;
- the sum of the consideration received from the transfer and, when the transferred financial
asset is a debt investment at FVOCI, any cumulative gain or loss that has been recognised
directly in other comprehensive income for the part derecognised.
The Group derecognises a financial liability (or part of it) only when its contractual obligation (or part of it) is extinguished.
(6) Impairment
The Group recognises loss allowances for expected credit loss (ECL) on:
- financial assets measured at amortised cost;
- lease receivables.
Financial assets measured at fair value, including debt investments or equity securities at FVPL, equity securities designated at FVOCI and derivative financial assets, are not subject to the ECL assessment.
Measurement of ECLs
ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of all cash shortfalls (i.e. the difference between the cash flows due to the entity in accordance with the contract and the cash flows that the Group expects to receive).
The maximum period considered when estimating ECLs is the maximum contractual period
(including extension options) over which the Group is exposed to credit risk.
Lifetime ECLs are the ECLs that result from all possible default events over the expected life of a financial instrument.
12-month ECLs are the portion of ECLs that result from default events that are possible within the
12 months after the balance sheet date (or a shorter period if the expected life of the instrument is less than 12 months).
31 Loss allowances for trade receivables and lease receivables are always measured at an amount equal to lifetime ECL. ECLs on these financial assets are estimated using a provision matrix based on the Group’s historical credit loss experience, adjusted for factors that are specific to the debtors and an assessment of both the current and forecast general economic conditions at the balance sheet date.
Except for trade receivables and lease receivables, the Group measures loss allowance at an amount equal to 12-month ECL for the following financial instruments, and at an amount equal to lifetime ECL for all other financial instruments.
- If the financial instrument is determined to have low credit risk at the balance sheet date; or
- If the credit risk on a financial instrument has not increased significantly since initial
recognition.
Financial instruments that have low credit risk
The credit risk on a financial instrument is considered low if the financial instrument has a low risk of default, the borrower has a strong capacity to meet its contractual cash flow obligations in the near term and adverse changes in economic and business conditions in the longer term may, but will not necessarily, reduce the ability of the borrower to fulfil its contractual cash flow obligations.
Significant increases in credit risk
In assessing whether the credit risk of a financial instrument has increased significantly since initial recognition, the Group compares the risk of default occurring on the financial instrument assessed at the balance sheet date with that assessed at the date of initial recognition.
When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL, the Group considers reasonable and supportable information that is relevant and available without undue cost or effort, including forward-looking information. In particular, the following information is taken into account:
- failure to make payments of principal or interest on their contractually due dates;
- an actual or expected significant deterioration in a financial instrument’s external or internal
credit rating (if available);
- an actual or expected significant deterioration in the operating results of the debtor; and
- existing or forecast changes in the technological, market, economic or legal environment that
32 have a significant adverse effect on the debtor’s ability to meet its obligation to the Group.
Depending on the nature of the financial instruments, the assessment of a significant increase in credit risk is performed on either an individual basis or a collective basis. When the assessment is performed on a collective basis, the financial instruments are grouped based on shared credit risk characteristics, such as past due status and credit risk ratings.
The Group assumes that the credit risk on a financial asset has increased significantly if it is more than 30 days past due.
The Group considers a financial asset to be in default when:
- the borrower is unlikely to pay its credit obligations to the Group in full, without recourse by the
Group to actions such as realising security (if any is held); or
- the financial asset is more than 90 days past due.
Credit-impaired financial assets
At each balance sheet date, the Group assesses whether financial assets carried at amortised cost and debt investments at FVOCI are credit-impaired. A financial asset is ‘credit-impaired’ when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred. Evidence that a financial asset is credit-impaired includes the following observable data:
- significant financial difficulty of the borrower or issuer;
- a breach of contract, such as a default or delinquency in interest or principal payments;
- for economic or contractual reasons relating to the borrower’s financial difficulty, the Group
having granted to the borrower a concession that would not otherwise consider;
- it is probable that the borrower will enter bankruptcy or other financial reorganisation; or
- the disappearance of an active market for that financial asset because of financial difficulties.
Presentation of allowance for ECL
ECLs are remeasured at each balance sheet date to reflect changes in the financial instrument’s credit risk since initial recognition. Any change in the ECL amount is recognised as an impairment gain or loss in profit or loss. The Group recognises an impairment gain or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for debt investments that are measured at FVOCI, for which the loss allowance is
33 recognised in other comprehensive income.
Write-off
The gross carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. A write-off constitutes a derecognition event. This is generally the case when the Group determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the write-off.
However, financial assets that are written off could still be subject to enforcement activities in order to comply with the Group’s procedures for recovery of amounts due.
Subsequent recoveries of an asset that was previously written off are recognised as a reversal of impairment in profit or loss in the period in which the recovery occurs.
(7) Equity instrument
The consideration received from the issuance of equity instruments net of transaction costs is recognised in shareholders’ equity. Consideration and transaction costs paid by the Company for repurchasing self-issued equity instruments are deducted from shareholders’ equity.
When the Company repurchases its own shares, those shares are treated as treasury shares. All expenditure relating to the repurchase is recorded in the cost of the treasury shares, with the transaction recording in the share register. Treasury shares are excluded from profit distributions and are presented as a deduction under shareholders’ equity in the balance sheet.
When treasury shares are cancelled, the share capital should be reduced to the extent of the total par value of the treasury shares cancelled. Where the cost of the treasury shares cancelled exceeds the total par value, the excess is deducted from capital reserve (share premium), surplus reserve and retained earnings sequentially. If the cost of treasury shares cancelled is less than the total par value, the difference is credited to the capital reserve (share premium).
When treasury shares are disposed of, any excess of proceeds above cost is recognised in capital reserve (share premium); otherwise, the shortfall is deducted against capital reserve (share premium), surplus reserve and retained earnings sequentially.
34 11 Bills receivable
12 Accounts receivable
13 Receivables under financing
14 Other receivables
15 Inventories
(1) Classification and cost
Inventories include reagents, consumables and low-value consumables, etc.
Inventories are initially measured at cost. Cost of inventories comprises all costs of purchase,
costs of conversion and other expenditure incurred in bringing the inventories to their present
location and condition.
(2) Measurement method of cost of inventories
Cost of inventories is calculated using the first-in-first-out method.
Consumables including low-value consumables and packaging materials are charged to profit
or loss upon receipt. The amortisation charge is included in the cost of the related assets or
recognised in profit or loss for the current period.
(3) Basis for determining the net realisable value and method for provision for obsolete inventories
At the balance sheet date, inventories are carried at the lower of cost and net realisable value.
Net realisable value is the estimated selling price in the ordinary course of business less the
estimated costs of completion and the estimated costs necessary to make the sale and
relevant taxes. The net realisable value of materials held for use in the production is measured
based on the net realisable value of the finished goods in which they will be incorporated. The
net realisable value of the inventory held to satisfy sales or service contracts is measured
based on the contract price, to the extent of the quantities specified in sales contracts, and the
excess portion of inventories is measured based on general selling prices.
Any excess of the cost over the net realisable value of each item of inventories is recognised
as a provision for impairment, and is recognised in profit or loss.
35 (4) Inventory count system
The Group maintains a perpetual inventory system.
16 Contract assets
17 Contract costs
18 Assets held for sale
19 Debt investments
20 Other debt investments
21 Long-term receivables
22 Long-term equity investments
(1) Investment cost of long-term equity investments
(a) Long-term equity investments acquired through a business combination
- The initial cost of a long-term equity investment acquired through a business
combination involving entities under common control is the Company’s share of the
carrying amount of the subsidiary’s equity in the consolidated financial statements of the
ultimate controlling party at the combination date. The difference between the initial
investment cost and the carrying amount of the consideration given is adjusted to the
share premium in the capital reserve, with any excess adjusted to retained earnings. For a
long-term equity investment in a subsidiary acquired through a business combination
achieved in stages which do not form a bundled transaction and involving entities under
common control, the Company determines the initial cost of the investment in accordance
with the above policies. The difference between this initial cost and the sum of the carrying
amount of previously-held investment and the consideration paid for the shares newly
acquired is adjusted to capital premium in the capital reserve, with any excess adjusted to
retained earnings.
36 - For a long-term equity investment obtained through a business combination not involving
entities under common control, the initial cost comprises the aggregate of the fair value of
assets transferred, liabilities incurred or assumed, and equity securities issued by the
Company, in exchange for control of the acquiree. For a long-term equity investment
obtained through a business combination not involving entities under common control and
achieved through multiple transactions in stages which do not form a bundled transaction,
the initial cost comprises the carrying amount of the previously-held equity investment in
the acquiree immediately before the acquisition date, and the additional investment cost at
the acquisition date.
(b) Long-term equity investments acquired other than through a business combination
- A long-term equity investment acquired other than through a business combination is
initially recognised at the amount of cash paid if the Group acquires the investment by
cash, or at the fair value of the equity securities issued if an investment is acquired by
issuing equity securities.
(2) Subsequent measurement of long-term equity investment
(a) Investments in subsidiaries
In the Company’s separate financial statements, long-term equity investments in subsidiaries
are accounted for using the cost method for subsequent measurement unless the investment
is classified as held for sale. Except for cash dividends or profit distributions declared but not
yet distributed that have been included in the price or consideration paid in obtaining the
investments, the Company recognises its share of the cash dividends or profit distributions
declared by the investee as investment income for the current period.
The investments in subsidiaries are stated in the balance sheet at cost less accumulated
impairment losses.
For the impairment of the investments in subsidiaries, refer to Note V.31.
In the Group’s consolidated financial statements, subsidiaries are accounted for in
accordance with the policies described in Note V.6.
(b) Investments in joint ventures and associates
A joint venture is an arrangement whereby the Group and other parties have joint control
(see Note V.22(3)) and rights to the net assets of the arrangement.
37 An associate is an entity over which the Group has significant influence (see Note V.22(3)).
An investment in a joint venture or an associate is accounted for using the equity method for subsequent measurement, unless the investment is classified as held for sale.
The accounting treatments under the equity method adopted by the Group are as follows:
- Where the initial cost of a long-term equity investment exceeds the Group’s interest in
the fair value of the investee’s identifiable net assets at the date of acquisition, the
investment is initially recognised at cost. Where the initial investment cost is less than the
Group’s interest in the fair value of the investee’s identifiable net assets at the date of
acquisition, the investment is initially recognised at the investor’s share of the fair value of
the investee’s identifiable net assets, and the difference is recognised in profit or loss.
- After the acquisition of the investment, the Group recognises its share of the investee’s
profit or loss and other comprehensive income as investment income or losses and other
comprehensive income respectively, and adjusts the carrying amount of the investment
accordingly. Once the investee declares any cash dividends or profit distributions, the
carrying amount of the investment is reduced by the amount attributable to the Group.
Changes in the Group’s share of the investee’s owners’ equity, other than those arising
from the investee’s net profit or loss, other comprehensive income or profit distribution
(referred to as “other changes in owners’ equity”), is recognised directly in the Group’s
equity, and the carrying amount of the investment is adjusted accordingly.
- In calculating its share of the investee’s net profits or losses, other comprehensive
income and other changes in owners’ equity, the Group recognises investment income
and other comprehensive income after making appropriate adjustments to align the
accounting policies or accounting periods with those of the Group based on the fair value
of the investee’s identifiable net assets at the date of acquisition. Unrealised profits and
losses resulting from transactions between the Group and its associates or joint ventures
are eliminated to the extent of the Group’s interest in the associates or joint ventures.
Unrealised losses resulting from transactions between the Group and its associates or
joint ventures are eliminated in the same way as unrealised gains but only to the extent
that there is no impairment.
38 - The Group discontinues recognising its share of further losses of the investee after the
carrying amount of the long-term equity investment and any long-term interest that in
substance forms part of the Group’s net investment in the joint venture or associate is
reduced to zero, except to the extent that the Group has an obligation to assume
additional losses. If the joint venture or associate subsequently reports net profits, the
Group resumes recognising its share of those profits only after its share of the profits
equals the share of losses not recognised.
For the impairment of the investments in joint ventures and associates, refer to Note V.31.
(3) Criteria for determining the existence of joint control or significant influence over an investee
Joint control is the contractually agreed sharing of control of an arrangement, which exists only when decisions about the relevant activities (activities with significant impact on the returns of the arrangement) require the unanimous consent of the parties sharing control.
The following factors are usually considered when assessing whether the Group can exercise joint control over an investee:
- Whether no single participant party is in a position to control the investee’s related activities
unilaterally;
- Whether strategic decisions relating to the investee’s related activities require the unanimous
consent of all participant parties that sharing of control.
Significant influence is the power to participate in the financial and operating policy decisions of an investee but does not have control or joint control over those policies.
23 Investment properties
Measurement model for investment properties: Not applicable
39 24 Fixed assets
(1) Recognition criteria
Fixed assets represent the tangible assets held by the Group for use in the supply of services or for administrative purposes with useful lives over one year. The cost of a purchased fixed asset comprises the purchase price, related taxes, and any directly attributable expenditure for bringing the asset to working condition for its intended use. The cost of self-constructed assets is measured in accordance with the policy set out in Note V.25. Costs of environmental protection and site restoration arising from obligations incurred upon disposal of fixed assets are included in the initial cost of fixed assets. Where the parts of an item of fixed assets have different useful lives or provide benefits to the Group in a different pattern, thus necessitating use of different depreciation rates or methods, each part is recognised as a separate fixed asset. Any subsequent costs including the cost of replacing part of an item of fixed assets are recognised as assets when it is probable that the economic benefits associated with the costs will flow to the Group, and the carrying amount of the replaced part is derecognised. The costs of the day-to-day maintenance of fixed assets are recognised in profit or loss as incurred. Fixed assets are stated in the balance sheet at cost less accumulated depreciation and impairment losses.
(2) Depreciation methods
Category Depreciation methods Depreciation period Residual value rate Depreciation rate
Plant and buildings Straight-line method 20 years, 40 years 5% 2.38%, 4.75%
Machinery and Straight-line method 5 years, 10 years 5% 9.5%, 19% equipment
Others Straight-line method 3 years, 5 years 5% 19%, 31.67%
Motor vehicles Straight-line method 8 years 5% 11.88%
(3) The basis of recognition, the measurement and depreciation methods for fixed assets acquired under finance leases
For the basis of recognition, the measurement and depreciation methods of fixed assets acquired under finance leases, refer to Note V.42(2).
40 25 Construction in progress
The cost of self-constructed assets includes the cost of materials, direct labour, capitalised borrowing costs (see Note V.26), and any other costs directly attributable to bringing the asset to working condition for its intended use.
A self-constructed asset is classified as construction in progress and transferred to fixed asset when it is ready for its intended use. No depreciation is provided against construction in progress.
Construction in progress is stated in the balance sheet at cost less accumulated impairment losses (see
Note V.31).
26 Borrowing costs
Borrowing costs incurred directly attributable to the acquisition and construction of a qualifying asset are capitalised as part of the cost of the asset. Other borrowing costs are recognised as financial expenses when incurred.
During the capitalisation period, the amount of interest (including amortisation of any discount or premium on borrowing) to be capitalised in each accounting period is determined as follows:
- Where funds are borrowed specifically for the acquisition and construction of a qualifying
asset, the amount of interest to be capitalised is the interest expense calculated using effective
interest rates during the period less any interest income earned from depositing the borrowed
funds or any investment income on the temporary investment of those funds before being used
on the asset.
- To the extent that the Group borrows funds generally and uses them for the acquisition and
construction of a qualifying asset, the amount of borrowing costs eligible for capitalisation is
determined by applying a capitalisation rate to the weighted average of the excess amounts of
cumulative expenditure on the asset over the above amounts of specific borrowings. The
capitalisation rate is the weighted average of the interest rates applicable to the general-
purpose borrowings.
The effective interest rate is determined as the rate that exactly discounts estimated future cash flow through the expected life of the borrowing or, when appropriate, a shorter period to the initially recognised amount of the borrowings.
41 During the capitalisation period, exchange differences related to the principal and interest on a specific-purpose borrowing denominated in foreign currency are capitalised as part of the cost of the qualifying asset. The exchange differences related to the principal and interest on foreign currency borrowings other than a specific-purpose borrowing are recognised as a financial expense when incurred.
The capitalisation period is the period from the date of commencement of capitalisation of borrowing costs to the date of cessation of capitalisation, excluding any period over which capitalisation is suspended. Capitalisation of borrowing costs commences when expenditure for the asset is being incurred, borrowing costs are being incurred and activities of acquisition and construction that are necessary to prepare the asset for its intended use are in progress, and ceases when the assets become ready for their intended use. Capitalisation of borrowing costs is suspended when the acquisition and construction activities are interrupted abnormally for a period of more than three months.
27 Biological assets
28 Oil and gas assets
29 Right-of-use assets
30 Intangible assets
(1) Measurement method, useful lives and impairment testing
Intangible assets are stated in the balance sheet at cost less accumulated amortisation (where the estimated useful life is finite) and impairment losses (see Note V.31). For an intangible asset with finite useful life, its cost less estimated residual value and accumulated impairment losses is amortised using the straight-line method over its estimated useful life, unless the intangible asset is classified as held for sale.
Items Amortisation periods (years) Software 10 years Trademark Infinite useful life
42 An intangible asset is regarded as having an indefinite useful life and is not amortised when there is no foreseeable limit to the period over which the asset is expected to generate economic benefits for the Group. The Group reassesses the useful lives of intangible assets with indefinite useful lives in each accounting period. If there is evidence indicating that the useful life of that intangible asset is finite, the Group estimates its useful life and accounts for it in accordance with the same policy as intangible assets with finite useful lives described above.
(2) Accounting policies for expenditure on internal research and development
Expenditure on an internal research and development project is classified into expenditure incurred during the research phase and expenditure during the development phase.
Expenditure during the research phase is expensed when incurred. Expenditure during the development phase is capitalised if development costs can be measured reliably, the product or process is technically and commercially feasible, and the Group intends to and has sufficient resources to complete the development. Capitalised development costs are stated in the balance sheet at cost less impairment losses (see Note V.31). Other development expenditure is recognised as an expense in the period in which it is incurred.
31 Impairment of long-term assets
The carrying amounts of the following assets are reviewed at each balance sheet date based on internal and external sources of information to determine whether there is any indication of impairment:
- fixed assets
- construction in progress
- intangible assets
- long-term equity investments
- goodwill
- long-term deferred expenses, etc.
43 If any indication exists, the recoverable amount of the asset is estimated. In addition, the Group estimates the recoverable amounts of goodwill and intangible assets with indefinite useful lives at each year-end, irrespective of whether there is any indication of impairment. Goodwill is allocated to each asset group, or set of asset groups, that is expected to benefit from the synergies of the combination for the purpose of impairment testing.
The recoverable amount of an asset (or asset group, set of asset groups) is the higher of its fair value less costs to sell and its present value of expected future cash flows.
An asset group is composed of assets directly related to cash generation and is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or asset groups.
The present value of expected future cash flows of an asset is determined by discounting the future cash flows, estimated to be derived from continuing use of the asset and from its ultimate disposal, to their present value using an appropriate pre-tax discount rate.
An impairment loss is recognised in profit or loss when the recoverable amount of an asset is less than its carrying amount. A provision for impairment of the asset is recognised accordingly.
Impairment losses related to an asset group or a set of asset groups are allocated first to reduce the carrying amount of any goodwill allocated to the asset group or set of asset groups, and then to reduce the carrying amount of the other assets in the asset group or set of asset groups on a pro rata basis. However, such allocation would not reduce the carrying amount of an asset below the highest of its fair value less costs to sell (if measurable), its present value of expected future cash flows (if determinable) and zero.
Once an impairment loss is recognised, it is not reversed in a subsequent period.
44 32 Long-term deferred expenses
Long-term deferred expenses are amortised using a straight-line method within the benefit period. The respective amortisation periods for such expenses are as follows:
Items Amortisation periods (years) Store decoration The shorter of the benefit period and 5 years Renovation costs of office buildings The shorter of the benefit period and 20 years Others The benefit period
33 Contract liabilities
34 Employee benefits
(1) Accounting treatments for short‑term employee benefits
Employee wages or salaries, bonuses, social security contributions such as medical insurance, work injury insurance, maternity insurance and housing fund, measured at the amount incurred or accrued at the applicable benchmarks and rates, are recognised as a liability as the employee provides services, with a corresponding charge to profit or loss or included in the cost of assets where appropriate.
(2) Accounting treatments for post-employment benefits
Pursuant to the relevant laws and regulations of the People’s Republic of China, the Group participated in a defined contribution basic pension insurance plan in the social insurance system established and managed by government organisations. The Group makes contributions to basic pension insurance plans based on the applicable benchmarks and rates stipulated by the government. Basic pension insurance contributions payable are recognised as a liability as the employee provides services, with a corresponding charge to profit or loss or included in the cost of assets where appropriate.
45 (3) Accounting treatments for termination benefits
When the Group terminates the employment with employees before the employment contracts expire, or provides compensation under an offer to encourage employees to accept voluntary redundancy, a provision is recognised with a corresponding expense in profit or loss at the earlier of the following dates:
- When the Group cannot unilaterally withdraw the offer of termination benefits because of an
employee termination plan or a curtailment proposal;
- When the Group has a formal detailed restructuring plan involving the payment of termination
benefits and has raised a valid expectation in those affected that it will carry out the
restructuring by starting to implement that plan or announcing its main features to those affected
by it.
(4) Accounting treatments for other long-term employee benefits
35 Lease liabilities
36 Provisions
A provision is recognised for an obligation related to a contingency if the Group has a present obligation that can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.
A provision is initially measured at the best estimate of the expenditure required to settle the related present obligation. Where the effect of the time value of money is material, provisions are determined by discounting the expected future cash flows. Factors pertaining to a contingency such as the risks, uncertainties and time value of money are taken into account as a whole in reaching the best estimate. Where there is a continuous range of possible outcomes for the expenditure required, and each possible outcome in that range is as likely as any other, the best estimate is the mid-point of that range. In other cases, the best estimate is determined according to the following circumstances:
- Where the contingency involves a single item, the best estimate is the most likely outcome.
- Where the contingency involves a large population of items, the best estimate is determined
46 by weighting all possible outcomes by their associated probabilities.
The Group reviews the carrying amount of a provision at the balance sheet date and adjusts the carrying amount to the current best estimate.
37 Share-based payments
38 Other financial instruments including preference shares and perpetual bonds
39 Revenue
Revenue is the gross inflow of economic benefits arising in the course of the Group’s ordinary activities when the inflows result in increase in shareholders’ equity, other than increase relating to contributions from shareholders.
Revenue is recognised when the Group satisfies the performance obligation in the contract by transferring the control over relevant goods to the customers. Obtaining control rights of relevant goods means the customer can direct the use of the goods and obtain substantially all of the economic benefits from that use.
Where a contract has two or more performance obligations, the Group determines the stand-alone selling price at contract inception of the distinct good or service underlying each performance obligation in the contract and allocates the transaction price in proportion to those stand-alone selling prices. The Group recognises as revenue the amount of the transaction price that is allocated to each performance obligation.
The transaction price is the amount of consideration to which the Group expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties. The Group recognises the transaction price only to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur when the uncertainty associated with the variable consideration is subsequently resolved.
Where the contract contains a significant financing component, the Group recognises the transaction price at an amount that reflects the price that a customer would have paid for the promised goods if the customer had paid cash for those goods when (or as) they transfer to the customer. The difference between the amount of promised consideration and the cash selling price
47 is amortised using an effective interest method over the contract term. The Group does not adjust the consideration for any effects of the financing component if the period between when the Group transfers a promised good to a customer and when the customer pays for that good will be one year or less.
A performance obligation is satisfied over time if one of the following criteria is met; or otherwise, a performance obligation is satisfied at a point in time:
- the customer simultaneously receives and consumes the benefits provided by the Group’s performance as the Group performs;
- the customer can control the asset created or enhanced during the Group’s performance; or
- the Group’s performance does not create an asset with an alternative use to it and the Group has an enforceable right to payment for performance completed to date.
For performance obligation satisfied over time, the Group recognises revenue over time by measuring the progress towards complete satisfaction of that performance obligation, unless the outcome of that performance obligation cannot be measured reasonably. The Group determines the extent of progress towards completion of rendering of services based on the input (or output) method. When the outcome of that performance obligation cannot be measured reasonably, but the Group expects to recover the costs incurred in satisfying the performance obligation, the Group recognises revenue only to the extent of the costs incurred until such time that it can reasonably measure the outcome of the performance obligation.
For performance obligation satisfied at a point in time, the Group recognises revenue at the point in time at which the customer obtains control of relevant goods. To determine whether a customer has obtained control of goods or services, the Group considers the following indicators:
- the Group has a present right to payment for the goods or services;
- the Group has transferred the legal title of the goods to the customer;
- the Group has transferred physical possession of the goods to the customer;
- the Group has transferred the significant risks and rewards of ownership of the goods to the customer; and
- the customer has accepted the goods.
48 A contract asset is the Group’s right to consideration in exchange for goods or services that it has transferred to a customer when that right is conditional on something other than the passage of time. The Group recognises loss allowances for expected credit loss on contract assets (see Note
V.10(6)). Accounts receivable is the Group’s right to consideration that is unconditional (only the passage of time is required). A contract liability is the Group’s obligation to transfer goods or services to a customer for which the Group has received consideration (or an amount of consideration is due) from the customer.
The following is the description of accounting policies regarding revenue from the Group’s principal activities:
The Group recognises revenue when the customer obtains control over relevant goods or services at the amount of consideration to which the Group expects to be entitled. The basis of revenue recognition for the Group is as follows:
(1) Recognition requirements for revenue from rendering of services
A service contract between the Group and the customer usually stipulates the performance obligation to provide physical examination services. Revenue is recognised upon completion of services based on the number of people who have been examined.
For most individual customers, the Group usually requires them to prepay physical examination service fees, while corporate customers prepay part of the physical examination service fees according to the terms of the signed service contracts. The Group includes such service charges in contract liabilities. Where the physical examination services rendered to employees of corporate customers was completed but the corporate customers have not yet made payments, the Group recognises the amount of the related service fees as accounts receivable.
The Group sells non-refundable package cards, customers can use them for consumption. Part of the package cards may not be consumed by customers. However, the Group does not expect to be entitled to the unexercised amount. The Group only recognises the expected unexercised amount as revenue when the likelihood of the customer exercising its remaining rights becomes remote.
(2) Recognition requirements for revenue from sale of goods
A contract on the sale of goods between the Company and the customers usually only contains the
49 performance obligation to transfer goods or services. Generally, revenue is recognised at the time
(or when) the control of goods is transferred based on comprehensive consideration of the following factors: the present right to payment for the goods, the transfer of significant risks and rewards of ownership of the goods, the transfer of the legal title of the goods, the transfer of physical possession of the goods, the fact that the customer accepts the goods.
40 Government grants
Government grants are non-reciprocal transfers of monetary or non-monetary assets from the government to the Group except for capital contributions from the government in the capacity as an investor in the Group.
A government grant is recognised when there is reasonable assurance that the grant will be received and that the Group will comply with the conditions attaching to the grant.
If a government grant is in the form of a transfer of a monetary asset, it is measured at the amount received or receivable. If a government grant is in the form of a transfer of a non-monetary asset, it is measured at fair value.
Government grants related to assets are grants whose primary condition is that the Group qualifying for them should purchase, construct or otherwise acquire long-term assets. Government grants related to income are grants other than those related to assets. A government grant related to an asset is recognised as deferred income and amortised over the useful life of the related asset on a reasonable and systematic manner as other income or non-operating income. A grant that compensates the Group for expenses or losses to be incurred in the future is recognised as deferred income, and included in other income or non-operating income in the periods in which the expenses or losses are recognised. Otherwise, the grant is included in other income or non- operating income directly.
41 Deferred tax assets / deferred tax liabilities
Current tax and deferred tax are recognised in profit or loss except to the extent that they relate to a business combination or items recognised directly in equity (including other comprehensive income).
Current tax is the expected tax payable calculated at the applicable tax rate on taxable income for
50 the year, plus any adjustment to tax payable in respect of previous years.
At the balance sheet date, current tax assets and liabilities are offset only if the Group has a legally enforceable right to set them off and also intends either to settle on a net basis or to realise the asset and settle the liability simultaneously.
Deferred tax assets and liabilities arise from deductible and taxable temporary differences respectively, being the differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax bases, which include the deductible losses and tax credits carried forward to subsequent periods. Deferred tax assets are recognised to the extent that it is probable that future taxable profits will be available against which deductible temporary differences can be utilised.
Deferred tax is not recognised for the temporary differences arising from the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting profit nor taxable profit (or deductible loss). Deferred tax is not recognised for taxable temporary differences arising from the initial recognition of goodwill.
At the balance sheet date, deferred tax is measured based on the tax consequences that would follow from the expected manner of recovery or settlement of the carrying amounts of the assets and liabilities, using tax rates enacted at the balance sheet date that are expected to be applied in the period when the asset is recovered or the liability is settled.
The carrying amount of a deferred tax asset is reviewed at each balance sheet date, and is reduced to the extent that it is no longer probable that the related tax benefits will be utilised. Such reduction is reversed to the extent that it becomes probable that sufficient taxable profits will be available.
At the balance sheet date, deferred tax assets and liabilities are offset if all of the following conditions are met:
- the taxable entity has a legally enforceable right to offset current tax liabilities and current tax
assets;
- they relate to income taxes levied by the same tax authority on either:
- the same taxable entity; or
- different taxable entities which intend either to settle the current tax liabilities and current
tax assets on a net basis, or to realise the assets and settle the liabilities simultaneously, in
51 each future period in which significant amounts of deferred tax liabilities or deferred tax assets
are expected to be settled or recovered.
42 Leases
(1) Accounting treatments for operating leases
(1) Operating lease charges
Rental payments under operating leases are recognised as part of the cost of another related asset or as expenses on a straight-line basis over the lease term. Contingent rental payments are expensed as incurred.
(2) Assets leased out under operating leases
Fixed assets leased out under operating leases, except for investment properties, are depreciated in accordance with the Group’s depreciation policies described in Note V.24(2). Impairment losses are recognised in accordance with the accounting policy described in Note V.31. Income derived from operating leases is recognised in profit or loss using the straight-line method over the lease term. If initial direct costs incurred in respect of the assets leased out are material, the costs are initially capitalised and subsequently amortised in profit or loss over the lease term on the same basis as the lease income. Otherwise, the costs are charged to profit or loss immediately.
Contingent rental payments are expensed as incurred.
(2) Accounting treatments for finance leases
(a) Assets acquired under finance leases
When the Group acquires an asset under a finance lease, the asset is measured at an amount equal to the lower of its fair value and the present value of the minimum lease payments, each determined at the inception of the lease. At the commencement of the lease term, the minimum lease payments are recorded as long-term payables. The difference between the carrying amount of the leased assets and the minimum lease payments is accounted for as unrecognised finance charges. Initial direct costs attributable to a finance lease that are incurred by the Group are added to the carrying amount of the leased asset. Depreciation and impairment losses are accounted for in accordance with the accounting policies described.
52 If there is reasonable certainty that the Group will obtain ownership of a leased asset at the end of the lease term, the leased asset is depreciated over its estimated useful life. Otherwise, the leased asset is depreciated over the shorter of the lease term and its estimated useful life.
Unrecognised finance charges arising from a finance lease are recognised using an effective interest method over the lease term. The amortisation is accounted for in accordance with the principles of borrowing costs.
At the balance sheet date, the long-term payables arising from finance leases, net of the unrecognised finance charges, are analysed and separately presented as long-term payables or non-current liabilities due within one year.
Contingent rental payments are expensed as incurred.
(b) Assets leased out under finance leases
At the commencement of the lease term, the Group recognises the aggregate of the minimum lease receipts determined at the inception of a lease and the initial direct costs as finance lease receivable, and recognises unguaranteed residual value at the same time. The difference between the aggregate of the minimum lease receipts, the initial direct costs and the unguaranteed residual value, and the aggregate of their present value is recognised as unearned finance income.
Unearned finance income is allocated to each accounting period during the lease term using the effective interest method. At the balance sheet date, finance lease receivables, net of unearned finance income, are analysed and separately presented as long-term receivables or non-current assets due within one year.
Contingent rental payments are expensed as incurred.
43 Other significant accounting policies and accounting estimates
The preparation of financial statements requires management to make estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates as well as underlying assumptions and uncertainties involved are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised and in any future periods affected.
53 (1) Significant accounting estimates
Except for accounting estimates relating to depreciation and amortisation of assets such as fixed assets and intangible assets (see Notes V.24 and 30) and provision for impairment of various types of assets (see Note V.31). Other significant accounting estimates are as follows:
(i) Note V.41: Recognition of deferred tax assets;
(ii) Note XI: Valuation of fair value of financial instruments.
(2) Significant accounting judgement
Significant judgement made by the Group in the application of accounting policies is as follow:
(i) Notes IX.3: Significant judgements and assumptions in determining control, joint control or significant influence over other entity.
44 Significant accounting policies and accounting estimates
(1) Changes in significant accounting policies
√Applicable □Not applicable Approval Description and reasons of changes in accounting policies Remark procedure Changes in accounting policies as a result of the implementation of the new revenue standard, Related the Ministry of Finance issued the “Accounting Standard for Business Enterprises No. 14 – resolution Revenue” in July 2017, which required enterprises listed in the Chinese mainland to adopt the has been new revenue standard since 1 January 2020. New revenue standard replaces the “Accounting approved by Standard for Business Enterprises No. 14 – Revenue” issued by the MOF in 2006. Under new the 16th revenue standard, revenue is recognised when the customer obtains control of the promised meeting of goods or services in the contract, while under previous revenue standard, the Group the 7th board recognised revenue when the risks and rewards had passed to the customers. Under new of directors revenue standard, the entity should identify each performance obligation in the contract and of the recognise revenue separately when each performance obligation is satisfied. New revenue Company on standard provides clearer guidance on the accounting treatments for contracts containing 28 April multiple transaction arrangements; it also specifies requirements for revenue recognition and 2020. measurement of certain specific transactions (or events). Major changes and the impact of adopting new revenue standard on the Company are as follows:
(1) The impact on the consolidated statements:
31 December 2019 (before changes) 1 January 2020 (after changes) Item Carrying amount Item Carrying amount Advance payments received 1,447,485,391.71 Advance payments received Contract liabilities 1,447,485,391.71 Other current liabilities
54 The Company has implemented the new revenue standard since 1 January 2020. As at 31 December 2019, advance payments received for the sales contract with the customers was included in “advance payments received”, but since 1 January 2020, advance payments received have been included in “contract liabilities”. (2) The impact on the financial statements of the parent company: the financial statements of the
parent company have not been affected.
(2) Changes in significant accounting estimates
□Applicable √Not applicable
(3) Adjusting the opening balances of relevant items in the financial statements in the initial year of application due to the initial application of new revenue standard and new leases standard since 2020
Applicable Does the Company need to adjust the accounting item in the balance sheet at the beginning of the year √Yes □No Consolidated balance sheet Expressed in Renminbi Yuan
Item 31 December 2019 1 January 2020 Adjustments Current assets Cash at bank and on hand 4,759,517,528.74 4,759,517,528.74 Settlement funds Lendings to banks and other financial institutions Financial assets held for trading Derivative financial assets Bills receivable 1,960,000.00 1,960,000.00 Accounts receivable 2,292,574,441.06 2,292,574,441.06 Receivables under financing Prepayments 214,342,103.57 214,342,103.57 Premium receivable Reinsurance receivables Reinsurance contract provisions receivable Other receivables 384,677,621.78 384,677,621.78 Including: Interest receivable 738,823.84 738,823.84 Dividends receivable 25,339,452.03 25,339,452.03 Financial assets purchased under reverse sale agreements Inventories 129,615,381.32 129,615,381.32 Contract assets Assets held for sale Non-current assets due within one year 653,333,835.18 653,333,835.18 Other current assets 255,395,925.36 255,395,925.36 Total current assets 8,691,416,837.01 8,691,416,837.01 Non-current assets
55 Loans and advances to customers Debt investments Other debt investments Long-term receivables 828,318,900.01 828,318,900.01 Long-term equity investments 162,090,985.54 162,090,985.54 Investments in other equity instruments Other non-current financial assets 1,226,749,518.89 1,226,749,518.89 Investment properties Fixed assets 2,608,356,009.29 2,608,356,009.29 Construction in progress 59,483,859.71 59,483,859.71 Bearer biological assets Oil and gas assets Right-of-use assets Intangible assets 163,907,170.30 163,907,170.30 Development costs Goodwill 4,104,391,143.02 4,104,391,143.02 Long-term deferred expenses 736,398,352.65 736,398,352.65 Deferred tax assets 100,159,632.69 100,159,632.69 Other non-current assets 237,348,067.10 237,348,067.10 Total non-current assets 10,227,203,639.20 10,227,203,639.20 Total assets 18,918,620,476.21 18,918,620,476.21 Current liabilities Short-term loans 2,309,069,932.12 2,309,069,932.12 Borrowings from the central bank Loans from banks and other financial institutions Financial liabilities held for trading Derivative financial liabilities Bills payable 636,592.00 636,592.00 Accounts payable 862,957,946.40 862,957,946.40 Advance payments received 1,447,485,391.71 -1,447,485,391.71 Contract liabilities 1,447,485,391.71 1,447,485,391.71 Financial assets sold under repurchase agreements Accepted deposits and deposits from banks Securities brokerage Securities underwriting brokerage Employee benefits payable 457,112,710.77 457,112,710.77 Taxes payable 200,243,964.38 200,243,964.38 Other payables 389,436,292.94 389,436,292.94 Including: Interest payable Dividends payable 7,767,421.57 7,767,421.57 Fee and commission payable Reinsurance payables Liabilities held for sale Non-current liabilities due within one year 2,316,036,316.81 2,316,036,316.81 Other current liabilities Total current liabilities 7,982,979,147.13 7,982,979,147.13 Non-current liabilities Provisions for insurance contracts Long-term loans 1,182,789,431.02 1,182,789,431.02 Debentures payable 1,367,746,765.24 1,367,746,765.24
56 Including: Preference shares Perpetual bonds Lease liabilities Long-term payables 217,928,737.12 217,928,737.12 Long-term employee benefits payable Provisions Deferred income 8,183,333.33 8,183,333.33 Deferred tax liabilities 3,957,992.89 3,957,992.89 Other non-current liabilities 1,013,418.15 1,013,418.15 Total non-current liabilities 2,781,619,677.75 2,781,619,677.75 Total liabilities 10,764,598,824.88 10,764,598,824.88 Owners’ equity Share capital 3,919,920,974.00 3,919,920,974.00 Other equity instruments Including: Preference shares Perpetual bonds Capital reserve 2,439,936,041.00 2,439,936,041.00 Less: Treasury shares 300,055,044.16 300,055,044.16 Other comprehensive income -379,371.01 -379,371.01 Specific reserve Surplus reserve 71,934,339.69 71,934,339.69 General risk reserve Retained earnings 1,184,276,684.09 1,184,276,684.09 Total equity attributable to owners of the Company 7,315,633,623.61 7,315,633,623.61 Non-controlling interests 838,388,027.72 838,388,027.72 Total owners’ equity 8,154,021,651.33 8,154,021,651.33 Total liabilities and owners’ equity 18,918,620,476.21 18,918,620,476.21 Information on the adjustments Company balance sheet Expressed in Renminbi Yuan
Item 31 December 2019 1 January 2020 Adjustments Current assets Cash at bank and on hand 1,641,522,730.76 1,641,522,730.76 Financial assets held for trading Derivative financial assets Bills receivable Accounts receivable 41,100,000.00 41,100,000.00 Receivables under financing Prepayments 5,325,113.47 5,325,113.47 Other receivables 280,176,115.49 280,176,115.49 Including: Interest receivable Dividends receivable 125,339,452.03 125,339,452.03 Inventories 99,547.38 99,547.38 Contract assets Assets held for sale Non-current assets due within one year Other current assets 14,582,000.90 14,582,000.90 Total current assets 1,982,805,508.00 1,982,805,508.00 Non-current assets Debt investments
57 Other debt investments Long-term receivables Long-term equity investments 9,680,902,711.89 9,680,902,711.89 Investments in other equity instruments Other non-current financial assets 466,288,823.14 466,288,823.14 Investment properties Fixed assets 2,969,362.51 2,969,362.51 Construction in progress Bearer biological assets Oil and gas assets Right-of-use assets Intangible assets Development costs Goodwill Long-term deferred expenses 10,105,733.60 10,105,733.60 Deferred tax assets Other non-current assets 100,640,000.00 100,640,000.00 Total non-current assets 10,260,906,631.14 10,260,906,631.14 Total assets 12,243,712,139.14 12,243,712,139.14 Current liabilities Short-term loans Financial liabilities held for trading Derivative financial liabilities Bills payable Accounts payable 2,581,565.16 2,581,565.16 Advance payments received Contract liabilities Employee benefits payable 6,292,870.59 6,292,870.59 Taxes payable 795,932.88 795,932.88 Other payables 1,164,582,227.11 1,164,582,227.11 Including: Interest payable Dividends payable Liabilities held for sale Non-current liabilities due within one year 959,903,895.89 959,903,895.89 Other current liabilities Total current liabilities 2,134,156,491.63 2,134,156,491.63 Non-current liabilities Long-term loans Debentures payable Including: Preference shares Perpetual bonds Lease liabilities Long-term payables Long-term employee benefits payable Provisions Deferred income Deferred tax liabilities, net Other non-current liabilities Total non-current liabilities Total liabilities 2,134,156,491.63 2,134,156,491.63 Owners’ equity
58 Share capital 3,919,920,974.00 3,919,920,974.00 Other equity instruments Including: Preference shares Perpetual bonds Capital reserve 6,254,583,180.37 6,254,583,180.37 Less: Treasury shares 300,055,044.16 300,055,044.16 Other comprehensive income Specific reserve Surplus reserve 136,626,800.32 136,626,800.32 Retained earnings 98,479,736.98 98,479,736.98 Total owners’ equity 10,109,555,647.51 10,109,555,647.51 Total liabilities and owners’ equity 12,243,712,139.14 12,243,712,139.14 Information on the adjustments: None
(4) Adjusting the comparative figures for the prior period retrospectively due to the initial application of new revenue standard and new leases standard since 2020
□Applicable √ Not applicable
45 Others
VI. Taxation
1 Main types of taxes and corresponding tax rates
Tax type Tax basis Tax rate Output VAT is calculated on product sales and taxable services revenue. VAT The basis for VAT payable is to deduct input VAT from the output VAT for 13%, 6%, 3% the period Urban maintenance and Based on VAT paid 7%, 5%, 1% construction tax Corporate income tax Based on taxable profits 25%, 15% Disclosures on taxable entities that apply different income tax rates Name of taxable entities The income tax rate The Company 25% of taxable income Domestic subsidiaries 25%, 15% of taxable income Overseas subsidiaries Calculation and payment of profit tax based on the laws at the place of registration (Hong Kong)
59 2 Tax preferential treatments
(1) Value-added tax
According to Cai Shui [2011] No.100 and Notice on Tax-related Matters (doc. no.:
WTSL180308966698) issued by the Shanghai Pudong State Administration of Taxation No.1 Tax
Office, Shanghai Meidong Software Development Co., Ltd., a subsidiary of the Company, is entitled to obtain refund upon payment of VAT on the software product revenue from 1 January
2018 to 31 December 2020.
(2) Corporate income tax
Ciming Health Checkup Management Group Co., Ltd., a subsidiary of the Company, was recognised as a high-tech enterprise (Certificate No.: GR201811007559) by Beijing Association for
Science and Technology, Beijing Municipal Finance Bureau and Beijing Municipal Tax Service of the State Taxation Administration in 2018 and was entitled to income tax concessions for high-tech enterprises, with the company income tax levied at a rate of 15% in 2020.
Mega Genomics Health Technology (Beijing) Co., Ltd., a subsidiary of the Company, was recognised as a high-tech enterprise (Certificate No.: GR201711001779) by Beijing Association for
Science and Technology, Beijing Municipal Finance Bureau and Beijing Local Taxation Bureau in
2017 and was entitled to income tax concessions for high-tech enterprises, with the company income tax levied at a rate of 15% in 2020.
In accordance with Notice of the Ministry of Finance, the General Administration of Customs and the State Administration of Taxation on Tax Policy Issues concerning Further Implementing the
Western China Development Strategy (Cai Shui [2011] No. 58), principal activities of Yunnan
Meinian Onehealth Healthcare Co., Ltd., Xichang Meinian Onehealth Health Management Co.,
Ltd., Yili Meinian Onehealth Management Co., Ltd., Hami Meinian Onehealth Health Management
Co., Ltd., Chengdu Meinian Onehealth Health Management Co., Ltd., Chengdu Meinian Onehealth
Checkup Hospital Co., Ltd., Chengdu Onehealth Technology Management Co., Ltd., Mianyang
Meinian Onehealth Technology Co., Ltd., Sichuan Hongkangjie Medical Investment Management
Co., Ltd., Chengdu Kaier Health Checkup Hospital Co., Ltd., Chengdu Tianfu New District Oasis
Hospital Co., Ltd., Leshan Meinian Onehealth Service Co., Ltd., Dali Meinian Onehealth Checkup
Hospital Co., Ltd., Deyang Meinian Onehealth Checkup Hospital Co., Ltd., Suining Meinian
60 Onehealth Checkup Hospital Co., Ltd., Nanning Meinian Onehealth Checkup Co., Ltd., Guizhou
Meinian Onehealth Kangyuan Checkup Centre Co., Ltd., Chongqing Meinian Onehealth
Management Co., Ltd., Chongqing Onehealth Health Checkup and Management Co., Ltd., Xi’an
Meinian Onehealth Health Management Co., Ltd., Xi’an Qujiang New District Onehealth Clinic Co.,
Ltd., Lanzhou Meinian Onehealth Health Management Co., Ltd., Lanzhou Meinian Onehealth
Jinmao Health Management Co., Ltd., Xinjiang Meinian Onehealth Health Management Co., Ltd.,
Chengdu Ciming Health Checkup Management Co., Ltd., Tongliao Ciming Health Management
Co., Ltd., Urumqi Huarui Tianmei Health Management Co., Ltd., Xinjiang Puhui Antai Health
Management Co., Ltd., Pu'er Meinian Onehealth Checkup Centre Co., Ltd., Guangyuan Meinian
Onehealth Technology Co., Ltd., Gansu Meinian Onehealth Health Management Co., Ltd.,
Qingyang Meinian Onehealth Health Management Co., Ltd., Xining Meinian Onehealth Health
Management Co., Ltd., Meishan Meinian Onehealth Management Co., Ltd., Neijiang Meinian
Onehealth Health Management Co., Ltd., Zigong Meinian Onehealth Checkup Hospital Co., Ltd. and Shaanxi Meinian Onehealth Health Management Co., Ltd., the Company’s subsidiaries, fall within the scope of industry projects set out in the Catalogue of Encouraged Industries in Western
China (National Development and Reform Order No.15 at the end of 2014 ), which has been supported by relevant approval documents from local tax bureaus and therefore, these enterprises are entitled to a 15% reduction of company income tax.
3 Others
VII. Notes to the consolidated financial statements
1 Cash at bank and on hand
Expressed in Renminbi Yuan Balance at the Balance at the end Item beginning of the of the period period Cash on hand 3,344,142.35 3,420,010.11 Deposits with banks 2,438,094,153.41 4,689,471,789.59 Other monetary funds 73,094,541.50 66,625,729.04 Total 2,514,532,837.26 4,759,517,528.74 Including: Total overseas deposits 120,973,933.07 173,713,600.13 The total balance of cash or other monetary funds that are 63,515,381.69 63,515,381.69 restricted because being pledged as security or frozen
61 Other description Note 1: Meinian Onehealth, a subsidiary of the Company, placed RMB 13,000,000.00 as deposit in China Merchants Bank Shanghai Branch in exchange for 62% of Xiamen Meinian Onehealth Management Co., Ltd.’s equity pledged to the bank for borrowings in 2017.
Note 2: Beijing Meinian Insurance Agent Co., Ltd., a subsidiary of the Company, placed RMB 50,497,456.60 of other monetary funds in the Trust Fund of China Minsheng Banking Corp., Ltd. Beijing Tiantongyuan Branch for the “operation of the Insurance Broker Business Licence”.
Note 3: For the Company’s subsidiaries, Nanning Meinian Onehealth Checkup Co., Ltd., Tianjin Meinian Investment Management Co., Ltd. and Guangyuan Meinian Onehealth Technology Co., Ltd., a total of RMB 8,300.00 of bank deposits have been frozen for the application of the ETC business.
Note 4: For Changsha Meinian Onehealth Health Management Co., Ltd., a subsidiary of the Company, bank deposits amounting to RMB 1,500.00 has been frozen as deposits for bank account opening.
Note 5: For Jiangxi Meinian Onehealth Management Co., Ltd., a subsidiary of the Company, bank deposits amounting to RMB 1,500.00 has been frozen as deposits for POS machine.
Note 6: For Meizhao Life Shanghai Capital Holdings Co., Ltd., the Company’s subsidiary, its bank deposits restricted in usage for long-suspended deposits amounted to RMB 6,625.09.
2 Financial assets held for trading
3 Derivative financial assets
4 Bills receivable
(1) Bills receivable by category:
Expressed in Renminbi Yuan
Item Balance at the end of the period Balance at the beginning of the period
Bank acceptance bills 1,339,476.00 1,960,000.00
Total 1,339,476.00 1,960,000.00
Description of the basis of determining the group: None. If the provision for bad and doubtful debts of bills receivable is made in accordance with the general expected credit loss model, please disclose the relevant information of the provision for bad and doubtful debts with reference to the disclosure methods adopted for other receivables: □Applicable √ Not applicable
62 (2) Additions, recoveries or reversals of provision for bad and doubtful debts during the period
Significant recoveries or reversals during the period: □Applicable √ Not applicable
(3) The pledged bills receivable of the Company at the end of the period
(4) Outstanding endorsed or discounted bills that have not matured at the end of the period
(5) Bills transferred to accounts receivable due to non-performance of the issuers at the end of the period
(6) Bills receivable written off during the period
5 Accounts receivable
(1) Accounts receivable by category:
Expressed in Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period
Provision for bad and Provision for bad and Category Book value Carrying amount Book value Carrying amount doubtful debts doubtful debts
Amount Percentage Amount Percentage Amount Percentage Amount Percentage
Accounts receivable for 2,947,943.16 0.13% 2,947,943.16 100.00% 2,947,943.16 0.12% 2,947,943.16 100.00% individual assessment
Including: Individually significant and assessed for impairment 2,947,943.16 0.13% 2,947,943.16 100.00% 2,947,943.16 0.12% 2,947,943.16 100.00% individually
Accounts receivable for 2,336,654,988.17 99.87% 205,711,227.30 8.80% 2,130,943,760.87 2,452,715,109.82 99.88% 160,140,668.76 6.53% 2,292,574,441.06 collective assessment
Including: Accounts receivables that are collectively assessed for 2,336,654,988.17 99.87% 205,711,227.30 8.80% 2,130,943,760.87 2,452,715,109.82 99.88% 160,140,668.76 6.53% 2,292,574,441.06 impairment based on credit risk characteristics
Total 2,339,602,931.33 100.00% 208,659,170.46 8.92% 2,130,943,760.87 2,455,663,052.98 100.00% 163,088,611.92 6.64% 2,292,574,441.06 Individual assessment: 2,947,943.16 Expressed in Renminbi Yuan Balance at the end of the period Name Provision for bad and Book value Percentage Rationale for provision doubtful debts Wang Shifang 2,947,943.16 2,947,943.16 100.00% Non-recoverable Total 2,947,943.16 2,947,943.16 -- -- Individual assessment: None. Collective assessment: 205,711,227.30
63 Expressed in Renminbi Yuan Balance at the end of the period Name Provision for bad and Book value Percentage doubtful debts Within 1 year (inclusive) 1,814,022,153.05 1,814,022.15 0.10% Over 1 year but within 2 400,148,144.09 120,044,443.23 30.00% years (inclusive) Over 2 years but within 3 77,263,858.22 38,631,929.11 50.00% years (inclusive) Over 3 years 45,220,832.81 45,220,832.81 100.00% Total 2,336,654,988.17 205,711,227.30 -- Description of the basis of determining the group: None Collective assessment: None Description of the basis of determining the group: None If the provision for bad and doubtful debts of accounts receivable is made in accordance with the general expected credit loss model, please disclose the relevant information of the provision for bad and doubtful debts with reference to the disclosure methods adopted for other receivables: □Applicable √ Not applicable By ageing Expressed in Renminbi Yuan Ageing Balance at the end of the period Within 1 year (inclusive) 1,814,022,153.05 Over 1 year but within 2 years 400,148,144.09 Over 2 years but within 3 years 77,263,858.22 Over 3 years 48,168,775.97 Over 3 year but within 4 years 17,896,346.83 Over 4 year but within 5 years 8,190,491.64 Over 5 years 22,081,937.50 Total 2,339,602,931.33
(2) Additions, recoveries or reversals of provision for bad and doubtful debts during the period
Additions of provision for bad and doubtful debts during the period: Expressed in Renminbi Yuan
Balance at the Changes during the period Balance at the Category beginning of the Recoveries end of the Additions Written-off Others period or reversals period Individually significant and assessed for 2,947,943.16 2,947,943.16 impairment individually Accounts receivables that are collectively assessed for impairment based on credit risk 160,140,668.76 47,161,660.91 1,211,211.92 379,890.45 205,711,227.30 characteristics Total 163,088,611.92 47,161,660.91 1,211,211.92 379,890.45 208,659,170.46
64 (3) Accounts receivable written off during the period
Expressed in Renminbi Yuan
Item Written-off amount
Accounts receivable written off 379,890.45
Significant accounts receivable written off: Nil Description of accounts receivable written off: None
(4) Five largest accounts receivable by debtor at the end of the period:
Expressed in Renminbi Yuan Balance of accounts Percentage of the total ending Ending balance of provision for Name of enterprise receivable at the end of the balance of accounts receivable bad and doubtful debts period No.1 120,926,019.87 5.17% 10,479,269.06 No.2 76,009,914.78 3.25% 4,074,244.33 No.3 49,200,749.30 2.10% 5,510,839.33 No.4 18,206,899.66 0.78% 1,511,331.24 No.5 13,936,733.55 0.60% 2,413,105.62 Total 278,280,317.16 11.90%
(5) Derecognition of accounts receivable due to transfer of financial assets:
(6) Assets and liabilities recognised due to the continuing involvement of accounts receivable transferred:
Other description: N/A
6 Receivables under financing
Changes in receivables under financing during the period and changes in their fair value □Applicable √ Not applicable If the provisions for impairment of receivables under financing is made in accordance with the general expected credit loss model, please disclose the relevant information of the provisions for impairment with reference to the disclosure methods adopted for other receivables: □Applicable √ Not applicable Other description: N/A
65 7 Prepayments
(1) The ageing analysis of prepayments is as follows:
Expressed in Renminbi Yuan Balance at the end of the period Balance at the beginning of the period Ageing Amount Percentage Amount Percentage Within 1 year 193,312,975.95 86.02% 194,497,812.28 90.74% Over 1 year but within 2 years 21,497,006.86 9.57% 13,860,848.52 6.47% Over 2 year but within 3 years 5,856,040.71 2.61% 4,241,566.48 1.98% Over 3 years 4,044,345.79 1.80% 1,741,876.29 0.81% Total 224,710,369.31 -- 214,342,103.57 -- The reason why the prepayments of significant amounts with ageing over one year are not settled in time:
(2) Five largest prepayments by debtor at the end of the period:
The total of five largest prepayments by debtor for the Company at the end of the year was RMB 38,475,660.11, representing 17.12% of the total prepayments. Other description: N/A
8 Other receivables
Expressed in Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Interest receivable 615,073.84 738,823.84 Dividends receivable 39,725,570.73 25,339,452.03 Other receivables 459,010,575.51 358,599,345.91 Total 499,351,220.08 384,677,621.78
(1) Interest receivable
1) Interest receivable by category
Expressed in Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Time deposits 615,073.84 738,823.84 Total 615,073.84 738,823.84
2) Significant overdue interest
66 3) Additions of provision for bad and doubtful debts
□Applicable √ Not applicable
(2) Dividends receivable
1) Dividends receivable by category
Expressed in Renminbi Yuan Balance at the end Balance at the beginning Item (or investee) of the period of the period Nantong Meifu Health Industry Investment Partnership 29,766,666.65 17,859,999.99 (Limited Partnership) Nantong Meizhao Meinian Health Industry M&A Investment Fund 9,958,904.08 7,479,452.04 (Limited Partnership) Total 39,725,570.73 25,339,452.03
2) Significant dividends receivable ageing over one year:
3) Additions of provision for bad and doubtful debts
□Applicable √ Not applicable Other description: N/A
(3) Other receivables
1) Other receivables categorised by nature
Expressed in Renminbi Yuan Book value at the end Book value at the Nature of other receivables of the period beginning of the period Deposits 150,846,427.16 135,595,553.00 Amounts due from other entities 83,089,058.80 102,395,415.42 Security deposit 184,426,927.83 93,826,663.11 Reserve funds 21,205,057.65 7,573,482.29 Others 27,412,742.63 25,869,425.52 Total 466,980,214.07 365,260,539.34
67 2) Additions of provision for bad and doubtful debts
Expressed in Renminbi Yuan Stage 1 Stage 2 Stage 3 Lifetime ECL Provision for bad and doubtful debts Lifetime ECL Total 12-month ECL (not credit (credit impaired) impaired) Balance at 1 January 2020 6,661,193.43 6,661,193.43 Balance at 1 January 2020 during the period —— —— —— —— Additions during the period 194,140.15 1,115,804.98 1,309,945.13 Reversals during the period 1,500.00 1,500.00 Balance at 30 June 2020 194,140.15 1,114,304.98 7,969,638.56 Changes in the book value with significant changes in loss allowances during the period □Applicable √ Not applicable By ageing Expressed in Renminbi Yuan Ageing Balance at the end of the period Within 1 year (inclusive) 292,440,493.72 Over 1 year but within 2 years 39,954,257.24 Over 2 year but within 3 years 52,973,912.49 Over 3 years 81,611,550.62 Over 3 year but within 4 years 25,409,329.19 Over 4 year but within 5 years 17,736,260.65 Over 5 years 38,465,960.78 Total 466,980,214.07
3) Additions, recoveries or reversals of provision for bad and doubtful debts during the period
Additions of provision for bad and doubtful debts during the period Expressed in Renminbi Yuan
Balance at the Changes during the period Balance at the Category beginning of Recoveries or end of the Additions Written-off Others the period reversals period Other receivables 6,661,193.43 1,309,945.13 1,500.00 7,969,638.56 Total 6,661,193.43 1,309,945.13 1,500.00 7,969,638.56 Significant reversal or recoveries during the period: Nil
4) Other receivables written off during the period
68 5) Five largest other receivables by debtor at the end of the period:
Expressed in Renminbi Yuan Percentage of the total Ending balance of Name of Nature of other Balance at the Ageing ending balance of provision for bad and enterprise receivables end of the period other receivables doubtful debts No.1 Deposits 33,000,000.00 Within 1 year 7.07% No.2 Deposits 15,000,000.00 Within 1 year 3.21% No.3 Deposits 10,000,000.00 Within 1 year 2.14% No.4 Deposits 8,593,500.00 Within 1 year 1.84% Receivables on No.5 7,201,700.00 Within 1 year 1.54% sale of equipment Total -- 73,795,200.00 -- 15.80%
6) Receivables relating to government grant
7) Derecognition of other receivables due to transfer of financial assets
8) Assets and liabilities recognised due to the continuing involvement of other receivables transferred
9 Inventories
Does the Company need to comply with the disclosure requirements for the real estate industry？ No
(1) Inventories by category:
Expressed in Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period Provision for Provision for impairment of impairment of inventories or inventories or Item Carrying Carrying Book value provision for Book value provision for amount amount impairment of costs to impairment of costs to fulfil a contract with a fulfil a contract with a customer customer Finished goods 1,129,925.22 1,129,925.22 1,314,932.90 1,314,932.90 Reagents and 118,748,968.13 118,748,968.13 128,300,448.42 128,300,448.42 consumables Total 119,878,893.35 119,878,893.35 129,615,381.32 129,615,381.32
(2) Provision for impairment of inventories and costs to fulfil a contract with a customer:
(3) Information on the period-end balance of inventories that include capitalised borrowing costs
(4) Description of the amount of amortisation of the costs to fulfil a contract during the period
69 10 Contract assets
11 Assets held for sale
12 Non-current assets due within one year
Expressed in Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Long-term receivables due within one 594,824,837.00 659,422,600.61 year Less: Provision for impairment -11,511,912.17 -6,088,765.43 Total 583,312,924.83 653,333,835.18 Significant debt investments / other debt investments: Nil
13 Other current assets
Expressed in Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Input tax to be deducted 202,974,843.57 250,438,166.25 Prepaid corporate income tax 10,022,590.99 4,957,759.11 Total 212,997,434.56 255,395,925.36 Other description: N/A
14 Debt investments
15 Other debt investments
70 16 Long-term receivables
(1) Information on long-term receivables
Expressed in Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period Range of Item Provision for Provision for discount Book value Carrying amount Book value Carrying amount impairment impairment rate Receivables on finance 1,221,025,525.17 25,351,636.81 1,195,673,888.36 1,469,566,247.25 13,459,120.72 1,456,107,126.53 leases Including: Unearned 96,716,782.67 96,716,782.67 132,023,477.38 132,023,477.38 finance income Receivables on 21,347,215.18 418,503.91 20,928,711.27 24,926,663.24 349,189.00 24,577,474.24 factoring business Deposit for finance 177,862.28 177,862.28 968,134.42 968,134.42 leases Less: Due within one -594,824,837.00 -11,511,912.17 -583,312,924.83 -659,422,600.61 -6,088,765.43 -653,333,835.18 year Total 647,725,765.63 14,258,228.55 633,467,537.08 836,038,444.30 7,719,544.29 828,318,900.01 -- Less: Provision for bad and doubtful debts for impairment Expressed in Renminbi Yuan
Stage 1 Stage 2 Stage 3 Provision for impairment Lifetime ECL Lifetime ECL Total 12-month ECL (not credit impaired) (credit impaired) Balance at 1 January 2020 3,575,844.11 5,931,254.57 4,301,211.04 13,808,309.72 Balance at 1 January 2020 during the period —— —— —— —— Additions during the period 972,703.79 4,020,440.95 6,968,686.26 11,961,831.00 Balance at 30 June 2020 4,548,547.90 9,951,695.52 11,269,897.30 25,770,140.72 Changes in the book balance with significant changes in loss allowances during the period □Applicable √ Not applicable
(2) Derecognition of long-term receivables due to transfer of financial assets:
(3) Assets and liabilities recognised due to the transfer and continuing involvement of long-term receivables
71 17 Long-term equity investments
Expressed in Renminbi Yuan
Movements during the period Balance of Balance provision Investment Adjustmen Balance (carrying Other Declared for income or losses ts to other Provision (carrying Investee amount) at the Decrease equity distribution of impairm Increase in capital recognised comprehe for Others amount) at the beginning of the in capital moveme cash dividends ent at under equity nsive impairment end of the period period nts or profits the end method income of the period I. Joint ventures II. Associates Hefei Ciming Oasis Health Management Co., 7,240,910.50 -212,389.47 7,028,521.03 Ltd. Dalian Pulan Meinian Health Comprehensive 2,896,172.01 953,072.07 3,849,244.08 Clinic Co., Ltd. Baoshan Meinian Onehealth Checkup Centre 6,291,797.31 -872,402.83 5,419,394.48 Co., Ltd. Jiangsu Huakang Occupational Health 3,699,061.16 32,717.51 3,731,778.67 Consulting Co., Ltd. Wenshan Meinian Onehealth Checkup Centre 5,679,145.09 1,132,040.84 6,811,185.93 Co., Ltd. Anshun Ciming Health Checkup Management 3,408,486.80 -142,066.44 3,266,420.36 Co., Ltd. Fuyang Meinian Onehealth Health 5,813,531.27 126,279.17 5,939,810.44 Management Co., Ltd. Weihai Guoji Meinian Onehealth Checkup 3,970,076.57 -492,986.64 3,477,089.93 Centre Co., Ltd. Weihai Meinian Onehealth Checkup Centre 2,562,919.88 -33,553.98 2,529,365.90 Co., Ltd. Yantai Meinian Onehealth Checkup 1,943,639.01 294,760.17 2,238,399.18 Management Co., Ltd. Dongying Meinian Onehealth Health 4,031,388.11 -505,292.01 3,526,096.10 Management Co., Ltd. Mengcheng Meinian Onehealth Management 2,243,563.36 196,357.30 2,439,920.66 Co., Ltd. Leshan Ciming Health Checkup Service Co., 1,122,101.02 2,100,000.00 289,663.01 3,511,764.03 Ltd.
72 Pizhou Ciming Health Checkup Clinic Co., Ltd. 1,500,913.11 -268,738.49 1,232,174.62 Lianjiang Ciming Health Management Co., Ltd. 1,097,366.34 281,091.30 1,378,457.64 Yangxin Ciming Health Checkup Management 1,599,988.12 -156,540.49 1,443,447.63 Co., Ltd. Luoyang Meinian Onehealth Medical 309,213.03 530,143.39 839,356.42 Technology Co., Ltd. Beijing Langmei Communication Co., Ltd. 413,397.40 79,605.14 493,002.54 Panzhihua Ciming Health Checkup Hospital 83,793.46 -83,793.46 0.00 Co., Ltd. Yinchuan Meinian Onehealth Hospital Co., Ltd. 12,642,815.68 -1,783,916.13 10,858,899.55 Foshan Meinian Onehealth Checkup 77,160,000.00 -2,725,969.95 74,434,030.05 Management Co., Ltd. Harbin Meiming Health Management Co., Ltd. 15,000,000.00 -10,561,036.59 -4,438,963.41 0.00 Guangdong Huanyue Healthcare Co., Ltd. 1,078,656.90 4,384,600.00 1,124,610.35 6,587,867.25 Zhaoqing Meinian Onehealth Health 302,049.41 4,384,600.00 1,290,495.27 5,977,144.68 Management Co., Ltd. Sub-total 162,090,985.54 10,869,200.00 -10,561,036.59 -5,385,777.78 157,013,371.17 Total 162,090,985.54 10,869,200.00 -10,561,036.59 -5,385,777.78 157,013,371.17
18 Investments in other equity instruments
73 19 Other non-current financial assets
Expressed in Renminbi Yuan
Item Balance at the end of the period Balance at the beginning of the period Financial assets at fair value through profit or loss Including: Investments in equity instruments 1,271,876,037.72 1,226,749,518.89 Total 1,271,876,037.72 1,226,749,518.89 Other description: N/A
20 Investment properties
(1) Investment properties measured using a cost model
□Applicable √ Not applicable
(2) Investment properties measured at fair value
□Applicable √ Not applicable
(3) Investment properties pending certificates of ownership
21 Fixed assets
Expressed in Renminbi Yuan
Item Balance at the end of the period Balance at the beginning of the period Fixed assets 2,472,855,083.89 2,608,356,009.29 Total 2,472,855,083.89 2,608,356,009.29
(1) Fixed assets
Expressed in Renminbi Yuan
Plant & Machinery and Item Motor vehicles Others Total buildings equipment I. Cost 1. Balance at the beginning of the 96,990,442.23 3,142,002,444.96 113,709,560.86 322,703,089.96 3,675,405,538.01 period 2. Additions during the period 6,736.85 75,661,995.05 1,563,363.76 7,844,685.58 85,076,781.24 (1) Purchases 29,261,781.15 1,245,294.65 3,929,097.68 34,436,173.48 (2) Transfers from construction in 3,780,290.00 333,800.00 4,114,090.00 progress (3) Additions due to business 6,736.85 42,619,923.90 318,069.11 3,581,787.90 46,526,517.76 combinations 3. Decrease during the period 42,430,689.52 2,304,815.00 5,378,561.39 50,114,065.91 (1) Disposals or written-offs 42,430,689.52 2,304,815.00 5,378,561.39 50,114,065.91 4. Balance at the end of the period 96,997,179.08 3,175,233,750.49 112,968,109.62 325,169,214.15 3,710,368,253.34 II. Accumulated depreciation 1. Balance at the beginning of the 14,294,344.17 829,321,950.98 48,810,458.35 174,622,775.22 1,067,049,528.72 period 2. Additions during the period 1,825,723.98 163,352,172.30 6,435,327.85 29,423,625.97 201,036,850.10
74 (1) Charge for the period 1,825,723.98 163,352,172.30 6,435,327.85 29,423,625.97 201,036,850.10 3. Decrease during the period 24,600,417.35 1,380,245.24 4,592,546.78 30,573,209.37 (1) Disposals or written-offs 24,600,417.35 1,380,245.24 4,592,546.78 30,573,209.37 4. Balance at the end of the period 16,120,068.15 968,073,705.93 53,865,540.96 199,453,854.41 1,237,513,169.45 III. Provision for impairment 1. Balance at the beginning of the
period 2. Additions during the period (1) Charge for the period 3. Decrease during the period (1) Disposals or written-offs 4. Balance at the end of the period IV. Carrying amounts 1. At the end of the period 80,877,110.93 2,207,160,044.56 59,102,568.66 125,715,359.74 2,472,855,083.89 2. At the beginning of the period 82,696,098.06 2,312,680,493.98 64,899,102.51 148,080,314.74 2,608,356,009.29
(2) Temporarily idle fixed assets
Expressed in Renminbi Yuan Accumulated Provision for Item Cost Carrying amount Note depreciation impairment Machinery & equipment 6,849,262.57 4,008,051.79 2,841,210.78
(3) Fixed assets acquired under finance leases
Expressed in Renminbi Yuan Accumulated Provision for Item Cost Carrying amount depreciation impairment Machinery & equipment 99,156,561.36 32,382,316.01 66,774,245.35
(4) Fixed assets leased out under operating leases
Expressed in Renminbi Yuan Item Carrying amount at the end of the period Machinery & equipment 27,981,289.19
(5) Fixed assets pending certificates of ownership
(6) Disposal of fixed assets
75 22 Construction in progress
Unit: Renminbi Yuan
Item Balance at the end of the period Balance at the beginning of the period Construction in progress 82,974,642.29 59,483,859.71 Total 82,974,642.29 59,483,859.71
(1) Construction in progress
Unit: Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period Item Provision for Carrying Provision for Carrying Book value Book value impairment amount impairment amount Store decoration 36,875,944.60 36,875,944.60 25,442,161.23 25,442,161.23 Machinery equipment under 38,750,762.52 38,750,762.52 26,641,876.52 26,641,876.52 installation Medical Service Informationalisation 7,347,935.17 7,347,935.17 7,399,821.96 7,399,821.96 System Construction Project Total 82,974,642.29 82,974,642.29 59,483,859.71 59,483,859.71
(2) Changes in significant construction in progress for the period:
Unit: Renminbi Yuan
Including: Interest rate Percentage Accumul Balance at the Interest for Additions during Transfers to fixed Balance at the of actual Project ated Sources Item Budget beginning of the Other decreases capitalised capitalisation the period assets end of the period cost to progress capitalise of funding period in the in the period budget (%) d interest period (%)
Store decoration 25,442,161.23 27,133,359.57 233,000.00 15,466,576.20 36,875,944.60 In progress Others Machinery equipment 26,641,876.52 15,989,976.00 3,881,090.00 0.00 38,750,762.52 In progress Others under installation Medical Service Informationalisation Fund System 88,424,000.00 7,399,821.96 361,334.12 0.00 413,220.91 7,347,935.17 74.47% In progress raising Construction Project Total 88,424,000.00 59,483,859.71 43,484,669.69 4,114,090.00 15,879,797.11 82,974,642.29 ------
(3) Provision for impairment of construction in progress
(4) Construction materials
23 Bearer biological assets
(1) Bearer biological assets measured at costs
□Applicable √Not applicable
(2) Bearer biological assets measured at fair value
□Applicable √Not applicable
76 24 Oil and gas assets
□Applicable √Not applicable
25 Right-of-use assets
26 Intangible assets
(1) Intangible assets
Unit: Renminbi Yuan
Item Land use rights Patents Non-patents Software Trademarks Total I. Book value 1. Balance at the beginning of 103,119,206.12 103,744,094.16 206,863,300.28 the period 2. Additions during the period 6,067,735.74 6,067,735.74 (1) Purchase 4,980,677.66 4,980,677.66 (2) Internal development (3) Through business 1,087,058.08 1,087,058.08 combination 3. Decreases during the period 232,200.00 232,200.00 (1) Disposal 232,200.00 232,200.00 4. Balance at the end of the 108,954,741.86 103,744,094.16 212,698,836.02 period II. Accumulated amortisation 1. Balance at the beginning of 30,872,092.48 84,037.50 30,956,129.98 period 2. Additions during the period 3,461,111.76 9,454.68 3,470,566.44 (1) Charge for the period 3,461,111.76 9,454.68 3,470,566.44 3. Decreases during the period 56,213.66 56,213.66 (1) Disposal 56,213.66 56,213.66 4. Balance at the end of the 34,276,990.58 93,492.18 34,370,482.76 period III. Provision for impairment 1. Balance at the beginning of 12,000,000.00 12,000,000.00 the period 2. Additions during the period (1) Charge for the period 3. Decreases during the period (1) Disposal 4. Balance at the end of the 12,000,000.00 12,000,000.00 period IV. Carrying value 1. At the end of the period 74,677,751.28 91,650,601.98 166,328,353.26 2. At the beginning of the 72,247,113.64 91,660,056.66 163,907,170.30 period
77 (2) Land use rights pending certificates of ownership
27 Development costs
28 Goodwill
(1) Book value of goodwill
Unit: Renminbi Yuan
Additions during Decrease during Balance at the the period the period Balance at the end Name of investee or events from which goodwill arose beginning of the of the period period for business for disposal combination Ciming Health Checkup Management Group Co., Ltd. 2,862,973,886.23 2,862,973,886.23 Shenzhen Hongkangjie Technology Co., Ltd. 254,541,769.69 254,541,769.69 Xin Xin Healthcare Holding Limited 154,211,053.19 154,211,053.19 Chengdu Tianfu New District Oasis Hospital Co., Ltd. 53,726,006.53 53,726,006.53 Shenzhen Meinian Onehealth Health Management Co., 45,161,039.79 45,161,039.79 Ltd. Urumqi Huarui Tianmei Health Management Co., Ltd. 44,534,692.16 44,534,692.16 Beijing Meinian Meifu Clinic Co., Ltd. 44,210,219.63 44,210,219.63 Chengdu Jinjiang Meinian Onehealth Weikang Checkup 40,543,460.68 40,543,460.68 Clinic Co., Ltd. Meinian Onehealth Healthcare Group Nantong Co., Ltd. 39,554,148.56 39,554,148.56 Hainan Meinian Onehealth Hospital Co., Ltd. 34,798,522.93 34,798,522.93 Hefei Ciming Health Checkup Management Co., Ltd. 33,820,711.17 33,820,711.17 Zhongshan Meinian Onehealth Management Co., Ltd. 31,230,102.57 31,230,102.57 Changchun Baiwei Cikang Hospital Co., Ltd. 30,333,493.00 30,333,493.00 Wuhan Gaoxin Clinic Co., Ltd. 28,736,159.04 28,736,159.04 Xiangyang Meinian Onehealth Management Co., Ltd. 25,797,617.78 25,797,617.78 Xinjiang Puhui Antai Health Management Co., Ltd. 25,685,129.27 25,685,129.27 Zhuzhou Meinian Onehealth Health Management Co., 25,431,489.53 25,431,489.53 Ltd. Dali Meinian Onehealth Checkup Hospital Co., Ltd. 25,152,873.60 25,152,873.60 Wenzhou Oasis Hospital Co., Ltd. 24,782,474.88 24,782,474.88 Dalian Lvshun Meinian Onehealth New Town 24,092,312.78 24,092,312.78 Comprehensive Clinic Co., Ltd. Luoyang Meinian Onehealth Technology Co., Ltd. 23,208,425.08 23,208,425.08 Liaoyang Meinian Onehealth Health Management Co., 22,460,719.71 22,460,719.71 Ltd. Hangzhou Meixi Medical Clinic Co., Ltd. 22,377,861.17 22,377,861.17 Yantai Ciming Health Checkup Management Co., Ltd. 22,367,134.88 22,367,134.88 Heyuan Meinian Onehealth Management Co., Ltd. 21,018,412.69 21,018,412.69 Pu'er Meinian Onehealth Checkup Centre Co., Ltd. 20,616,526.97 20,616,526.97 Tianjin Binhai New Area Meixin Clinic Co., Ltd. 20,607,947.55 20,607,947.55 Huludao Meinian Onehealth Management Co., Ltd. 20,262,901.85 20,262,901.85 Xiangtan Meinian Onehealth Health Management Co., 20,192,982.14 20,192,982.14 Ltd. Xinxiang Meinian Onehealth Management Co., Ltd. 19,618,877.76 19,618,877.76 Puyang Meinian Onehealth Consulting Co., Ltd. 19,563,520.73 19,563,520.73 Mianyang Meinian Onehealth Technology Co., Ltd. 19,463,255.70 19,463,255.70 Heze Meinian Onehealth Checkup Management Co., 19,239,221.74 19,239,221.74
78 Ltd. Pingdingshan Meinian University Health Science and 18,733,424.54 18,733,424.54 Technology Service Co., Ltd. Ningbo Haishu Meinian Comprehensive Clinic Co., Ltd. 18,493,131.07 18,493,131.07 Yuxi Meinian Onehealth Healthcare Co., Ltd. 17,405,420.27 17,405,420.27 Xinyang Meinian Onehealth Management Co., Ltd. 17,374,313.70 17,374,313.70 Dandong Meinian Onehealth Health Management Co., 16,972,358.06 16,972,358.06 Ltd. Leshan Meinian Onehealth Service Co., Ltd. 16,831,918.70 16,831,918.70 Suzhou Meida Clinic Co., Ltd. 16,805,612.94 16,805,612.94 Xiamen Meinian Onehealth Management Co., Ltd. 16,743,631.51 16,743,631.51 Xichang Meinian Onehealth Health Management Co., 16,526,450.46 16,526,450.46 Ltd. Nanchang Meikang Health Checkup Centre Co., Ltd. 16,268,029.59 16,268,029.59 Wuhan Meinian Yisheng Health Management Co., Ltd. 15,407,646.36 15,407,646.36 Yili Meinian Onehealth Management Co., Ltd. 15,243,237.37 15,243,237.37 Suining Meinian Onehealth Checkup Hospital Co., Ltd. 15,162,158.92 15,162,158.92 Chongqing Meinian Onehealth Management Co., Ltd. 15,141,474.53 15,141,474.53 Daye Meinian Onehealth Checkup Management Co., 14,851,246.44 14,851,246.44 Ltd. Tongliao Ciming Health Management Co., Ltd. 14,101,048.93 14,101,048.93 Deyang Meinian Onehealth Checkup Hospital Co., Ltd. 13,979,871.26 13,979,871.26 Guangyuan Meinian Onehealth Technology Co., Ltd. 13,249,795.94 13,249,795.94 Zhengzhou Meinian Healthcare Management Co., Ltd. 13,241,169.48 13,241,169.48 Wuhan Meinian Health Management Co., Ltd. 12,672,055.29 12,672,055.29 Handan Meinian Onehealth Management Co., Ltd. 12,625,237.93 12,625,237.93 Songyuan Meinian Onehealth Health Management Co., 12,293,726.18 12,293,726.18 Ltd. Yueyang Meinian Onehealth Health Management Co., 12,198,944.99 12,198,944.99 Ltd. Anhui Ciji Medical Investment Management Co., Ltd. 11,952,496.78 11,952,496.78 Bozhou Meinian Onehealth Health Management Co., 11,804,045.18 11,804,045.18 Ltd. Jinzhong Meinian Onehealth Management Co., Ltd. 11,707,167.20 11,707,167.20 Jiaxing Meinian Onehealth Management Co., Ltd. 11,610,377.94 11,610,377.94 Ezhou Meinian Onehealth Management Co., Ltd. 11,413,988.07 11,413,988.07 Taian Meinian Onehealth Checkup Management Co., 11,387,029.68 11,387,029.68 Ltd. Nanchang Honggu Changgeng Health Checkup Centre 11,022,422.73 11,022,422.73 Co., Ltd. Beijing Ciming Oasis Shangdi Brilliant Clinic Co., Ltd. 10,610,598.31 10,610,598.31 Xi’an Meinian Onehealth Health Management Co., Ltd. 9,852,788.67 9,852,788.67 Hami Meinian Onehealth Health Management Co., Ltd. 9,758,261.51 9,758,261.51 Yichun Meinian Onehealth Checkup Centre Co., Ltd. 8,806,225.48 8,806,225.48 Lanzhou Meinian Onehealth Jinmao Health Management 8,805,882.61 8,805,882.61 Co., Ltd. Linyi Onehealth Health Checkup Archives Management 8,782,601.72 8,782,601.72 Co., Ltd. Weifang Meinian Huier Health Management Co., Ltd. 8,210,833.00 8,210,833.00 Linyi Meinian Health Checkup Management Co., Ltd. 7,810,130.25 7,810,130.25 Changchun Meinian Onehealth Yuchen Hospital Co., Ltd. 7,776,353.10 7,776,353.10 Ningbo Yinzhou Yihe Comprehensive Clinic Co., Ltd. 7,539,701.89 7,539,701.89 Wuhan Meinian Onehealth Checkup Management Co., 7,270,863.41 7,270,863.41 Ltd.
79 Beijing Meinian Jiajing Clinic Co., Ltd. 6,422,121.73 6,422,121.73 Beijing Lvshengyuan Outpatient Dept Co., Ltd. 5,956,525.00 5,956,525.00 Weifang Meinian Onehealth Health Management Co., 5,588,566.83 5,588,566.83 Ltd. Guizhou Meinian Onehealth Kangyuan Checkup Centre 5,051,457.36 5,051,457.36 Co., Ltd. Guangdong Youyi Health Management Co., Ltd. 5,009,235.97 5,009,235.97 Anhui Meinian Onehealth Management Consulting Co., 4,247,500.31 4,247,500.31 Ltd. Jiangsu Huakang Investment Development Co., Ltd. 4,216,052.41 4,216,052.41 Chengdu Kaier Health Checkup Hospital Co., Ltd. 3,493,347.97 3,493,347.97 Kaifeng Meinian Onehealth Health Management Co., 2,486,575.83 2,486,575.83 Ltd. Changshu Meinian Onehealth Clinic Co., Ltd. 2,010,087.46 2,010,087.46 Jinzhou Meinian Health Management Co., Ltd. 1,893,765.66 1,893,765.66 Jiyuan Meinian Onehealth Technology Co., Ltd. 1,732,493.87 1,732,493.87 Nanjing Yikang Special Out-patient Department Co., Ltd. 839,465.05 839,465.05 Sichuan Hongkangjie Medical Investment Management 91,940.40 91,940.40 Co., Ltd. Anhui Nuoyi Health Management Co., Ltd. 109,184,600.05 109,184,600.05 Fuqing Meinian Onehealth Management Co., Ltd. 45,272,666.54 45,272,666.54 Tangshan Meinian Onehealth Health Checkup 36,223,524.36 36,223,524.36 Management Co., Ltd. Hainan Ciming Oasis Checkup Hospital Co., Ltd. 25,887,689.51 25,887,689.51 Hangzhou Xiaoshan Meinian Jincheng Comprehensive 24,722,422.62 24,722,422.62 Clinic Co., Ltd. Jiangmen Meinian Onehealth Health Management Co., 24,685,452.97 24,685,452.97 Ltd. Zigong Meinian Onehealth Checkup Hospital Co., Ltd. 18,135,727.98 18,135,727.98 Xining Meinian Onehealth Health Management Co., Ltd. 17,252,848.83 17,252,848.83 Zhumadian Meinian Onehealth Technology Co., Ltd. 16,512,093.80 16,512,093.80 Huizhou Meinian Onehealth Health Management Co., 16,402,015.11 16,402,015.11 Ltd. Qingyang Meinian Onehealth Health Management Co., 16,116,850.67 16,116,850.67 Ltd. Anyang Meinian Onehealth Management Co., Ltd. 14,208,309.91 14,208,309.91 Neijiang Meinian Onehealth Health Management Co., 13,231,552.78 13,231,552.78 Ltd. Shantou Meinian Health Management Co., Ltd. 13,177,404.57 13,177,404.57 Meishan Meinian Onehealth Management Co., Ltd. 12,802,135.40 12,802,135.40 Suzhou Meinian Onehealth Health Management Co., 10,613,557.69 10,613,557.69 Ltd. Liaocheng Meinian Onehealth Management Co., Ltd. 10,143,665.41 10,143,665.41 Suizhou Meinian Onehealth Management Co., Ltd. 8,845,502.82 8,845,502.82 Fuxin Meinian Onehealth Health Management Co., Ltd. 7,990,344.27 7,990,344.27 Harbin Meiming Health Management Co., Ltd. 41,744,537.03 41,744,537.03 Anhui Meixin Health Management Consulting Co., Ltd. 18,892,099.60 18,892,099.60 Wuxi Meihua Clinic Co., Ltd. 24,671,894.26 24,671,894.26 Wuhan Dongxihu Ciming Checkup Management Co., 16,411,088.68 16,411,088.68 Ltd. Total 5,139,206,124.11 101,719,619.57 5,240,925,743.68
80 (2) Provision for impairment of goodwill
Unit: Renminbi Yuan
Additions Decrease Balance at the during the during the Balance at the end Name of investee or events from which goodwill arose beginning of the period period of the period period Provision Disposal Ciming Health Checkup Management Group Co., Ltd. 572,888,613.49 572,888,613.49 Shenzhen Hongkangjie Technology Co., Ltd. 66,810,311.94 66,810,311.94 Xin Xin Healthcare Holding Limited 95,821,706.84 95,821,706.84 Anhui Nuoyi Health Management Co., Ltd. 10,896,907.63 10,896,907.63 Chengdu Tianfu New District Oasis Hospital Co., Ltd. 44,810,200.12 44,810,200.12 Chengdu Jinjiang Meinian Onehealth Weikang Checkup Clinic 6,946,731.51 6,946,731.51 Co., Ltd. Meinian Onehealth Healthcare Group Nantong Co., Ltd. 12,266,372.30 12,266,372.30 Tangshan Meinian Onehealth Health Checkup Management Co., 1,905,779.78 1,905,779.78 Ltd. Hainan Meinian Onehealth Hospital Co., Ltd. 9,288,322.11 9,288,322.11 Wuhan Gaoxin Clinic Co., Ltd. 11,383,345.73 11,383,345.73 Xinjiang Puhui Antai Health Management Co., Ltd. 6,602,904.33 6,602,904.33 Zhuzhou Meinian Onehealth Health Management Co., Ltd. 9,496,047.36 9,496,047.36 Wenzhou Oasis Hospital Co., Ltd. 18,719,275.20 18,719,275.20 Hangzhou Xiaoshan Meinian Jincheng Comprehensive Clinic 18,802,496.69 18,802,496.69 Co., Ltd. Hangzhou Meixi Medical Clinic Co., Ltd. 3,031,393.18 3,031,393.18 Pu'er Meinian Onehealth Checkup Centre Co., Ltd. 10,716,152.83 10,716,152.83 Xiangtan Meinian Onehealth Health Management Co., Ltd. 15,669,950.00 15,669,950.00 Mianyang Meinian Onehealth Technology Co., Ltd. 19,463,255.70 19,463,255.70 Zigong Meinian Onehealth Checkup Hospital Co., Ltd. 7,715,408.09 7,715,408.09 Leshan Meinian Onehealth Service Co., Ltd. 31,230.41 31,230.41 Suzhou Meida Clinic Co., Ltd. 8,118,597.24 8,118,597.24 Xichang Meinian Onehealth Health Management Co., Ltd. 4,391,268.33 4,391,268.33 Wuhan Meinian Yisheng Health Management Co., Ltd. 11,482,307.98 11,482,307.98 Deyang Meinian Onehealth Checkup Hospital Co., Ltd. 11,171,023.21 11,171,023.21 Guangyuan Meinian Onehealth Technology Co., Ltd. 7,702,423.25 7,702,423.25 Meishan Meinian Onehealth Management Co., Ltd. 5,491,708.06 5,491,708.06 Ezhou Meinian Onehealth Management Co., Ltd. 1,442,654.86 1,442,654.86 Nanchang Honggu Changgeng Health Checkup Centre Co., Ltd. 8,810,098.78 8,810,098.78 Suizhou Meinian Onehealth Management Co., Ltd. 820,194.59 820,194.59 Weifang Meinian Huier Health Management Co., Ltd. 8,210,833.00 8,210,833.00 Ningbo Yinzhou Yihe Comprehensive Clinic Co., Ltd. 7,539,701.89 7,539,701.89 Wuhan Meinian Onehealth Checkup Management Co., Ltd. 961,943.65 961,943.65 Beijing Meinian Jiajing Clinic Co., Ltd. 1,067,764.28 1,067,764.28 Beijing Lvshengyuan Outpatient Dept Co., Ltd. 1,287,275.32 1,287,275.32 Weifang Meinian Onehealth Health Management Co., Ltd. 4,090,933.33 4,090,933.33 Guangdong Youyi Health Management Co., Ltd. 4,135,484.55 4,135,484.55 Chengdu Kaier Health Checkup Hospital Co., Ltd. 3,049,001.23 3,049,001.23 Jinzhou Meinian Health Management Co., Ltd. 935,897.25 935,897.25 Nanjing Yikang Special Out-patient Department Co., Ltd. 839,465.05 839,465.05 Total 1,034,814,981.09 1,034,814,981.09
81 Information about an asset group or a set of asset groups which goodwill is allocated to Description of the process, the parameters (such as the growth rate for the forecast period, growth rate for the stable period, profit margin, discount rate and forecast period used to estimate the present value of expected future cash flows) used for impairment testing for goodwill, and the method used to determine the impairment loss: Nil The impact of the impairment testing: Nil Other description: N/A
29 Long-term deferred expenses
Unit: Renminbi Yuan Balance at the Additions during Amortisation for Balance at the end Item beginning of the Other decreases the period the period of the period period Store decoration 635,559,341.54 62,610,090.84 132,290,352.10 221,893.98 565,657,186.30 Office buildings 62,252,269.77 2,505,383.58 59,746,886.19 renovation Prepayment for obligations under 15,750,000.21 605,769.24 15,144,230.97 leases Financial services 13,542,273.07 1,471,698.11 12,070,574.96 custody fee Others 9,294,468.06 8,704,895.42 8,030,344.62 9,969,018.86 Total 736,398,352.65 71,314,986.26 144,903,547.65 221,893.98 662,587,897.28
30 Deferred tax assets/deferred tax liabilities
(1) Deferred tax assets before offsetting
Unit: Renminbi Yuan Balance at the beginning of the Balance at the end of the period period Item Deductible Deductible Deferred tax Deferred tax temporary temporary assets assets differences differences Provision for impairment of assets 233,300,041.52 48,881,719.18 184,216,615.65 38,214,217.93 Unrealised profits of intra-group 13,656,811.24 3,414,202.81 17,530,430.11 4,382,607.53 transactions Deductible tax losses 1,320,407,211.27 277,627,503.10 354,023,428.32 50,029,387.22 Acquisition of fixed assets under finance 31,801,104.23 7,163,351.92 24,577,743.28 5,509,371.83 leases Deferred income 15,726,923.04 3,526,730.76 8,183,333.33 1,610,833.33 Impairment due to business combinations involving entities not under common 538,649.88 134,662.47 799,811.63 199,952.91 control Financial assets held for trading 6,978,395.06 1,395,679.01 Others 9,681,300.07 1,775,605.48 1,028,067.84 213,261.94 Total 1,632,090,436.31 343,919,454.73 590,359,430.16 100,159,632.69
82 (2) Deferred tax liabilities before offsetting
Unit: Renminbi Yuan Balance at the beginning of the Balance at the end of the period period Item Taxable temporary Deferred tax Taxable temporary Deferred tax differences liabilities differences liabilities Revaluation due to business combinations involving entities not 17,939,931.44 3,451,642.81 20,568,260.79 3,957,992.89 under common control Changes in fair value of other debt 2,266,671.52 671,122.71 investments Changes in fair value of investments in 4,424,000.00 1,106,000.00 other equity instruments Total 24,630,602.96 5,228,765.52 20,568,260.79 3,957,992.89
(3) Deferred tax assets/liabilities after offsetting:
Unit: Renminbi Yuan Amount of offsetting of Balances of deferred Amount of offsetting of Balances of deferred deferred tax assets tax assets or liabilities deferred tax assets tax assets or liabilities Item and liabilities at the after offsetting at the and liabilities at the after offsetting at the end of the period end of the period beginning of the period beginning of the period Deferred tax assets 343,919,454.73 100,159,632.69 Deferred tax liabilities 5,228,765.52 3,957,992.89
(4) Details of unrecognised deferred tax assets
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Deductible tax losses 1,338,879,379.83 1,141,158,664.63 Total 1,338,879,379.83 1,141,158,664.63
(5) Deductible tax losses, for which no deferred tax assets were recognised, will expire in the following years
Unit: Renminbi Yuan Amount at the end of the Amount at the beginning of Year Note period the period 2020 22,505,539.09 33,986,068.92 2021 138,382,107.95 143,422,531.74 2022 176,888,445.82 190,326,903.25 2023 193,918,826.41 163,070,904.58 2024 499,965,486.19 610,352,256.14 2025 307,218,974.37 Total 1,338,879,379.83 1,141,158,664.63 --
83 31 Other non-current assets
Unit: Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period Item Provision for Provision for Book value Carrying amount Book value Carrying amount impairment impairment Prepayments for 536,862,039.68 536,862,039.68 208,958,230.00 208,958,230.00 equity acquisition Prepayments for the 22,085,912.64 22,085,912.64 28,389,837.10 28,389,837.10 equipment Total 558,947,952.32 558,947,952.32 237,348,067.10 237,348,067.10
32 Short-term loans
(1) Short-term loans by category
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Pledged loans 64,328,380.65 116,295,256.70 Mortgaged loans 47,000,000.00 42,000,000.00 Guaranteed loans 1,921,600,000.00 2,142,500,000.00 Unsecured loans 5,800,000.00 Interest on short-term loans 2,532,250.39 8,274,675.42 Total 2,041,260,631.04 2,309,069,932.12 Description of short-term loans classification:
Pledged loans:
Note 1: In 2019, Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged finance lease receivables as security for the borrowings from BNP Paribas (China) Ltd., with maximum guarantee amount of RMB 100 million offered by the Company. As at 30 June 2020, the loan balance is RMB 64,328,400.
Mortgaged loans:
Note 2: In 2019, Ciming Health Checkup Management Group Co., Ltd., a subsidiary of the Company, borrowed RMB 42 million from China Guangfa Bank Co., Ltd. Beijing Weigongcun Branch against the fixed assets. As at 30 June 2020, the loan balance is RMB 42 million. Note 3: In 2020, Hainan Meinian Onehealth Hospital Co., Ltd., a subsidiary of the Company, borrowed RMB 3.5 million from Bank of Communications Co. Ltd. Hainan Province Branch by securing a store located at Store A301, Floor 3, Building 1 and 2, Binjiang Holiday City, No. 362, Binjiang Road, Qiongshan District, Haikou City (Property Ownership Certificate No.: Haikou City Property Ownership Certificate Hai Fang Zi No. HK454142) with joint liability guarantee provided by Sha Qibin and Liu Xiaofeng. As at 30 June 2020, the loan balance is RMB 3.5 million.
84 Note 4: In 2020, Zigong Meinian Onehealth Checkup Hospital Co., Ltd., a subsidiary of the Company, borrowed RMB 1.5 million from Zigong Bank Co., Ltd. against the fixed assets. Bai Huifang, a shareholder, and Wu Xueying, a natural person, provided guarantees for the loan with maximum guarantee amount of RMB 1.8 million; He Lipei, a natural person, provided his property located at No. 10, Unit 1, Block 24, Group 10, Lvsheng Community Neighbourhood Committees, New Huidong District (Property Ownership Certificate No.: Zi Property Ownership Certificate Gao Xin Zi No. 00108134, Zi Guo Yong 2004 No. 01420) as collateral for the loan with maximum guarantee amount of RMB 579,000; and Qiu Wei, a natural person, provided his property located at No. 1, Floor 1, Unit 2, Block 4, Xiandu Garden, Fenghuang Country Ji Gong Community Neighbourhood Committees, Da’an District, Zigong City (Property Ownership Certificate No.: Zi Property Ownership Certificate Shi Zi No. 00163843, Zi Guo Yong 2009 No. 042426) as collateral for the loan with maximum guarantee amount of RMB 615,500. As at 30 June 2020, the loan balance is RMB 1.5 million.
Guaranteed loans：
Note 5: In 2019 and 2020, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, for the cumulative loan amounted to RMB 1,091.5 million obtained from China Minsheng Bank Co., Ltd., Shanghai Branch. As at 30 June 2020, the loan balance is RMB 530 million. Note 6: In 2019 and 2020, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, for the cumulative loan amounted to RMB 525 million obtained from Shanghai Pudong Development Bank Co., Ltd. Qingpu Branch. As at 30 June 2020, the loan balance is RMB 330 million. Note 7: In 2019, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, for the cumulative loan amounted to RMB 300 million obtained from China Citic Bank Corporation Limited Shanghai Branch. As at 30 June 2020, the loan balance is RMB 300 million. Note 8: In 2020, the Company provided guarantee for its subsidiary, Meinian Onehealth, for the revolving loan amounted to RMB 210 million obtained from Citibank (China) Co., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 200 million. Note 9: In 2018, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, to borrow RMB 80 million from Ping An Bank Co., Ltd. Shanghai Branch. Meinian Onehealth also provided pledge guarantee for the performance of the contract under the Company’s guarantee by using 100% of its equity in Shanghai Meijian Clinic Co., Ltd. and Shanghai Meijin Clinic Co., Ltd. as collateral. As at 30 June 2020, the loan balance is RMB 52 million. Note 10: In 2020, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, to borrow RMB 80 million from HSBC Bank (China) Company Limited Shanghai Branch. As at 30 June 2020, the loan balance is RMB 80 million. Note 11: In 2020, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, to borrow RMB 200 million from China Merchants Bank Co., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 200 million.
85 Note 12: In 2020, the Company provided guarantee for Meinian Onehealth, a subsidiary of the Company, to borrow RMB 150 million from Bank of Shanghai Co., Ltd. Pudong Branch. As at 30 June 2020, the loan balance is RMB 150 million. Note 13: In 2019, the Company provided guarantee for Shanghai Meixin Financial Leasing Co., Ltd., a subsidiary of the Company, to borrow RMB 30 million from Ningbo Commerce Bank Co., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 29.8 million. Note 14: In 2019, Wuxi Huakang Clinic Co., Ltd., a subsidiary of the Company, borrowed RMB 4 million from Agricultural Bank of China Co., Ltd. Wuxi Binhu Branch. guaranteed by Xu Zhaorong and Ren Liping with the maximum guarantee amount of RMB 5.5 million. As at 30 June 2020, the loan balance is RMB 4 million. Note 15: In 2019, Jiaxing Meinian Onehealth Management Co., Ltd., a subsidiary of the Company, entered into a loan contract with Bank of Jiaxing Co., Ltd. Technology Branch guaranteed by Xu Yongjun and Wu Minhua. As at 30 June 2020, the loan balance is RMB 3 million. Note 16: In 2019, Jiangmen Meinian Onehealth Health Management Co., Ltd., a subsidiary of the Company, entered into a loan contract with China Construction Bank Corporation Jiangmen Branch guaranteed by Wang Chaoting and Xiao Yu. As at 30 June 2020, the loan balance is RMB 1 million. Note 17: In 2020, the Company provided guarantee for Shanghai Meinian Clinic Co., Ltd., a subsidiary of the Company, to borrow RMB 30 million from Bank of Nanjing Co., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 30 million. Note 18: In 2020, Suzhou Industrial Park Meinian Clinic Co., Ltd., a subsidiary of the Company, entered into a loan contract with Bank of China Co., Ltd. Suzhou High-tech Industry Development Zone Branch guaranteed by Li Lin and Li Ruihong with the maximum guarantee amount of RMB 6 million. As at 30 June 2020, the loan balance is RMB 6 million. Note 19: In 2020, Shanghai Meidong Clinic Co., Ltd. a subsidiary of the Company, entered into a loan contract with Bank of China Co., Ltd. Shanghai Zhabei Branch guaranteed by Li Lin and Li Ruihong with the maximum guarantee amount of RMB 3 million. As at 30 June 2020, the loan balance is RMB 3 million. Note 20: In 2020, Ningbo Haishu Meinian Comprehensive Clinic Co., Ltd., a subsidiary of the Company, entered into a loan contract with Zhejiang Tailong Commercial Bank Co., Ltd. Ningbo Haishu Branch guaranteed by Cao Kejian. As at 30 June 2020, the loan balance is RMB 2.8 million.
86 Unsecured loans:
Note 21: In 2020, Ningbo Haishu Meinian Comprehensive Clinic Co., Ltd., a subsidiary of the Company, entered into a loan contract with Ningbo Urban Area Rural Credit Cooperative Association Credit Union Xijiao. As at 30 June 2020, the loan balance is RMB 3 million. Note 22: In 2020, Weifang Meinian Onehealth Health Management Co., Ltd., a subsidiary of the Company, entered into a loan contract with Industrial and Commercial Bank of China Limited Weifang Dongguan Branch. As at 30 June 2020, the loan balance is RMB 2 million. Note 23: In 2020, Hunan Meinian Onehealth Management Co., Ltd., a subsidiary of the Company, borrowed RMB 0.8 million from China Construction Bank Co., Ltd. Changsha Huoxing Branch. As at 30 June 2020, the loan balance is RMB 0.8 million.
(2) Past due short-term loans
33 Financial liabilities held for trading
34 Derivative financial liabilities
35 Bills payable
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Bank acceptance bills 16,050,200.00 636,592.00 Total 16,050,200.00 636,592.00 The total balance of due but unpaid bills payable at the end of the period is RMB 0.
36 Accounts payable
(1) Details of accounts payable are as follows:
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Materials fee payable 365,964,810.06 368,900,965.14 Housing rent and property charges 244,318,201.89 202,369,216.04 payable Examination delivery fee payable 142,311,502.08 117,161,597.06 Outsourced checkup fee payable 41,839,009.76 123,913,589.79 Consulting fee payable 17,706,746.32 20,734,151.99 Equipment detection and maintenance 2,346,936.92 3,526,800.82 fees payable Vehicle renting fee payable 2,999,723.41 4,700,883.84 Others 21,406,701.95 21,650,741.72 Total 838,893,632.39 862,957,946.40
87 (2) Significant accounts payable with ageing of more than one year
37 Advance payments received
(1) Details of advance payments received are as follows:
(2) Significant advance payments received with ageing of more than one year:
38 Contract liabilities
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Physical examination fee 1,184,164,386.58 1,197,582,771.81 Finance leases consulting fee 184,453,253.05 221,030,265.40 Membership expense 15,238,628.21 19,496,516.70 Testing fee 7,435,011.45 6,229,544.62 Franchise fee 2,450,000.00 3,146,293.18 Total 1,393,741,279.29 1,447,485,391.71
39 Employee benefits payable
(1) Employee benefits payable:
Unit: Renminbi Yuan
Balance at the Balance at the Accrued during the Decreased during Item beginning of the end of the period the period period period I. Short-term employee benefits 450,889,700.27 1,166,262,509.06 1,217,451,010.19 399,701,199.14 II. Post-employment benefits - defined contribution plan 6,223,010.50 34,849,616.70 24,675,388.86 16,397,238.34 Total 457,112,710.77 1,201,112,125.76 1,242,126,399.05 416,098,437.48
(2) Short-term employee benefits:
Unit: Renminbi Yuan
Balance at the Balance at the Accrued during the Decreased during Item beginning of the end of the period the period period period 1. Salaries, bonuses, allowances 438,909,202.38 1,055,118,073.89 1,130,054,583.52 363,972,692.75 2. Staff welfare 779,091.93 27,715,995.97 27,441,154.03 1,053,933.87 3. Social insurance 4,167,726.47 42,393,437.79 29,738,824.05 16,822,340.21 Including: Medical insurance 3,611,037.54 38,924,664.08 27,796,724.45 14,738,977.17 Work-related injury insurance 136,311.02 629,467.02 498,751.46 267,026.58 Maternity insurance 420,377.91 2,839,306.69 1,443,348.14 1,816,336.47 4. Housing fund 2,622,085.28 33,994,764.94 24,287,373.16 12,329,477.06 5. Labour union fee, staff and workers’ education fee 4,411,594.21 7,040,236.47 5,929,075.43 5,522,755.25 Total 450,889,700.27 1,166,262,509.06 1,217,451,010.19 399,701,199.14
88 (3) Defined contribution plans
Unit: Renminbi Yuan Balance at the Accrued during the Decreased during the Balance at the end of Item beginning of the period period period the period 1. Basic pension 5,939,373.60 33,925,579.50 24,135,427.70 15,729,525.40 insurance 2. Unemployment 283,636.90 924,037.20 539,961.16 667,712.94 insurance Total 6,223,010.50 34,849,616.70 24,675,388.86 16,397,238.34 Other description: N/A
40 Taxes payable
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Value-added tax (VAT) 4,161,028.20 13,406,224.42 Corporate income tax 28,974,528.96 172,283,308.43 Individual income tax 5,719,033.56 11,757,922.71 Urban maintenance and construction 29,592.02 474,771.22 tax Education surcharges 32,600.69 412,462.91 Security fund for the disabled 1,476,054.55 1,361,142.20 Stamp duty 63,005.79 302,558.42 Others 249,375.20 245,574.07 Total 40,705,218.97 200,243,964.38 Other description: N/A
41 Other payables
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Dividends payable 5,790,503.84 7,767,421.57 Others 334,596,324.61 381,668,871.37 Total 340,386,828.45 389,436,292.94
(1) Interest payable
(2) Dividends payable
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Dividends for ordinary shares 5,790,503.84 7,767,421.57 Total 5,790,503.84 7,767,421.57 Other descriptions, including reasons for significant dividends not paid in one year: Not applicable
89 (3) Others
1) Details of others by nature are as follows:
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Equity acquisition fee 45,698,089.04 103,255,550.88 Equipment fee payable for finance 4,210,000.00 37,725,400.00 lease company Amounts due to other entities 90,551,616.81 66,985,686.42 Renovation costs payable 34,724,150.05 42,127,572.24 Equipment fee payable 35,680,309.39 26,102,571.15 Deposits 19,274,863.41 23,310,714.43 Warranty for acquisition of equipment 18,501,000.00 18,501,000.00 Borrowings from non-controlling 23,092,331.13 23,117,290.71 shareholders Service fee payable 4,634,855.02 5,984,351.19 Withholding social insurance 23,447,272.15 7,118,518.86 Others 34,781,837.61 27,440,215.49 Total 334,596,324.61 381,668,871.37
2) Significant other payables aged over one year:
Unit: Renminbi Yuan Item Balance at the end of the period Reason for no repayment or transfer Shanghai United Imaging Healthcare Deposit for acquisition of equipment 18,501,000.00 Co., Ltd. of finance lease company Borrowings from non-controlling Zhou* 15,094,972.10 shareholders Shanghai Seagull Holding (Group) 6,660,000.00 Pending debt-for-equity swap Co., Ltd. Luo* 5,227,972.00 Equity acquisition fee Total 45,483,944.10 --
42 Liabilities held for sale
90 43 Non-current liabilities due within one year
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Long-term loans due within one year 1,016,343,024.93 1,180,384,604.47 Debentures payable due within one 1,398,604,809.04 898,696,132.75 year Long-term payables due within one 134,325,015.79 160,350,161.52 year Interest on long-term loans due within 9,269,814.41 8,997,541.61 one year Interest on debentures payable due 26,823,436.21 67,607,876.46 within one year Total 2,585,366,100.38 2,316,036,316.81 Other description: N/A
44 Other current liabilities
45 Long-term loans
(1) Long-term loans by category
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Pledged loans 1,325,256,652.68 1,350,035,715.07 Mortgaged loans 6,973,461.61 9,138,320.42 Guaranteed loans 1,062,000,000.00 984,000,000.00 Unsecured loans 170,000,000.00 20,000,000.00 Less: Long-term loans due within one -1,016,343,024.93 -1,180,384,604.47 year Total 1,547,887,089.36 1,182,789,431.02 Description of long-term loans classification:
Pledged loans: Note 1: In 2015, Meinian Onehealth, a subsidiary of the Company, pledged 31% of its equity in Shenzhen Hongkangjie Technology Co., Ltd. as security for borrowings of RMB 42 million from Shanghai Pudong Development Bank Co., Ltd. Qingpu Branch. As at 30 June 2020, the loan balance is RMB 32 million, with RMB 2 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 2: In 2017, Meinian Onehealth, a subsidiary of the Company, obtained RMB 50 million of borrowings from China Merchants Bank Co., Ltd. Shanghai Branch by pledging 85% of its equity in Chengdu Tianfu New District Oasis Hospital Co., Ltd., 51% of its equity in Ningbo Haishu Meinian Comprehensive Clinic Co., Ltd., 80.66% of its equity in Suzhou Meida Clinic Co., Ltd. and its deposit of RMB 13 million as security. As at 30 June 2020, the loan balance is RMB 13 million and has been recognised in “non-current liabilities due within one year”.
91 Note 3: In 2018 and 2019, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 349.42 million from Ping An Bank Co., Ltd. Shanghai Branch by pledging 51% of its equity in Xinxiang Meinian Onehealth Management Co., Ltd., 51% of its equity in Wuhan Meinian Health Management Co., Ltd., 72% of its equity in Xiangyang Meinian Onehealth Management Co., Ltd., 75% of its equity in Hainan Meinian Onehealth Hospital Co., Ltd. and 100% of its equity in Beijing Meinian Meifu Clinic Co., Ltd. as security. As at 30 June 2020, the loan balance is RMB 214.2 million, with RMB 71.4 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 4: In 2019, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 7 million from China Everbright Bank Shanghai Songjiang Branch by pledging 58.66% of its equity in Hangzhou Meixi Medical Clinic Co., Ltd. as security, guaranteed by the Company. As at 30 June 2020, the loan balance is RMB 4.9 million, with RMB 1.4 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 5: In 2016, 2017, 2018 and 2019, Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged finance lease receivables as security for borrowings from Shanghai Pudong Development Bank Corp., Ltd. Qingpu Branch, with maximum guarantee amount not exceeding RMB 194 million offered by the Company from period from 2016 to 2024. As at 30 June 2020, the loan balance is RMB 231,831,100, with RMB 90,993,800 to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 6: In 2016, 2017, 2018, 2019 and 2020, Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged finance lease receivables as security for borrowings from HSBC Bank (China) Company Limited Shanghai Branch, with maximum guarantee amount not exceeding RMB 495 million offered by the Company. As at 30 June 2020, the loan balance is RMB 286,349,300, with RMB 227,432,200 to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 7: In 2017, 2018, 2019, and 2020, Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged finance lease receivables as security for borrowings from Hang Seng Bank (China) Limited Shanghai Branch, with maximum guarantee amount not exceeding RMB 150 million offered by the Company. As at 30 June 2020, the loan balance is RMB 44,186,500 and has been recognised in “non- current liabilities due within one year”. Note 8: In 2018 and 2019, Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged finance lease receivables as security for borrowings from China Everbright Bank Shanghai Songjiang Branch, with maximum guarantee amount not exceeding RMB 200 million offered by the Company. As at 30 June 2020, the loan balance is RMB 100,106,200, with RMB 39,837,100 to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”.
92 Note 9: In 2018 and 2019, Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged finance lease receivables as security for borrowings from DBS Bank (China) Limited, with maximum guarantee amount not exceeding RMB 200 million offered by the Company. As at 30 June 2020, the loan balance is RMB 99,983,600, with RMB 69,145,500 to be due on 30 June 2021 and recognised in “non- current liabilities due within one year”. Note 10: In 2020, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 15 million from China Everbright Bank Shanghai Songjiang Branch by pledging 100% of its equity in Wuhan Gaoxin Clinic Co., Ltd. as security, guaranteed by the Company. As at 30 June 2020, the loan balance is RMB 13.5 million, with RMB 3 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 11: In 2020, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 14 million from China Everbright Bank Shanghai Songjiang Branch by pledging 100% of its equity in Dalian Lvshun Meinian Onehealth New Town Comprehensive Clinic Co., Ltd. as security, guaranteed by the Company. As at 30 June 2020, the loan balance is RMB 12.6 million, with RMB 2.8 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 12: In 2020, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 14 million from China Everbright Bank Shanghai Songjiang Branch by pledging 84.17% of its equity in Chongqing Meinian Onehealth Management Co., Ltd. as security, guaranteed by the Company. As at 30 June 2020, the loan balance is RMB 12.6 million, with RMB 2.8 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 13: In 2020, Meinian Onehealth, a subsidiary of the Company, obtained the borrowing of RMB 260 million from China Railway Trust Co., Ltd. by pledging 100% of its equity income rights in Shenzhen Meinian Onehealth Health Management Co., Ltd. as security, guaranteed by the Company. As at 30 June 2020, the loan balance is RMB 260 million.
Mortgaged loans:
Note 14: In 2018, Hainan Meinian Onehealth Hospital Co., Ltd., a subsidiary of the Company, secured its store located at Store A201, Floor 2, Building 1 and 2, Binjiang Holiday City, No. 362, Binjiang Road, Qiongshan District, Haikou City (Property Ownership Certificate No.: Haikou City Property Ownership Certificate Hai Fang Zi No. HK454292) for the borrowing of RMB 16.05 million from Postal Savings Bank of China Co., Ltd. Haikou Branch, with joint liability guarantee provided by Sha Qibin and Liu Xiaofeng and Haikou Ciming Health Checkup Clinic (GP). As at 30 June 2020, the loan balance is RMB 6,973,500, with RMB 6,348,000 to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”.
93 Guaranteed loans：
Note 15: In 2017, the Company provided guarantee for Meinian Onehealth Healthcare (Group) Co., Ltd., a subsidiary of the Company, to borrow RMB 235.5 million from Ping An Bank Co., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 47 million and has been recognised in “non-current liabilities due within one year”. Note 16: From 2019 to 2020, the Company provided guarantee for Meinian Onehealth Healthcare (Group) Co., Ltd., a subsidiary of the Company, to borrow RMB 700 million from China Minsheng Banking Corp., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 665 million, with RMB 175 million to be due on 30 June 2021 and recognised in “non-current liabilities due within one year”. Note 17: In 2018, the Company provided guarantee for Meinian Onehealth Healthcare (Group) Co., Ltd., a subsidiary of the Company, to borrow RMB 400 million from Ping An Bank Co., Ltd. Shanghai Branch. As at 30 June 2020, the loan balance is RMB 200 million and has been recognised in “non-current liabilities due within one year”. Note 18: In 2019, the Company provided guarantee for Meinian Onehealth Healthcare (Group) Co., Ltd., a subsidiary of the Company, to borrow RMB 150 million from China Everbright Bank Shanghai Songjiang Branch. As at 30 June 2020, the loan balance is RMB 150 million.
Unsecured loans:
Note 19: In 2018, the Company borrowed RMB 20 million from Industrial & Commercial Bank of China Limited Nantong South Renmin Road Branch. As at 30 June 2020, the loan balance is RMB 20 million and has been recognised in “non-current liabilities due within one year”. Note 20: In 2020, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 20 million from Shanghai Lubinghua Health Management Co., Ltd. As at 30 June 2020, the loan balance is RMB 20 million. Note 21: In 2020, Meinian Onehealth, a subsidiary of the Company, borrowed RMB 130 million from Beijing Hezongfu Information Technology Co., Ltd. As at 30 June 2020, the loan balance is RMB 130 million.
46 Debentures payable
(1) Debentures payable
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period 17 Meinian MTN001 [Note 1] 0.00 399,150,358.08 18 Meinian 01 [Note 2] 0.00 499,545,774.67 XS1897431570 [Note 3] 1,398,604,809.04 1,367,746,765.24 Less: Debentures payable due within -1,398,604,809.04 -898,696,132.75 one year Total 1,367,746,765.24
94 (2) Movements of debentures payable (excluding other financial instruments classified as financial liabilities, such as preference shares and perpetual bonds):
Unit: Renminbi Yuan
Balance at the Amortisation of Balance at the end Interest at face Repayment Balance at the end Debenture Face value Issuance date Issuance amount beginning of the premium or of the period value during the period of the period
period discounts (Original currency)
theperiod
Maturityperiod Issuance during
17 Meinian MTN001 400,000,000 06-06-17 3 396,037,735.85 399,150,358.08 11,676,666.67 849,642.67 400,000,000.00 0.00 0.00 18 Meinian 01 500,000,000 03-19-18 3 497,641,509.43 499,545,774.67 7,117,500.00 454,225.33 500,000,000.00 0.00 0.00 XS1897431570 200,000,000 04-03-19 2 193,996,950.00 1,367,746,765.24 7,750,000.02 1,498,008.26 7,750,000.00 197,557,003.90 1,398,604,809.04 Sub-total 2,266,442,897.99 1,398,604,809.04 Less: Debentures payable due -898,696,132.75 -1,398,604,809.04 within one year Total ------1,367,746,765.24 0.00
(3) Description of conditions and timing of conversion for convertible bonds
(4) Description of other financial instruments classified as financial liabilities:
Basic information about other financial instruments (including preference shares and perpetual bonds) that remain outstanding at the end of the period: Not applicable Movement of the financial instruments (including preference shares and perpetual bonds) that remain outstanding at the end of the period: Not applicable Description of basis for classifying other financial instruments as financial liabilities: Not applicable Other descriptions: Note 1: In 2016, the Company completed Notice of Admission for Registration (Zhong Shi Xie Zhu [2017] No. MTN110) in the national inter-bank bond market and issued on 6 June 2017, which was due and repaid on 5 June 2020. Note 2: With the approval document [2017] No.1904 of the China Securities Regulatory Commission (CSRC), the Company issued a corporate bond with a total face value of no greater than RMB 500 million to qualified investors, supplied with put option of the investors. The Company issued a corporate bond of RMB 500 million in 2018 and had paid all the principal of the bond back to investors on 19 March 2020. Note 3: MeiNianInvestmentLimited, a subsidiary of the Company, issued relevant bonds according to the bond issuance programme and went public with the approval of the Stock Exchange of Hong Kong Limited, which was guaranteed by Meinian Healthcare and supplied with redemption right of the issuer.
47 Lease liabilities
95 48 Long-term payables
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Long-term payables 166,250,368.81 217,128,737.12 Special payables 1,488,300.00 800,000.00 Total 167,738,668.81 217,928,737.12
(1) Details of long-term payables by nature are as follows:
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period VAT payable for finance lease 191,963,203.92 251,190,425.33 Equipment fee payable for finance 8,508,596.50 11,574,865.11 lease Deposit for finance leases 85,163,809.00 91,210,326.00 Equipment fee payable for sale- 14,590,523.75 22,719,455.42 leaseback Amounts payable for equipment 349,251.43 783,826.78 purchased on instalments Less: Due within one year -134,325,015.79 -160,350,161.52 Other description: N/A
(2) Special payables
Unit: Renminbi Yuan Balance at Additions Reductions Balance at the the Item during the during the end of the Causes beginning of period period period the period Taian Ciming Health Checkup Special funds offered 800,000.00 800,000.00 Construction Project by Finance Bureau Checkup Health Construction Special funds offered Project for Industrial Holding 2,028,300.00 1,340,000.00 688,300.00 by Finance Bureau Company Total 800,000.00 2,028,300.00 1,340,000.00 1,488,300.00 -- Other description: N/A
49 Long-term employee benefits payable
(1) Long-term employee benefits payable
(2) Changes in defined benefit plan
50 Provisions
96 51 Deferred income
Unit: Renminbi Yuan
Balance at the Balance at the Additions during Reductions during Item beginning of end of the Reason for deferral the period the period the period period Government grant 8,183,333.33 9,900,000.00 2,356,410.30 15,726,923.03 Government grants related to assets Others 109,579.00 109,579.00 Total 8,183,333.33 10,009,579.00 2,356,410.30 15,836,502.03 -- Items relating to government grant: Unit: Renminbi Yuan
Amount Amount Amount offset Balance at the Additions recognised in recognised in against cost Other Balance at Related to Liability beginning of during the non-operating other income expenses chang the end of the assets/incom the period period income during during the during the es period e the period period period Small and medium enterprises (SME) Related to public service 4,350,000.00 300,000.00 4,050,000.00 assets platform construction subsidy Meinian Onehealth Group central Related to 3,833,333.33 1,916,666.67 1,916,666.66 equipment room assets construction Shanghai Zizhu High- Tech Industry Related to Development Zone 9,900,000.00 139,743.63 9,760,256.37 assets Management Committee
52 Other non-current liabilities
Unit: Renminbi Yuan Balance at the end of the Balance at the Item period beginning of the period Other partners’ equity in Haikou Ciming Health Checkup Clinic (GP) 1,541,009.17 1,013,418.15 Total 1,541,009.17 1,013,418.15 Other description: N/A
53 Share capital
Unit: Renminbi Yuan
Changes during the period (+/-) Balance at the beginning Balance at the Issuance of Bonus Transfer from of the period Others Sub-total end of the period new shares shares reserves Total shares 3,919,920,974.00 3,919,920,974.00 Other description: N/A
97 54 Other equity instruments
(1) Basic information about other financial instruments (including preference shares and perpetual bonds) that remain outstanding at the end of the period:
(2) Movement of the financial instruments (including preference shares and perpetual bonds) that remain outstanding at the end of the period:
55 Capital reserve
Unit: Renminbi Yuan Balance at the Additions during Reductions Balance at the Item beginning of the the period during the period end of the period period Capital premium (share premium) 2,439,936,041.00 71,988,537.99 2,511,924,578.99 Total 2,439,936,041.00 71,988,537.99 2,511,924,578.99 Other descriptions, including descriptions about movements during the period and causes:
56 Treasury shares
Unit: Renminbi Yuan Balance at the Additions during Reductions Balance at the Item beginning of the the period during the period end of the period period The Company’s shares acquired for employee stock ownership plan or equity 300,055,044.16 0.00 0.00 300,055,044.16 incentive plan Total 300,055,044.16 300,055,044.16 Other descriptions, including descriptions about movements during the period and causes:
57 Other comprehensive income
Unit: Renminbi Yuan
Accrued during the period Less: Less: Net-of-tax Previously Net-of-tax Balance at the Previously Less: amount Balance at the recognised amount Item beginning of Before-tax recognised Income attributable end of the amount attributable to the period amount amount tax to non- period transferred to shareholders of transferred to expense controlling retained the Company profit or loss interests earnings II. Items that may be reclassified -379,371.01 -1,340,948.05 -1,340,948.05 -1,720,319.06 to profit or loss Translation differences arising from translation of foreign -379,371.01 -1,340,948.05 -1,340,948.05 -1,720,319.06 currency financial statements Total other comprehensive -379,371.01 -1,340,948.05 -1,340,948.05 -1,720,319.06 income
98 58 Specific reserve
59 Surplus reserve
Unit: Renminbi Yuan Balance at the Additions during the Reductions during Balance at the end of Item beginning of the period the period the period period Statutory surplus reserve 71,934,339.69 71,934,339.69 Total 71,934,339.69 71,934,339.69
60 Retained earnings
Unit: Renminbi Yuan Item Current period Prior period Retained earnings at the end of the period 1,184,276,684.09 2,123,783,947.53 (before adjustment) Total adjustments for opening retained earnings 92,059,435.82 (“+” for increase; “-” for decrease) Retained earnings at the beginning of the period 1,184,276,684.09 2,215,843,383.35 (after adjustment) Add: Net profits for the period attributable to -782,386,107.24 -866,474,165.82 shareholders of the Company Dividends to ordinary shares 165,092,533.44 Retained earnings at the end of the period 401,890,576.85 1,184,276,684.09 Adjustments on beginning retained earnings are as follows: 1) Retrospective adjustments of RMB 0 made on beginning retained earnings in accordance with CAS and related new regulations. 2) RMB XXX on beginning retained earnings due to changes in accounting policies. 3) RMB XXX on beginning retained earnings due to corrections of significant accounting errors. 4) RMB XXX on beginning retained earnings due to changes in consolidation scope resulting from business combinations involving entities under common control. 5) RMB XXX on beginning retained earnings due to other adjustments.
61 Operating income and operating costs
Unit: Renminbi Yuan Accrued during the period Accrued during the prior period Item Income Cost Income Cost Principal activities 1,804,151,138.05 1,726,816,549.91 3,632,378,722.62 2,336,389,562.53 Other operating activities 10,299,687.71 6,158,203.52 8,681,943.90 7,775,737.16 Total 1,814,450,825.76 1,732,974,753.43 3,641,060,666.52 2,344,165,299.69 Information about performance obligations: Revenue from the Company’s checkup business is recognised when checkup business is completed (i.e. when the Company satisfies the performance obligation in the contract). Other description: N/A
99 62 Taxes and surcharges
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Urban maintenance and construction tax 90,314.79 129,783.33 Education surcharges 100,643.43 111,673.44 Property tax 332,156.33 378,674.27 Vehicle and vessel use tax 25,595.66 Stamp duty 452,009.56 994,241.89 Water conservancy fund 172,756.04 210,429.02 Security fund for the disabled 1,050,211.82 4,348,987.74 Others 23,934.58 50,045.08 Total 2,247,622.21 6,223,834.77 Other description: N/A
63 Selling and distribution expenses
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Labour cost 489,215,088.02 669,292,617.34 Business development expenses 62,450,116.12 53,027,993.85 Advertising and promotion expenses 37,450,217.59 49,828,002.56 Office rental 29,784,901.67 36,623,853.72 Motor vehicle expenses 15,867,364.46 36,115,350.16 Administrative expenses 12,677,523.10 21,890,918.90 Meeting affair charges 4,334,869.96 9,436,500.69 Travelling expenses 1,793,738.15 7,616,045.91 Others 15,790,401.98 26,471,300.37 Total 669,364,221.05 910,302,583.50 Other description: N/A
100 64 General and administrative expenses
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Labour cost 119,911,485.82 171,552,672.77 Agent service fee 53,909,612.79 43,625,217.11 Office rental 14,091,845.31 20,782,809.29 Travelling expenses 3,102,296.98 11,308,103.17 Amortisation expenses 7,119,687.27 7,516,074.11 Entertainment expenses 5,709,380.96 7,012,243.59 Administrative expenses 8,780,473.66 9,517,716.63 Depreciation expenses 6,712,755.98 8,287,533.44 Motor vehicle expenses 3,023,418.15 4,258,570.92 Conference expenses 1,556,989.84 3,184,975.33 Pre-operating expenses 2,780,055.06 5,083,768.44 Others 18,402,701.57 16,435,853.74 Total 245,100,703.39 308,565,538.54 Other description: N/A
65 Research and development costs
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Labour cost 14,222,516.80 20,369,262.73 Depreciation and amortisation 2,748,445.95 2,288,802.12 Others 676,458.37 306,036.36 Total 17,647,421.12 22,964,101.21 Other description: N/A
66 Financial expenses
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Interest expense 204,797,359.52 197,564,525.14 Less: Interest income 19,911,737.88 12,710,587.25 Less: Capitalised interest Foreign exchange losses and gains 16,499,473.92 -5,316,542.26 Less: Capitalised foreign exchange
losses and gains Others 7,662,096.17 8,047,314.97 Total 209,047,191.73 187,584,710.60 Other description: N/A
101 67 Other income
Unit: Renminbi Yuan Sources of other income Accrued during the period Accrued during the prior period Refund of individual income tax 2,846,839.40 441,994.92 Meinian Onehealth Group central 1,916,666.67 equipment room construction Shanghai Zizhu High-Tech Industry Development Zone Management 139,743.63 Committee Job stabilisation subsidy 2,477,937.11 339,165.33 SME public service platform construction 300,000.00 300,000.00 subsidy Social insurance subsidy 440,683.75 267,686.33 VAT additional deduction 368,504.61 194,888.51 Refund upon payment of VAT 2,554,929.44 134,055.70 Other subsidies 322,364.63 116,706.63 Zhongguancun Enterprises Information 353,151.41 Promotion Association subsidy Total 11,367,669.24 2,147,648.83
68 Investment income
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Income from long-term equity investments -5,385,777.78 -3,672,776.99 accounted for using equity method Investment income from disposal of long- -601,269.17 term equity investments Income from fair value adjustments through multiple transactions in stages until 24,179,120.89 business combination involving entities under common control achieved Interest income from finance lease 34,298,581.26 25,124,065.61 Investment income from other non-current 17,146,716.08 19,478,968.79 financial assets during the holding period Return from wealth-management products 107,015.62 Total 69,637,371.28 41,037,273.03 Other description: N/A
69 Gains from net exposure hedge
102 70 Gains from changes in fair value
Unit: Renminbi Yuan Source of gains from changes in fair value Accrued during the period Accrued during the prior period Other non-current financial assets Other non-current financial assets Including: Financial liabilities designated at fair 7,355,571.02 183,835,590.00 value through profit or loss Total 7,355,571.02 183,835,590.00 Other description: N/A
71 Credit losses
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Bad and doubtful loans provision for other -1,308,445.13 -3,809,797.15 accounts receivable Bad and doubtful loans provision for accounts -45,950,448.99 -4,718,126.65 receivable Bad and doubtful loans provision for long-term -6,538,684.26
receivables Bad and doubtful loans provision for non- -5,423,146.74
current assets due within one year Total -59,220,725.12 -8,527,923.80 Other description: N/A
72 Impairment losses
73 Gains from asset disposals
Unit: Renminbi Yuan Source of gains from disposal of assets Accrued during the period Accrued during the prior period Disposal of fixed assets -1,260,186.25 -497,308.27
74 Non-operating income
Unit: Renminbi Yuan Accrued during the Accrued during the Amount recognised in Item period prior period extraordinary gain and loss Government grants 4,322,989.47 4,236,619.81 4,322,989.47 Gains from damage or scrapping of non- 283,030.65 33,310.39 283,030.65 current assets Others 480,096.53 110,841.82 480,096.53 Total 5,086,116.65 4,380,772.02 5,086,116.65 Government grants recognised in profit or loss for the current period:
103 Unit: Renminbi Yuan
Whether Reason Whether a affecting profit Accrued during Accrued during Related to Item Granting entity for Type special and loss for the period the prior period assets/income granting grant the year Pudong New Area Pudong New Area Compliance with local government Bureau of Related to financial supporting Grants investment promotion and other Yes No 3,388,645.87 3,161,000.00 Finance of income fund local supporting policies Shanghai Jing’an Bureau of Compliance with local government Jing’an District Related to Finance of Grants investment promotion and other Yes No 270,000.00 financial subsidy income Shanghai local supporting policies Xuhui Bureau of Compliance with local government Xuhui District financial Related to Finance of Grants investment promotion and other Yes No 740,000.00 subsidy income Shanghai local supporting policies Office of Finance of Fuqing Compliance with local government Related to Taxation incentives Longshan Rewards investment promotion and other Yes No 157,542.81 income Residential local supporting policies District Rewards for enterprises newly included in the list of Compliance with local government government statistics Shizhong Business Related to Grants investment promotion and other Yes No 100,000.00 department and Bureau of Leshan income local supporting policies required to submit relevant statistical reports Enterprise Chancheng Compliance with local government development reward Bureau of Related to Grants investment promotion and other Yes No 50,000.00 supporting special Finance of income local supporting policies fund Foshan Development fund rewards for industrial enterprises above designated size, construction Bureau of Finance enterprises with of Zhengzhou qualification Compliance with local government Airport Economic Related to certificate, wholesale Rewards investment promotion and other Yes No 250,000.00 Comprehensive income and retail, local supporting policies Experimental accommodation and Zone catering enterprises above designated sales scale and national key service- sector enterprises Jiaxing Nanhu Training service for Compliance with local government District Related to highly skilled Rewards investment promotion and other Yes No 52,000.00 Management income personnel local supporting policies Committee Shinan Bureau of Compliance with local government Related to SME rewards Finance of Rewards investment promotion and other Yes No 50,000.00 income Qingdao local supporting policies Compliance with local government Business Bureau Related to Government rewards Rewards investment promotion and other Yes No 50,000.00 of Dali income local supporting policies Baoshan Yuepu Compliance with local government People’s Related to Government rewards Rewards investment promotion and other Yes No 20,000.00 Government of income local supporting policies Foshan Xihu Bureau of Compliance with local government Related to Government rewards Finance of Rewards investment promotion and other Yes No 30,000.00 income Nanchang local supporting policies Zizhu High-Tech Zizhu High-Tech Compliance with local government Industry Industry Related to Rewards investment promotion and other Yes No 139,743.60 Development Zone Development income local supporting policies supporting fund Zone Related to Other subsidies 72,600.00 28,077.00 income
104 75 Non-operating expenses
Unit: Renminbi Yuan Accrued during the prior Amount recognised in Item Accrued during the period period extraordinary gain and loss Donations provided 13,393,831.26 4,667,101.22 13,393,831.26 Losses from damage or scrapping of non-current 4,079,861.78 1,155,760.71 4,079,861.78 assets Fines and overdue fines 196,510.60 158,081.17 196,510.60 Compensation expenditure 550,150.66 792,993.50 550,150.66 Others 3,002,003.26 833,933.72 3,002,003.26 Total 21,222,357.56 7,607,870.32 21,222,357.56 Other description: N/A
76 Income tax expenses
(1) Income tax
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Current income tax expense 30,958,478.32 66,993,669.76 Deferred tax expense -232,443,107.61 -35,930,887.30 Total -201,484,629.29 31,062,782.46
(2) Adjustment process of accounting profits and income tax expenses
Unit: Renminbi Yuan Item Accrued during the period Profit before tax -1,050,187,627.91 Income tax expense at statutory/applicable tax rate -262,546,906.98 Effect of different tax rates applied by subsidiaries 9,267,624.47 Adjustments to income tax of previous periods 1,947,994.61 Effect of non-taxable income -7,829,771.26 Effect of non-deductible costs, expense and losses 1,502,623.72 Effect of using the deductible losses for which no deferred -9,921,556.38 tax asset was recognised in previous periods Effect of deductible temporary differences or deductible losses for which no deferred tax asset was recognised -46,033,709.54 this period Preferential tax treatments 14,220,137.86 Income tax expenses -201,484,629.29
77 Other comprehensive income
Refer to Note VII.57 for details.
105 78 Cash flow statement
(1) Proceeds relating to other operating activities:
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Amounts due to other entities 210,897,573.43 68,212,117.62 Interest income 20,035,487.88 12,710,587.25 Subsidy income 21,913,523.18 6,250,212.94 Others 28,941,889.63 110,841.82 Total 281,788,474.12 87,283,759.63 Descriptions of proceeds relating to other operating activities: Not applicable
(2) Payments relating to other operating activities:
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Payment for selling and distribution 168,594,640.30 230,310,368.36 expenses Payment for general and 107,228,579.55 119,948,742.00 administrative expenses Amounts due to other entities 342,141,025.05 164,765,664.48 Bank service charges 7,143,883.13 Others 18,483,443.85 6,452,109.61 Total 636,447,688.75 528,620,767.58 Description of payments relating to other operating activities: Not applicable
(3) Proceeds relating to other investing activities:
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Rent received from finance lease and 244,119,589.74 257,804,075.72 factoring Excess of carrying amount of the acquisition of subsidiary over 321,946.59 consideration paid Total 244,119,589.74 258,126,022.31 Description of proceeds relating to other investing activities: Not applicable
106 (4) Payments relating to other investing activities:
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Finance lease and factoring 64,871,674.45 611,088,342.69 Special funds for handling Insurance Broker 68,523.23 Business Licence Total 64,871,674.45 611,156,865.92 Description of payments relating to other investing activities:
(5) Proceeds relating to other financing activities:
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Deposits related to borrowings 25,030,000.00 Recovery of bill deposit 15,430,000.00 Instalment collection of equipment sales 390,000.00 Meiyin’s compensation for gambling 71,988,537.99 Total 71,988,537.99 40,850,000.00 Description of proceeds relating to other financing activities: Not applicable
(6) Payments relating to other financing activities:
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Payment for acquisition of non-controlling interests 161,581,950.00 Payment for shares repurchase 96,000,000.00 Previous year’s payment for business combination 70,491,940.00 not involving entities under common control Rental paid for sale-leaseback 15,621,520.06 8,603,301.00 Rental paid for finance leases 6,028,601.73 6,585,055.39 Management fee charged by the bank 17,113,666.68 5,496,627.32 Rental paid on instalments 325,924.14 Total 38,763,788.47 349,084,797.85 Description of payments relating to other financing activities: Not applicable
107 79 Supplementary information on cash flow statement
(1) Supplementary information on cash flow statement
Unit: Renminbi Yuan Supplementary information Current period Prior period 1 Reconciliation of net profit to cash flows from operating activities: -- -- Net profit -848,702,998.62 44,959,997.24 Add: Credit impairment losses 59,220,725.12 8,527,923.80 Depreciation of fixed assets, depletion of oil and gas assets, 201,036,850.10 187,686,350.22 depreciation of productive biological assets Amortisation of intangible assets 7,620,566.44 4,882,699.65 Amortisation of long-term deferred expenses 144,903,547.65 143,604,549.26 Losses from disposal of fixed assets, intangible assets, and other 1,260,186.25 497,308.27 long-term assets (“-” for gains) Losses from scrapping of fixed assets (“-” for gains) 4,079,861.78 1,122,450.32 Losses from changes in fair value (“-” for gains) -7,355,571.02 -183,835,590.00 Financial expenses (“-” for income) 204,797,359.52 186,767,768.12 Losses arising from investments (“-” for gains) -69,637,371.28 -41,037,273.03 Decrease in deferred tax assets (“-” for increase) -243,759,822.04 -79,385,856.57 Increase in deferred tax liabilities (“-” for decrease) 1,270,772.63 44,866,699.40 Decrease in gross inventories (“-” for increase) 10,885,191.99 18,125,711.28 Decrease in operating receivables (“-” for increase) 67,352,660.70 -731,208,792.13 Increase in operating payables (“-” for decrease) -263,861,567.65 -209,098,981.15 Net cash flows from operating activities -730,889,608.43 -603,525,035.32 2 Significant investing and financing activities not requiring the use of cash: -- -- 3 Change in cash and cash equivalents: -- -- Cash at the end of the period 2,451,017,455.57 1,975,111,054.99 Less: Cash at the beginning of the period 4,696,002,147.05 2,390,222,654.49 Net increase in cash and cash equivalents -2,244,984,691.48 -415,111,599.50
(2) Net cash paid to acquire subsidiaries during the period
Unit: Renminbi Yuan Amount Cash or cash equivalents paid during the period for business 48,532,500.00 combinations during the period Including: -- Less: Cash and cash equivalents held by subsidiaries at the 1,555,111.45 acquisition date Including: -- Add: Cash or cash equivalents paid during the period for 20,207,550.00 business combinations in previous periods Including: -- Net payment for acquisition of subsidiaries 67,184,938.55 Other description: N/A
108 (3) Net cash received from disposal of subsidiaries during the period
(4) Details of cash and cash equivalents
Unit: Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period I. Cash at bank and on hand 2,451,017,455.57 4,696,002,147.05 Including: Cash on hand 3,344,142.35 3,420,010.11 Bank deposits available on 2,438,094,153.41 4,689,471,789.59 demand Other monetary funds 9,579,159.81 3,110,347.35 available on demand III. Cash and cash equivalents at the end 2,451,017,455.57 4,696,002,147.05 of the period Other description: N/A
80 Notes to statement of changes in owner’s equity
Disclose the name and adjusted amount of items included in “others” in the adjustments of the closing balance of owners’ equity during the last period:
81 Assets with restrictive ownership title or right of use
Unit: Renminbi Yuan
Carrying amount at the end Item Reason for restriction of the period
Cash at bank and on hand 63,515,381.69 Note VII.1
Fixed assets 67,443,583.32 Note 1 - 5
Long-term receivables 1,134,314,089.32 Note 6
Total 1,265,273,054.33 --
Other descriptions:
Note 1: Ciming Health Checkup Management Group Co., Ltd., a subsidiary of the Company, applied for a loan from China Guangfa Bank Co., Ltd. Beijing Weigongcun Branch by using its properties located at Store No. 3, Floor 1 and 2, Building 28, Panjia Yuan, Chaoyang District (Property Ownership Certificate No.: Jing (2016) Chaoyang District Property Ownership No. 0068139), Store No. 4, Floor 1 and 2, Building 28, Panjia Yuan, Chaoyang District (Property Ownership Certificate No.: Jing (2016) Chaoyang District Property Ownership No. 0068208), Room 201, Unit 1, Floor 1 and 2, No. 7, Beitucheng West Road, Chaoyang District (Property Ownership Certificate No.: Jing (2016) Chaoyang District Property Ownership No. 0067295), and Room 201, Unit 2, Floor 2 and 3, No. 7, Beitucheng West Road, Chaoyang District (Property Ownership Certificate No.: Jing (2016) Chaoyang District Property Ownership No. 0067294) as collaterals, the closing carrying amounts of which totalled RMB 47,580,421.05.
109 Note 2: Hainan Meinian Onehealth Hospital Co., Ltd., a subsidiary of the Company, applied for a loan from Postal Savings Bank of China Co., Ltd. Haikou Branch by using its property located at Store A201, Floor 2, Building 1 and 2, Binjiang Holiday City, No. 362, Binjiang Road, Qiongshan District, Haikou City (Property Ownership Certificate No.: Haikou City Property Ownership Certificate Hai Fang Zi No. HK454292) as collateral with the closing carrying amount of RMB 14,225,986.17. Note 3: Hainan Meinian Onehealth Hospital Co., Ltd., a subsidiary of the Company, applied for a loan from Bank of Communications Co. Ltd. Hainan Province Branch by using its property located at Store A301, Floor 3, Building 1 and 2, Binjiang Holiday City, No. 362, Binjiang Road, Qiongshan District, Haikou City (Property Ownership Certificate No.: Haikou City Property Ownership Certificate Hai Fang Zi No. HK454142) as collateral with the closing carrying amount of RMB 2,365,126.11. Note 4: Hainan Meinian Onehealth Hospital Co., Ltd., a subsidiary of the Company, entered into a sale-leaseback agreement with Ping An International Financial Leasing Co., Ltd. by taking fixed assets of Hainan Meinian Onehealth Hospital Co., Ltd. as lease items, the closing carrying amount of which amounted to RMB 1,955,692.35. Note 5: Haikou Ciming Health Checkup Clinic (GP), a subsidiary of the Company, entered into a sale-leaseback agreement with Ping An International Financial Leasing Co., Ltd. by taking fixed assets of Haikou Ciming Health Checkup Clinic (GP) as lease items, the closing carrying amount of which amounted to RMB 1,316,357.64. Note 6: Shanghai Meixin Finance Lease Co., Ltd., a subsidiary of the Company, pledged its finance lease receivables (carrying amount: RMB 1,134,314,089.32) as security for the liquidity loans from Standard Chartered Bank (China) Limited Shanghai Branch and BNP Paribas (China) Limited and for the factoring loans from Shanghai Pudong Development Bank Corp., Ltd. Qingpu Branch, HSBC Bank (China) Company Limited Shanghai Branch, Hang Seng Bank (China) Limited Shanghai Branch, China Everbright Bank Shanghai Songjiang Branch and DBS Bank (China) Limited.
110 82 Monetary items denominated in foreign currencies
(1) Monetary items denominated in foreign currencies
Unit: Renminbi Yuan Closing balance at foreign Closing balance at RMB Item Exchange rate currency equivalent Cash at bank and on hand -- -- Including: USD 16,998,265.19 7.0795 120,339,218.41 EUR HKD 2.05 0.9134 1.87 SGD 139,200.00 5.0813 707,316.96 Accounts receivable -- -- Including: USD EUR HKD Long-term loans -- -- Including: USD EUR HKD Other receivables Including: USD 11,468.80 7.0795 81,193.37 Debentures payable due
within one year Including: USD 197,557,003.89 7.0795 1,398,604,809.04 Other payables Including: USD 24,344.92 7.0795 172,349.86 Other description: N/A
(2) Description of foreign operations, including significant foreign operations, shall disclose their principal place of business, functional currency and basis for determining the functional currency. If there are changes in functional currency, the reasons shall also be disclosed.
□Applicable √Not applicable
83 Hedge
The qualitative and quantitative information about the hedged item, the hedging instrument and the hedged risk is disclosed based on the type of hedge as follows:
84 Government grants
(1) Details of government grants
Unit: Renminbi Yuan
111 Amount recognised Presentation Item Amount in profit or loss for item the current period Shanghai Zizhu High-Tech Industry Development 9,900,000.00 Deferred income 139,743.63 Zone Management Committee Refund of individual income tax 2,846,839.40 Other income 2,846,839.40 Job stabilisation subsidy 2,477,937.11 Other income 2,477,937.11 SME public service platform construction subsidy 300,000.00 Other income 300,000.00 project Social insurance subsidy 440,683.75 Other income 440,683.75 VAT additional deduction 368,504.61 Other income 368,504.61 Refund upon payment of VAT 2,554,929.44 Other income 2,554,929.44 Other subsidies 322,364.63 Other income 322,364.63 Meinian Onehealth Group central equipment room 5,750,000.00 Deferred income 1,916,666.67 construction Non-operating Pudong New Area financial supporting fund 3,388,645.87 3,388,645.87 income Non-operating Jing’an District financial subsidy 270,000.00 270,000.00 income Development fund rewards for industrial enterprises above designated size, construction enterprises with qualification certificate, wholesale and retail, Non-operating 250,000.00 250,000.00 accommodation and catering enterprises above income designated sales scale and national key service- sector enterprises Non-operating Training service for highly skilled personnel 52,000.00 52,000.00 income Non-operating SME rewards 50,000.00 50,000.00 income Non-operating Government rewards 100,000.00 100,000.00 income Non-operating Other subsidies 212,343.60 212,343.60 income
(2) Details of repayments of government grants
□Applicable √Not applicable Other description: N/A
85 Others
VIII. Change of consolidation scope
1 Business combinations involving entities not under common control
(1) Business combinations involving entities not under common control occurred during the period
Unit: Renminbi Yuan
Cost of equity Shareholding Acquisition Acquisition Name of acquiree Acquisition Basis of Income of the Net profit of the date of equity investment acquired method date acquisition date acquiree from acquiree from
112 investment determination the acquisition the acquisition date to the end date to the end of the period of the period 1 January Capital 1 January The gain of Wuxi Meihua Clinic Co., Ltd. 36,728,395.06 40.50% 6,203,590.82 -5,275,631.87 2020 increase 2020 control Anhui Meixin Health Management The gain of 1 June 2020 12,240,000.00 51.00% Purchase 1 June 2020 3,076,557.12 -1,679,876.61 Consulting Co., Ltd. control Wuhan Dongxihu Ciming Checkup The gain of 1 June 2020 21,000,000.00 70.00% Purchase 1 June 2020 -601,156.43 Management Co., Ltd. control Harbin Meiming Health Management Capital The gain of 30 June 2020 44,740,157.48 12.70% 30 June 2020 Co., Ltd. increase control Other descriptions:
Note 1: In May 2017, the Company acquired 19% of Wuxi Meihua Clinic Co., Ltd.’s equity with a consideration of RMB 4,151,900. During the period, the Company increased its capital contribution by RMB 25 million, after which its shareholding percentage was increased to 59.50%. The acquisition date was 1 January 2020. Note 2: In September 2019, the Company acquired 44.12% of Harbin Meiming Health Management Co., Ltd.’s equity with a consideration of RMB 15 million. During the period, the Company increased its capital contribution by RMB 10 million, after which its shareholding percentage was increased to 56.82%. The acquisition date was 30 June 2020.
(2) Acquisition cost and goodwill
Unit: Renminbi Yuan Anhui Meixin Wuhan Dongxihu Harbin Meiming Health Wuxi Meihua Ciming Checkup Health Acquisition cost Management Clinic Co., Ltd. Management Co., Management Co., Consulting Co., Ltd. Ltd. Ltd. --Cash 25,000,000.00 12,240,000.00 21,000,000.00 10,000,000.00 --Carrying amount of equity interests held before acquisition 11,728,395.06 34,740,157.48 date at acquisition date Total acquisition cost 36,728,395.06 12,240,000.00 21,000,000.00 44,740,157.48 Less: Share of the fair value of the identifiable net assets 12,056,500.80 -6,652,099.60 4,588,911.32 2,995,620.45 acquired Goodwill/Amount of acquisition cost less than share of the 24,671,894.26 18,892,099.60 16,411,088.68 41,744,537.03 fair value of the identifiable net assets acquired
Description of the determination method of fair value of acquisition cost, contingent consideration and its changes: The fair value of these acquirees is determined by the valuation results determined based on the asset-based approach by Chungrui Worldunion Assets Appraisal (Beijing) Co., Ltd.
The primary reason for the generation of significant goodwill:
Other description: N/A
(3) Identifiable assets and liabilities of the acquiree at the acquisition date
Unit: Renminbi Yuan
Wuhan Dongxihu Ciming Anhui Meixin Health Management Harbin Meiming Health Wuxi Meihua Clinic Co., Ltd. Checkup Management Co., Consulting Co., Ltd. Management Co., Ltd. Ltd. Carrying Carrying Carrying Fair value at Carrying Fair value at amount at Fair value at amount at Fair value at amount at acquisition amount at acquisition acquisition acquisition date acquisition acquisition date acquisition date acquisition date date date date date
113 Cash at bank and 263,666.40 263,666.40 571,121.54 571,121.54 7,255.05 7,255.05 468,512.15 468,512.15 on hand Receivables 15,031,608.43 15,031,608.43 4,221,262.59 4,221,262.59 404,344.81 404,344.81 Inventories 494,309.74 494,309.74 283,862.97 283,862.97 370,531.31 370,531.31 Fixed assets 8,015,281.40 8,015,281.40 14,352,868.82 14,352,868.82 5,450,598.87 5,450,598.87 18,707,768.67 18,707,768.67 Intangible assets 240,000.00 240,000.00 400,498.88 400,498.88 887,265.62 887,265.62 Other current 10,123.65 10,123.65 assets Prepayments 1,348,026.03 1,348,026.03 960,753.00 960,753.00 136,082.09 136,082.09 Other receivables 2,836,958.00 2,836,958.00 2,085,701.91 2,085,701.91 540,529.50 540,529.50 829,696.26 829,696.26 Long-term deferred 5,972,752.39 5,972,752.39 6,971,881.75 6,971,881.75 5,218,633.56 5,218,633.56 12,295,780.31 12,295,780.31 expenses Deferred tax 393,305.29 393,305.29 assets Other non-current 684,360.00 684,360.00 250,000.00 250,000.00 assets Payables 6,018,178.53 6,018,178.53 18,318,388.41 18,318,388.41 1,373,455.70 1,373,455.70 3,578,249.20 3,578,249.20 Advance payments 2,149,109.55 2,149,109.55 4,442,715.00 4,442,715.00 1,613,460.50 1,613,460.50 received Employee benefits 652,560.06 652,560.06 1,683,612.72 1,683,612.72 335,512.32 335,512.32 1,940,081.73 1,940,081.73 payable Taxes payable 120,504.66 120,504.66 336,211.36 336,211.36 1,575.00 1,575.00 Other payables 4,661,646.69 4,661,646.69 15,151,538.21 15,151,538.21 2,616,250.00 2,616,250.00 13,597,223.46 13,597,223.46 Non-current liabilities due 1,142,441.00 1,142,441.00 3,174,525.00 3,174,525.00 2,597,284.00 2,597,284.00 within one year Long-term 6,153,413.00 6,153,413.00 payables Net assets 20,263,026.56 20,263,026.56 -13,043,332.54 -13,043,332.54 6,555,587.60 6,555,587.60 5,272,123.27 5,272,123.27 Less: Non- controlling 8,206,525.76 -6,391,232.94 1,966,676.28 2,276,502.82 interests Net assets 12,056,500.80 -6,652,099.60 4,588,911.32 2,995,620.45 acquired Determination method for fair value of identifiable assets and liabilities:
114 The Company applied valuation techniques to determine the fair value of the acquiree’ assets and liabilities at the acquisition date. The valuation techniques and key assumptions for the primary assets are disclosed as follows: the valuation assumes that transactions are made in the open market; the fair value of each asset and liability in the companies’ financial statements is assessed reasonably based on the balance sheet of the companies at the appraisal base date where each production factor is assumed to be reset.
Contingent liabilities of the acquirees assumed in business combinations: Not applicable Other description: N/A
(4) Gain or loss from remeasurement of equity interests held prior to acquisition date to fair value
Whether there is any transaction where business combination is achieved in stages and the control right is obtained during the reporting period √Yes □No Unit: Renminbi Yuan
Fair value of Carrying Method and key Investment income or equity interests amount of Gain or loss of equity assumptions for loss transferred from held prior to equity interests interests held prior to determining fair other comprehensive Name of acquiree acquisition held prior to acquisition date from value of equity income related to date at the acquisition date remeasurement to interests held prior to equity interests held acquisition at the fair value acquisition date at prior to acquisition date acquisition date the acquisition date date Wuxi Meihua Clinic Co., Ltd. 4,750,000.00 11,728,395.06 6,978,395.06 Harbin Meiming Health Management 10,561,036.59 34,740,157.48 24,179,120.89 Co., Ltd.
(5) Explanation that consideration or fair value of the acquiree’s identifiable assets and liabilities cannot be reasonably determined at the acquisition date or at the end of the period
(6) Other descriptions
2 Business combinations involving entities under common control
(1) Business combinations involving entities under common control occurred during the period
(2) Acquisition cost
(3) Carrying amount of assets and liabilities of the acquiree at the acquisition date:
3 Reverse acquisition
Basic information of the transaction, basis for the transaction constituting reverse acquisition, whether assets and liabilities retained by the listed company constitute a business and corresponding basis, the determination of acquisition cost, adjusted amount of equity and the calculation when the transaction is
115 accounted for based on equity transaction: Not applicable
4 Disposal of subsidiaries
Whether there is any disposal of investments in subsidiaries through a single transaction resulting in loss of control □Yes √ No Whether there is any disposal of investments in subsidiaries through multiple transactions resulting in loss of control during the period □Yes √No
5 Other reasons for change of consolidation scope
Disclose other reasons causing the changes of consolidation scope (e.g. newly subsidiaries, the liquidation of subsidiaries, etc.) and related situations: Not applicable
6 Others
IX. Interests in other entities
1 Interests in subsidiaries
(1) Composition of the Group
Principal Shareholding Registered Acquisition Name of the subsidiary place of Business nature percentage place method business Direct Indirect Meinian Onehealth Healthcare (Group) Shanghai Shanghai Investment management 100.00% Acquisition Co., Ltd. Shanghai Meizhao Health Management Nutrition and health Shanghai Shanghai 100.00% Establishment Co., Ltd. consulting Nutrition and health Shanghai Meijian Oasis Health Shanghai Shanghai consulting and enterprise 100.00% Establishment Management Co., Ltd. management consulting Insurance brokerage Beijing Meinian Insurance Broker Co., Ltd. Beijing Beijing 100.00% Establishment business Ciming Health Checkup Management Beijing Beijing Physical examination 72.88% 27.12% Acquisition Group Co., Ltd. Zhoushan Meici Investment Management Zhoushan Zhoushan Investment management 100.00% Establishment Co., Ltd. Shanghai Elephant Medical Technology Shanghai Shanghai Medical technical services 51.00% Acquisition Co., Ltd. Mainline Health Technology (Beijing) Co., Beijing Beijing Medical technical services 50.56% Acquisition Ltd. Nanjing Meiyin Health Technology Co., Nanjing Nanjing Medical technical services 100.00% Acquisition Ltd. Beijing Meiyin Medical Laboratory Co., Beijing Beijing Medical technical services 100.00% Acquisition Ltd. Mein Meikang Gene Technology (Wuhan) Wuhan Wuhan Medical technical services 100.00% Acquisition Co., Ltd. Shanghai Meiling Medical Imaging Shanghai Shanghai Medical technical services 51.00% Establishment Diagnosis Centre Co., Ltd.
116 Shanghai Meinian Health Artificial Shanghai Shanghai Others 100.00% Establishment Intelligence Technology Co., Ltd. Shanghai Meinian Onehealth Checkup Shanghai Shanghai Investment management 100.00% Establishment Investment Management Co., Ltd. Physical examination Shanghai Meidong Software Development Shanghai Shanghai management software 100.00% Establishment Co., Ltd. development and sales Shanghai Meixin Financial Leasing Co., Financial leasing, factoring Shanghai Shanghai 75.00% Establishment Ltd. and consulting business Shanghai Meiai Investment Management Shanghai Shanghai Investment management 100.00% Establishment Co., Ltd. Meinian Investment Co., Ltd. BVI BVI Investment management 100.00% Establishment Meijian Co., Ltd. BVI BVI Investment management 100.00% Establishment Xin Xin Healthcare Holding Limited BVI BVI Investment management 100.00% Acquisition Meijia Health Holdings Co., Ltd. Hong Kong Hong Kong Investment management 81.00% Acquisition Meizhao Life Beijing Capital Holdings Co., Samoa Samoa Investment management 81.00% Acquisition Ltd. Meizhao Life Shanghai Capital Holdings Samoa Samoa Investment management 81.00% Acquisition Co., Ltd. Beijing Meizhao Physical Examination Beijing Beijing Physical examination 56.70% Acquisition Centre Co., Ltd. Shanghai Meizhao Clinic Co., Ltd. Shanghai Shanghai Physical examination 56.70% Acquisition Meinian Healthcare Co., Ltd. Hong Kong Hong Kong Investment management 100.00% Establishment Shanghai Meinian Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Jiaxing Meinian Onehealth Management Jiaxing Jiaxing Physical examination 51.00% Acquisition Co., Ltd. Fuqing Meinian Onehealth Management Fuqing Fuqing Physical examination 100.00% Acquisition Co., Ltd. Shanghai Meiyi Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Shanghai Meijian Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Shanghai Meidong Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Shanghai Meijin Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Shanghai Meiheng Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Ningbo Haishu Meinian Comprehensive Ningbo Ningbo Physical examination 100.00% Acquisition Clinic Co., Ltd. Xiamen Meinian Onehealth Management Xiamen Xiamen Physical examination 100.00% Acquisition Co., Ltd. Ningbo Yinzhou Yihe Comprehensive Ningbo Ningbo Physical examination 51.00% Acquisition Clinic Co., Ltd. Wenzhou Oasis Hospital Co., Ltd. Wenzhou Wenzhou Physical examination 82.00% Acquisition Shanghai Meiyan Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Shanghai Meiyang Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Nanjing Meinian Onehealth Management Nanjing Nanjing Physical examination 100.00% Establishment Co., Ltd. Nanjing Yikang Special Out-patient Nanjing Nanjing Physical examination 51.00% Acquisition Department Co., Ltd. Meinian Onehealth Healthcare Group Nantong Nantong Physical examination 51.00% Acquisition Nantong Co., Ltd. Hangzhou Meinian Medical Clinic Co., Ltd. Hangzhou Hangzhou Physical examination 100.00% Establishment Changshu Meinian Onehealth Checkup Changshu Changshu Physical examination 100.00% Acquisition Centre Co., Ltd. Jiangsu Huakang Investment Wuxi Wuxi Investment management 100.00% Acquisition Development Co., Ltd. Wuxi Huakang Clinic Co., Ltd. Wuxi Wuxi Physical examination 100.00% Acquisition Suzhou Chunshenhu Meinian Onehealth Suzhou Suzhou Physical examination 100.00% Establishment Clinic Co., Ltd. Suzhou Meida Clinic Co., Ltd. Suzhou Suzhou Physical examination 100.00% Acquisition
117 Suzhou Industrial Park Meinian Clinic Co., Suzhou Suzhou Physical examination 100.00% Establishment Ltd. Wuxi Meinian Sanatorium Co., Ltd. Wuxi Wuxi Physical examination 100.00% Establishment Wuxi Binhu District Meinian Onehealth Wuxi Wuxi Physical examination 100.00% Establishment Clinic Co., Ltd. Hangzhou Meinian Binhe Medical Clinic Hangzhou Hangzhou Physical examination 100.00% Establishment Co., Ltd. Kunshan Meida Clinic Co., Ltd. Kunshan Kunshan Physical examination 100.00% Establishment Anhui Meinian Onehealth Management Hefei Hefei Physical examination 100.00% Acquisition Consulting Co., Ltd. Anhui Ciji Medical Investment Bengbu Bengbu Physical examination 52.01% Acquisition Management Co., Ltd. Suzhou Meinian Onehealth Health Suzhou Suzhou Physical examination 51.00% Acquisition Management Co., Ltd. Wuhan Meinian Onehealth Checkup Wuhan Wuhan Physical examination 100.00% Establishment Management Co., Ltd. Wuhan Gaoxin Clinic Co., Ltd. Wuhan Wuhan Physical examination 100.00% Acquisition Wuhan Meinian Health Management Co., Wuhan Wuhan Physical examination 51.00% Acquisition Ltd. Xiangyang Meinian Onehealth Xiangyang Xiangyang Physical examination 72.00% Acquisition Management Co., Ltd. Wuhan Meinian Yisheng Health Health management Wuhan Wuhan 100.00% Acquisition Management Co., Ltd. consulting Wuhan Meinian Yisheng Comprehensive Wuhan Wuhan Physical examination 100.00% Acquisition Clinic Co., Ltd. Wuhan Renfuyisheng Health Pharmacy Retail of drugs and medical Wuhan Wuhan 100.00% Acquisition Co., Ltd. devices I and II Daye Meinian Onehealth Checkup Daye Daye Physical examination 51.00% Acquisition Management Co., Ltd. Huangshi Meinian Onehealth Checkup Huangshi Huangshi Physical examination 51.00% Acquisition Management Co., Ltd. Ezhou Meinian Onehealth Management Ezhou Ezhou Physical examination 51.00% Acquisition Co., Ltd. Suizhou Meinian Onehealth Management Suizhou Suizhou Physical examination 51.00% Acquisition Co., Ltd. Zhengzhou Meinian Onehealth Zhengzhou Zhengzhou Physical examination 100.00% Acquisition Technology Co., Ltd. Xinxiang Meinian Onehealth Management Xinxiang Xinxiang Physical examination 51.00% Acquisition Co., Ltd. Luoyang Meinian Onehealth Technology Luoyang Luoyang Physical examination 51.00% Acquisition Co., Ltd. Puyang Meinian Onehealth Consulting Puyang Puyang Physical examination 51.00% Acquisition Co., Ltd. Zhengzhou Meinian Healthcare Zhengzhou Zhengzhou Physical examination 100.00% Acquisition Management Co., Ltd. Pingdingshan Meinian University Health Pingdingsha Pingdingsha Science and Technology Service Co., Physical examination 51.00% Acquisition n n Ltd. Xinyang Meinian Onehealth Management Xinyang Xinyang Physical examination 51.00% Acquisition Co., Ltd. Zhumadian Meinian Onehealth Zhumadian Zhumadian Physical examination 51.00% Acquisition Technology Co., Ltd. Anyang Meinian Onehealth Management Anyang Anyang Physical examination 51.00% Acquisition Co., Ltd. Changsha Meinian Onehealth Health Changsha Changsha Physical examination 100.00% Acquisition Management Co., Ltd. Zhuzhou Meinian Onehealth Health Zhuzhou Zhuzhou Physical examination 100.00% Acquisition Management Co., Ltd. Yueyang Meinian Onehealth Health Yueyang Yueyang Physical examination 51.00% Acquisition Management Co., Ltd.
118 Xiangtan Meinian Onehealth Health Xiangtan Xiangtan Physical examination 91.76% Acquisition Management Co., Ltd. Jiangxi Meinian Onehealth Management Health consultation and Nanchang Nanchang 100.00% Establishment Co., Ltd. enterprise management Nanchang Honggu Changgeng Health Nanchang Nanchang Physical examination 100.00% Acquisition Checkup Centre Co., Ltd. Nanchang Qingshanhu Changgeng Health Nanchang Nanchang Physical examination 100.00% Establishment Checkup Centre Co., Ltd. Yichun Meinian Onehealth Checkup Yichun Yichun Physical examination 51.00% Acquisition Centre Co., Ltd. Nanchang Meikang Health Checkup Nanchang Nanchang Physical examination 100.00% Acquisition Centre Co., Ltd. Jiyuan Meinian Onehealth Technology Jiyuan Jiyuan Physical examination 60.00% Acquisition Co., Ltd. Taian Meinian Onehealth Checkup Taian Taian Physical examination 100.00% Acquisition Management Co., Ltd. Linyi Meinian Health Checkup Linyi Linyi Physical examination 58.90% Acquisition Management Co., Ltd. Linyi Onehealth Health Checkup Archives Linyi Linyi Physical examination 100.00% Acquisition Management Co., Ltd. Linyi Meigu Health Checkup Management Health management Linyi Linyi 100.00% Acquisition Co., Ltd. consulting Kaifeng Meinian Onehealth Health Kaifeng Kaifeng Physical examination 51.00% Acquisition Management Co., Ltd. Liaocheng Meinian Onehealth Health management Liaocheng Liaocheng 51.00% Acquisition Management Co., Ltd. consulting Tianjin Meinian Investment Management Tianjin Tianjin Physical examination 100.00% Establishment Co., Ltd. Tianjin Binhai New Area Meijian Clinic Co., Tianjin Tianjin Physical examination 100.00% Establishment Ltd. Tianjin Binhai New Area Meixin Clinic Co., Tianjin Tianjin Physical examination 100.00% Acquisition Ltd. Beijing Meinian Health Technology Co., Beijing Beijing Investment management 100.00% Establishment Ltd. Beijing Meinian Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Establishment Beijing Meinian Meikang Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Establishment Beijing Meinian Traditional Chinese Beijing Beijing Physical examination 100.00% Establishment Medical Hospital Co., Ltd. Beijing Meinian Jiajing Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Acquisition Beijing Lvshengyuan Outpatient Dept Co., Beijing Beijing Physical examination 100.00% Acquisition Ltd. Beijing Meinian Meijia Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Establishment Beijing Meinian Meifu Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Acquisition Guangdong Meinian National Medical Guangzhou Guangzhou Investment management 85.00% Establishment Investment Co., Ltd. Beijing Yangniantang Traditional Chinese Beijing Beijing Physical examination 72.35% Establishment Medical Clinic Co., Ltd. Shenzhen Meinian Onehealth Health Shenzhen Shenzhen Physical examination 100.00% Acquisition Management Co., Ltd. Guangzhou Meinian Onehealth Medical Guangzhou Guangzhou Investment management 97.00% Establishment Technology Co., Ltd. Guangzhou Meinian Onehealth Medical Guangzhou Guangzhou Investment management 97.00% Establishment Clinic Co., Ltd. Guangzhou Meinian Health Fuhai Clinic Guangzhou Guangzhou Physical examination 97.00% Establishment Co., Ltd. Guangdong Youyi Health Management Guangzhou Guangzhou Physical examination 67.90% Acquisition Co., Ltd. Zhongshan Meinian Onehealth Health management Zhongshan Zhongshan 77.60% Acquisition Management Co., Ltd. consulting
119 Zhongshan Meinian Clinic Co., Ltd. Zhongshan Zhongshan Physical examination 77.60% Acquisition Jiangmen Meinian Onehealth Health Jiangmen Jiangmen Physical examination 70.00% Acquisition Management Co., Ltd. Heyuan Meinian Onehealth Management Heyuan Heyuan Physical examination 65.96% Acquisition Co., Ltd. Huizhou Meinian Onehealth Health Huizhou Huizhou Physical examination 51.00% Acquisition Management Co., Ltd. Dongguan Meinian Onehealth Hospital Dongguan Dongguan Investment management 100.00% Acquisition Investment Management Co., Ltd. Dongguan Nancheng Meinian Onehealth Dongguan Dongguan Physical examination 100.00% Establishment Clinic Co., Ltd. Shenzhen Hongkangjie Technology Co., Shenzhen Shenzhen Physical examination 91.00% Acquisition Ltd. Zhengzhou Hongkangjie Technology Co., Zhengzhou Zhengzhou Physical examination 91.41% Establishment Ltd. Sichuan Hongkangjie Medical Investment Chengdu Chengdu Physical examination 91.41% Acquisition Management Co., Ltd. Shantou Meinian Health Management Co., Shantou Shantou Physical examination 56.50% Acquisition Ltd. Hainan Meinian Onehealth Hospital Co., Haikou Haikou Physical examination 75.00% Acquisition Ltd. Haikou Ciming Health Checkup Clinic Haikou Haikou Physical examination 74.25% Acquisition (GP) Hainan Ciming Oasis Checkup Hospital Haikou Haikou Physical examination 57.65% Acquisition Co., Ltd. Nanning Meinian Onehealth Checkup Co., Nanning Nanning Physical examination 100.00% Establishment Ltd. Jinzhou Meinian Health Management Co., Jinzhou Jinzhou Physical examination 67.00% Acquisition Ltd. Changchun Meinian Onehealth Yuchen Changchun Changchun Physical examination 100.00% Acquisition Hospital Co., Ltd. Shenyang Meinian Health Technology Health management Shenyang Shenyang 100.00% Acquisition Health Management Co., Ltd. consulting Dandong Meinian Onehealth Health Dandong Dandong Physical examination 70.00% Acquisition Management Co., Ltd. Huludao Meinian Onehealth Management Huludao Huludao Physical examination 65.00% Acquisition Co., Ltd. Songyuan Meinian Onehealth Health Songyuan Songyuan Physical examination 60.00% Acquisition Management Co., Ltd. Fuxin Meinian Onehealth Health Fuxin Fuxin Physical examination 51.00% Acquisition Management Co., Ltd. Tangshan Meinian Onehealth Health Tangshan Tangshan Physical examination 68.76% Acquisition Checkup Management Co., Ltd. Shenyang Onehealth and Wellness Shenyang Shenyang Physical examination 100.00% Acquisition Management Co., Ltd. Liaoyang Meinian Onehealth Health Liaoyang Liaoyang Physical examination 100.00% Acquisition Management Co., Ltd. Shenyang Meinian Onehealth Clinic Co., Shenyang Shenyang Physical examination 100.00% Establishment Ltd. Dalian Meinian Onehealth Management Dalian Dalian Physical examination 100.00% Acquisition Co., Ltd. Dalian Lvshun Meinian Onehealth New Dalian Dalian Physical examination 100.00% Acquisition Town Comprehensive Clinic Co., Ltd. Dalian Meinian Health Xinghai Dalian Dalian Physical examination 100.00% Establishment Comprehensive Clinic Co., Ltd. Dalian Meinian Health Hongxia Road Comprehensive Clinic Department Co., Dalian Dalian Physical examination 100.00% Establishment Ltd. Dalian Meinian Onehealth Life Technology Dalian Dalian Physical examination 100.00% Establishment Co., Ltd.
120 Harbin Meinian Onehealth Checkup Harbin Harbin Physical examination 100.00% Acquisition Station Co., Ltd. Jilin Onehealth Technology Management Jilin Jilin Physical examination 100.00% Acquisition Co., Ltd. Yanbian Onehealth Comprehensive Clinic Yanji Yanji Physical examination 100.00% Acquisition Co., Ltd. Taiyuan Meinian Onehealth Technology Taiyuan Taiyuan Physical examination 75.00% Acquisition Health Management Co., Ltd. Yuncheng Onehealth Checkup Co., Ltd. Yuncheng Yuncheng Physical examination 51.00% Establishment Jinzhong Meinian Onehealth Management Jinzhong Jinzhong Physical examination 51.00% Acquisition Co., Ltd. Qingdao Onehealth Technology Health Qingdao Qingdao Physical examination 100.00% Acquisition Management Co., Ltd. Qingdao Nanda Health Clinic Co., Ltd. Qingdao Qingdao Physical examination 99.90% Acquisition Qingdao Shinan Meinian Onehealth Clinic Qingdao Qingdao Physical examination 100.00% Establishment Co., Ltd. Hohhot Meinian Onehealth Health Hohhot Hohhot Physical examination 89.64% Establishment Checkup Co., Ltd. Jinan Onehealth Health Checkup Jinan Jinan Physical examination 100.00% Acquisition Management Co., Ltd. Weifang Meinian Onehealth Health Weifang Weifang Physical examination 51.00% Acquisition Management Co., Ltd. Weifang Meinian Huier Health Weifang Weifang Physical examination 51.00% Acquisition Management Co., Ltd. Yantai Ciming Health Checkup Yantai Yantai Physical examination 89.79% Acquisition Management Co., Ltd. Shijiazhuang Meinian Onehealth Checkup Shijiazhuang Shijiazhuang Physical examination 100.00% Acquisition Management Co., Ltd. Handan Meinian Onehealth Management Handan Handan Physical examination 51.00% Acquisition Co., Ltd. Xi’an Meinian Onehealth Health Xi’an Xi’an Physical examination 100.00% Acquisition Management Co., Ltd. Xi'an Qujiang New District Meinian Health Xi’an Xi’an Physical examination 100.00% Acquisition Checkup Centre Co., Ltd. Lanzhou Meinian Onehealth Health Lanzhou Lanzhou Physical examination 100.00% Establishment Management Co., Ltd. Lanzhou Meinian Onehealth Jinmao Lanzhou Lanzhou Physical examination 51.00% Acquisition Health Management Co., Ltd. Qingyang Meinian Onehealth Health Qingyang Qingyang Physical examination 51.00% Acquisition Management Co., Ltd. Xining Meinian Onehealth Health Xining Xining Physical examination 51.00% Acquisition Management Co., Ltd. Xinjiang Meinian Onehealth Health Urumqi Urumqi Physical examination 100.00% Establishment Management Co., Ltd. Xinjiang Meinian Health Consulting Co., Urumqi Urumqi Physical examination 100.00% Establishment Ltd. Xinjiang Puhui Antai Health Management Urumqi Urumqi Physical examination 100.00% Acquisition Co., Ltd. Hami Meinian Onehealth Health Hami Hami Physical examination 51.00% Acquisition Management Co., Ltd. Yili Meinian Onehealth Management Co., Yili Yili Physical examination 60.00% Acquisition Ltd. Chengdu Meinian Onehealth Health Chengdu Chengdu Physical examination 100.00% Establishment Management Co., Ltd. Suining Meinian Onehealth Checkup Suining Suining Physical examination 51.00% Acquisition Hospital Co., Ltd. Deyang Meinian Onehealth Checkup Deyang Deyang Physical examination 51.00% Acquisition Hospital Co., Ltd. Chengdu Jinjiang Meinian Onehealth Chengdu Chengdu Physical examination 55.00% Acquisition Weikang Checkup Clinic Co., Ltd.
121 Chengdu Wuhou Weikang Meinian Chengdu Chengdu Physical examination 55.00% Acquisition Onehealth Checkup Clinic Co., Ltd. Pu'er Meinian Onehealth Checkup Centre Pu'er Pu'er Physical examination 64.00% Acquisition Co., Ltd. Guangyuan Meinian Onehealth Guangyuan Guangyuan Physical examination 60.00% Acquisition Technology Co., Ltd. Meishan Meinian Onehealth Management Meishan Meishan Physical examination 51.00% Acquisition Co., Ltd. Neijiang Meinian Onehealth Health Neijiang Neijiang Physical examination 51.00% Acquisition Management Co., Ltd. Chengdu Meinian Checkup Hospital Co., Chengdu Chengdu Physical examination 100.00% Establishment Ltd. Zigong Meinian Onehealth Checkup Zigong Zigong Physical examination 51.00% Acquisition Hospital Co., Ltd. Chengdu Onehealth Technology Chengdu Chengdu Physical examination 100.00% Acquisition Management Co., Ltd. Mianyang Meinian Onehealth Technology Mianyang Mianyang Physical examination 60.00% Acquisition Co., Ltd. Dali Meinian Onehealth Checkup Hospital Dali Dali Physical examination 47.25% Acquisition Co., Ltd. Chengdu Kaier Health Checkup Hospital Chengdu Chengdu Physical examination 100.00% Acquisition Co., Ltd. Chengdu Tianfu New District Oasis Chengdu Chengdu Physical examination 100.00% Acquisition Hospital Co., Ltd. Leshan Meinian Onehealth Service Co., Leshan Leshan Physical examination 51.00% Acquisition Ltd. Chongqing Meinian Onehealth Chongqing Chongqing Physical examination 96.04% Acquisition Management Co., Ltd. Xichang Meinian Onehealth Health Xichang Xichang Physical examination 51.00% Acquisition Management Co., Ltd. Yunnan Meinian Onehealth Healthcare Kunming Kunming Physical examination 75.00% Establishment Co., Ltd. Chongqing Meinian Onehealth Healthcare Chongqing Chongqing Investment management 51.00% Establishment Co., Ltd. Chongqing Onehealth Health Checkup Chongqing Chongqing Physical examination 75.01% Acquisition Management Co., Ltd. Guizhou Meinian Onehealth Kangyuan Guiyang Guiyang Physical examination 100.00% Acquisition Checkup Centre Co., Ltd. Hangzhou Meixi Medical Clinic Co., Ltd. Hangzhou Hangzhou Physical examination 70.00% Acquisition Nutrition and health Shanghai Meinian Health Management Shanghai Shanghai consulting and enterprise 100.00% Establishment Consulting Co., Ltd. management consulting Shanghai Meishunhe Health Consulting Shanghai Shanghai Nutrition and health 100.00% Establishment Co., Ltd. consulting and enterprise management consulting Shanghai Meizhi Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Establishment Heze Meinian Onehealth Checkup Heze Heze Physical examination 51.00% Acquisition Management Co., Ltd. Heze Meinian Onehealth Health Heze Heze Physical examination 26.01% Acquisition Management Co., Ltd. Chuanyu Meinian (Chongqing) Health Chongqing Chongqing Health management 100.00% Establishment Management Co., Ltd. consulting Bozhou Meinian Onehealth Health Bozhou Bozhou Physical examination 51.00% Acquisition Management Co., Ltd. Sichuan Meinian Onehealth Management Chengdu Chengdu Health management 100.00% Establishment Co., Ltd. consulting Henan Meinian Enterprise Management Zhengzhou Zhengzhou Health management 100.00% Establishment Consulting Co., Ltd. consulting Hunan Meinian Onehealth Management Changsha Changsha Health management 100.00% Establishment Co., Ltd. consulting
122 Shanxi Meinian Health Management Co., Taiyuan Taiyuan Health management 100.00% Establishment Ltd. consulting Meinian Onehealth Healthcare Jinan Jinan Investment management 100.00% Establishment (Shandong) Co., Ltd. Meinian Onehealth Healthcare Group Jilin Changchun Changchun Health management 100.00% Establishment Branch Co., Ltd. consulting Yunnan Meinian Health Management Co., Kunming Kunming Health management 100.00% Establishment Ltd. consulting Dali Ciming Health Management Co., Ltd. Dali Dali Physical examination 51.00% Establishment Yuxi Meinian Onehealth Healthcare Co., Yuxi Yuxi Health management 47.00% Acquisition Ltd. consulting Yuxi Meinian Onehealth Checkup Centre Yuxi Yuxi Physical examination 47.00% Acquisition Co., Ltd. Zhejiang Meinian Onehealth Management Hangzhou Hangzhou Health consultation and 100.00% Establishment Co., Ltd. enterprise management Inner Mongolia Meinian Health and Health Hohhot Hohhot Health management 100.00% Establishment Management Co., Ltd. consulting Guangdong Meinian Management Shenzhen Shenzhen Health management 100.00% Establishment Consulting Co., Ltd. consulting Guangxi Meinian Health Management Co., Nanning Nanning Health management 100.00% Establishment Ltd. consulting Liaoning Meijian Health Management Co., Shenyang Shenyang Health management 100.00% Establishment Ltd. consulting Anhui Meinian Meikang Enterprise Maonshan Maonshan Enterprise management 100.00% Establishment Management Co., Ltd. consulting Anhui Nuoyi Health Management Co., Ltd. Hefei Hefei Health management 51.00% Acquisition consulting Huainan Ainuo Health Checkup Co., Ltd. Huainan Huainan Physical examination 100.00% Acquisition Bengbu Economic Development Zone Bengbu Bengbu Physical examination 100.00% Acquisition Ainuo Clinic Co., Ltd. Fuyang Yingzhou Ainuo Comprehensive Fuyang Fuyang Physical examination 100.00% Acquisition Clinic Co., Ltd. Hefei Shushan Ainuo Health Checkup Hefei Hefei Physical examination 100.00% Acquisition Clinic Co., Ltd. Hefei Luyang Ainuo Clinic Co., Ltd. Hefei Hefei Physical examination 100.00% Acquisition Lu'an Ainuo Health Checkup Clinic Co., Lu'an Lu'an Physical examination 100.00% Acquisition Ltd. Chaohu Ainuo Health Checkup Chaohu Chaohu Physical examination 100.00% Acquisition Comprehensive Clinic Co., Ltd. Wuhu Ainuo Clinic Co., Ltd. Wuhu Wuhu City Physical examination 100.00% Acquisition Huaibei Ainuo Wanjia Health Checkup Huaibei Huaibei Physical examination 100.00% Acquisition Co., Ltd. Chuzhou Ainuo Health Checkup Clinic Chuzhou Chuzhou Physical examination 100.00% Acquisition Co., Ltd. Anqing Ainuo Health Checkup Clinic Co., Anqing Anqing Physical examination 100.00% Acquisition Ltd. Fujian Meinian Enterprise Management Xiamen Xiamen Enterprise management 100.00% Establishment Co., Ltd. consulting Shaanxi Meinian Onehealth Health Xi’an Xi’an Health management 100.00% Establishment Management Co., Ltd. consulting Jiangsu Meinian Onehealth Management Nanjing Nanjing Health management 100.00% Establishment Co., Ltd. consulting Gansu Meinian Onehealth Health Lanzhou Lanzhou Health management 100.00% Establishment Management Co., Ltd. consulting Hubei Meinian Onehealth Management Wuhan Wuhan Health management 100.00% Establishment Co., Ltd. consulting Hangzhou Xiaoshan Meinian Jincheng Hangzhou Hangzhou Physical examination 51.00% Acquisition Comprehensive Clinic Co., Ltd. Ciming Health Checkup Management Beijing Beijing Physical examination 100.00% Acquisition Group Beijing Ciming Lenovo Bridge
123 Clinic Co., Ltd. Ciming Health Checkup Management Beijing Beijing Physical examination 100.00% Acquisition Group Beijing Ciming Shangdi Clinic Co., Ltd. Ciming Health Checkup Management Beijing Beijing Physical examination 100.00% Acquisition Group Beijing Ciming Ciyun Temple Clinic Co., Ltd. Beijing Ciming Oasis Xidan Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Acquisition Beijing Ciming Star Information Beijing Beijing Information technology 100.00% Acquisition Technology Co., Ltd. services Ciming Health Checkup Management Shanghai Shanghai Physical examination 100.00% Acquisition Group Shanghai Co., Ltd. Shanghai Ciming Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Acquisition Shanghai Zhuoyue Ciming Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Acquisition Shanghai Zhicheng Ciming Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Acquisition Shanghai Zhengyuan Ciming Clinic Co., Shanghai Shanghai Physical examination 100.00% Acquisition Ltd. Shanghai Chuyuan Ciming Clinic Co., Ltd. Shanghai Shanghai Physical examination 100.00% Acquisition Shenzhen Ciming Health Checkup Shenzhen Shenzhen Physical examination 100.00% Acquisition Management Co., Ltd. Dongguan Ciming Health Checkup Dongguan Dongguan Physical examination 100.00% Acquisition Management Co., Ltd. Dongguan Nancheng Ciming Clinic Co., Dongguan Dongguan Physical examination 100.00% Establishment Ltd. Ciming Health Checkup Management Guangzhou Guangzhou Physical examination 100.00% Acquisition Group Guangzhou Co., Ltd. Guangzhou Ciming Clinic Co., Ltd. Guangzhou Guangzhou Physical examination 100.00% Acquisition Guangzhou Ciming Dongfeng Clinic Co., Guangzhou Guangzhou Physical examination 100.00% Acquisition Ltd. Guangzhou Ciming Zhuoyue Clinic Co., Guangzhou Guangzhou Physical examination 100.00% Acquisition Ltd. Ciming Health Checkup Management Wuhan Wuhan Physical examination 100.00% Acquisition Group Wuhan Co., Ltd. Ciming Health Checkup Management Dalian Dalian Physical examination 100.00% Acquisition Group (Dalian) Co., Ltd. Dalian Ciming Comprehensive Clinic Co., Dalian Dalian Physical examination 100.00% Acquisition Ltd. Dalian Ciming Xinghai Xin Tiandi Dalian Dalian Physical examination 100.00% Acquisition Comprehensive Clinic Co., Ltd. Dalian Ciming High-tech Comprehensive Dalian Dalian Physical examination 100.00% Acquisition Clinic Co., Ltd. Ciming Health Checkup Management Nanjing Nanjing Physical examination 100.00% Acquisition Group Nanjing Co., Ltd. Ciming Health Checkup Management Tianjin Tianjin Physical examination 99.00% Acquisition Group Tianjin Co., Ltd. Shandong Ciming Health Checkup Jinan Jinan Physical examination 79.00% Acquisition Management Co., Ltd. Chengdu Ciming Health Management Co., Chengdu Chengdu Physical examination 100.00% Acquisition Ltd. Linyi Ciming Health Checkup Linyi Linyi Physical examination 100.00% Acquisition Management Group Co., Ltd. Jilin Ciming Health Checkup Management Changchun Changchun Physical examination 100.00% Acquisition Group Co., Ltd. Ciming Health Checkup Management Hangzhou Hangzhou Health management 100.00% Acquisition Group Hangzhou Co., Ltd. consulting Hangzhou Ciming Youhao Comprehensive Hangzhou Hangzhou Physical examination 100.00% Acquisition Clinic Co., Ltd. Jinhua Ciming Health Management Co., Jinhua Jinhua Physical examination 100.00% Acquisition Ltd.
124 Qingdao Ciming Health Management Co., Qingdao Qingdao Physical examination 93.00% Acquisition Ltd. Qingdao Oasis Health Management Co., Qingdao Qingdao Health management 51.00% Establishment Ltd. consulting Ningbo Ciming Health Checkup Ningbo Ningbo Physical examination 55.56% Acquisition Investment Management Group Co., Ltd. Hefei Ciming Health Checkup Hefei Hefei Physical examination 100.00% Acquisition Management Co., Ltd. Urumqi Huarui Tianmei Health Urumqi Urumqi Physical examination 90.00% Acquisition Management Co., Ltd. Ciming Oasis Hospital Management Co., Beijing Beijing Hospital management and 100.00% Acquisition Ltd. enterprise management Beijing Ciming Oasis Shangdi Brilliant Beijing Beijing Physical examination 100.00% Acquisition Clinic Co., Ltd. Tongliao Ciming Health Management Co., Tongliao Tongliao Physical examination 51.00% Acquisition Ltd. Suzhou Meijian Oasis Health Checkup Suzhou Suzhou Physical examination 100.00% Establishment Centre Co., Ltd. Tianjin Hedong District Meinian Meishang Tianjin Tianjin Physical examination 100.00% Establishment Health Checkup Centre Co., Ltd. Changchun Baiwei Cikang Hospital Co., Changchun Changchun Physical examination 80.00% Acquisition Ltd. Wuxi Meihua Clinic Co., Ltd. Wuxi Wuxi Physical examination 59.50% Acquisition Anhui Meixin Health Management Hefei Hefei Health management 51.00% Acquisition Consulting Co., Ltd. consulting Beijing Ciming Lize Clinic Co., Ltd. Beijing Beijing Physical examination 100.00% Acquisition Wuhan Dongxihu Ciming Checkup Wuhan Wuhan Physical examination 70.00% Acquisition Management Co., Ltd. Harbin Meiming Health Management Co., Harbin Harbin Health management 56.82% Acquisition Ltd. consulting
Reasons for the inconsistency between the proportion of shareholdings in a subsidiary and the proportion of voting rights: Not applicable
Basis for controlling investee even though holding half or less than half of the voting rights and not controlling investee even though holding half or more than half of the voting rights: Not applicable
Basis of control over material structured entities included in the consolidation scope: Note applicable
Basis for determining whether the company is an agent or a principal: Not applicable
Other description: N/A
125 (2) Material non-wholly owned subsidiaries
Unit: Renminbi Yuan
Closing balance Shareholding proportion Profit or loss attributable Dividends distributed to non- of non- Name of the subsidiary of non-controlling to non-controlling controlling shareholders this controlling shareholders (%) shareholders this period period shareholders’ equity Shenzhen Hongkangjie 6.00% 337,424.35 9,030,719.29 Technology Co., Ltd. Hainan Meinian Onehealth 25.00% -2,305,179.76 16,692,245.98 Hospital Co., Ltd. Yunnan Meinian Onehealth 25.00% -5,830,420.02 13,440,196.92 Healthcare Co., Ltd. Reasons for the inconsistency between the proportion of shareholdings of the non-controlling interests in a subsidiary and the proportion of voting rights: N/A Other description: N/A
(3) Key financial information about material non-wholly owned subsidiaries
Unit: Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period
Name of the subsidiary Current Non-current Current Non-current Current assets Non-current assets Total assets Total liabilities Current assets Non-current assets Total assets Total liabilities liabilities liabilities liabilities liabilities
Shenzhen Hongkangjie 203,522,922.47 29,669,212.77 233,192,135.24 44,540,318.54 214,758.00 44,755,076.54 210,877,788.14 32,006,445.05 242,884,233.19 59,460,303.85 606,120.00 60,066,423.85 Technology Co., Ltd.
Hainan Meinian Onehealth 59,956,370.69 116,858,624.92 176,814,995.61 87,552,556.75 7,874,998.87 95,427,555.62 61,541,004.00 123,748,236.01 185,289,240.01 73,668,691.08 21,077,914.68 94,746,605.76 Hospital Co., Ltd.
Yunnan Meinian Onehealth 55,914,963.77 103,536,593.17 159,451,556.94 75,930,186.18 3,521,289.00 79,451,475.18 97,044,142.06 111,127,379.07 208,171,521.13 99,187,722.98 5,662,036.32 104,849,759.30 Healthcare Co., Ltd.
Unit: Renminbi Yuan
Accrued during the period Accrued during the prior period Name of the Total Cash flows from Total Cash flows from Operating Operating subsidiary Net profit comprehensive operating Net profit comprehensive operating income income income activities income activities Shenzhen Hongkangjie 37,799,820.06 5,623,739.17 5,623,739.17 -12,991,295.35 44,914,643.60 9,719,448.92 9,719,448.92 5,650,492.94 Technology Co., Ltd. Hainan Meinian Onehealth 13,706,445.81 -9,220,719.02 -9,220,719.02 -5,838,300.74 22,369,722.08 -716,817.56 -716,817.56 -41,454,211.70 Hospital Co., Ltd. Yunnan Meinian Onehealth 19,143,406.80 -23,321,680.07 -23,321,680.07 -3,776,468.16 49,346,126.88 -13,716,268.03 -13,716,268.03 -11,735,326.96 Healthcare Co., Ltd.
126 (4) Material restriction on the use of the Group’s assets and the settlement of the Group’s liabilities
(5) Financial support or other assistance provided to structured entities included in the consolidated financial statements
2 Transactions that cause changes in the Group’s interests in subsidiaries that do not result in loss of control
(1) Changes in the Group’s interests in subsidiaries:
(2) Impact from transactions with non-controlling interests and equity attributable to the shareholders of the Company:
3 Equity in joint venture arrangements or associates
(1) Material joint ventures or associates
Shareholding Accounting Principal percentage treatment of Registere Name of joint ventures or associates place of Business nature investments in joint d place business Direct Indirect ventures or associates Technology consultancy and technology service Shanghai Haozhuo Data Service Co., Ltd. Shanghai Shanghai 11.40% The equity method in data service sector Jiangsu Huakang Occupational Health Consulting and service and marketing planning Wuxi Wuxi 35.00% The equity method Consulting Co., Ltd. for prevention of occupational diseases Reasons for the inconsistency between the proportion of shareholdings in joint ventures or associates and the proportion of voting rights: Not applicable Basis for having significant influence even though holding less than 20 percent of the voting rights or not having significant influence even though holding 20 percent or more than 20 percent of the voting rights: Not applicable
(2) Key financial information about material joint ventures
(3) Key financial information about material associates
(4) Summarised financial information of immaterial joint ventures and associates:
Unit: Renminbi Yuan Closing balance/amount accrued Opening balance/amount accrued
during the period during the prior period Joint ventures: -- -- Aggregate amount of share of -- -- Associates: -- -- Aggregate carrying amount of 157,013,371.17 162,090,985.54 investments Aggregate amount of share of ------Net profit -5,385,777.78 -3,475,216.95 --Total comprehensive income -5,385,777.78 -3,475,216.95
127 (5) Description of material restrictions on transfers of funds from joint ventures or associates to the Company
(6) Excess loss from joint ventures or associates
Unit: Renminbi Yuan Unrecognised loss (or Accumulated Name of joint ventures or Accumulated unrecognised share of net profit) in the unrecognised loss at the associates loss in prior periods current period end of the period Shanghai Haozhuo Data 2,092,916.07 -213,603.73 1,879,312.34 Service Co., Ltd.
(7) Unrecognised commitments related to investments in joint ventures
(8) Contingent liabilities related to investments in joint ventures or associates
4 Material joint operations
5 Interests in structured entities not included in the consolidated financial statements
6 Others
X. Risk related to financial instruments
XI. Fair value disclosure
1 Fair value of assets and liabilities measured at fair value at the end of the period
Unit: Renminbi Yuan
Fair value at the end of the period Item Level 1 Fair value Level 2 Fair value Level 3 Fair value Total measurement measurement measurement I. Recurring fair value measurements ------Other non-current financial assets 1,271,876,037.72 1,271,876,037.72 Total assets measured at fair value on 1,271,876,037.72 1,271,876,037.72 a recurring basis II. Non-recurring fair value ------measurements
2 Basis for determining the market price for recurring and non-recurring fair value measurements categorised within Level 1
3 Valuation techniques used and the qualitative and quantitative information of key parameters for recurring and non-recurring fair value measurements categorised within Level 2
4 Valuation techniques used and the qualitative and quantitative information of key parameters for recurring and non-recurring fair value measurements categorised within Level 3
128 5 Reconciliation from the opening balances to the closing balances, and sensitivity analysis on unobservable inputs for items measured at recurring Level 3 fair value measurements
6 Reasons for transfers between different levels, and the policy about the timing of those transfers for recurring fair value measurements
7 Current changes in valuation techniques and the reasons
8 Fair values of financial assets and liabilities not measured at fair value
9 Others
XII. Related parties and related party transactions
1 Information about the parent of the Company
The Company has no holding company and the final control party is Yu Rong.
2 Information about the subsidiaries of the Company
For information about the subsidiaries of the Company refer to Note IX.1.
3 Information about joint ventures and associates of the Company
For information about significant joint ventures and associates of the Company, refer to Note IX.3. Other joint ventures or associates that have related party transactions with the Company during the period or prior period with balance occurred are as follows: Not applicable Other description: N/A
4 Information on other related parties
Name of other related parties Relationship of other related parties with the Company Shareholder of Shandong Ciming Health Checkup Management Wang Shifang Co., Ltd. Cixin (Beijing) Medicare Investment Co., Ltd. Company controlled by directors of important subsidiaries Beijing Ciji Network Technology Co., Ltd. Company controlled by directors of important subsidiaries Wuhan Meizhao Health Management Co., Ltd. The actual controller significantly affects the company Beijing Wandong Medical Technology Co., Ltd. The actual controller significantly affects the company Esaote (Shenzhen) Medical Equipment Co., Ltd. The actual controller significantly affects the company Taiyuan Baozhongtang Health Technology Co., The actual controller significantly affects the company Ltd. Beijing Huamei Kangxun Information Technology The actual controller significantly affects the company Co., Ltd.
129 Shanghai Bao Zhong Tang Eshan Traditional The actual controller significantly affects the company Chinese Medicine Clinic Co., Ltd. Beijing YS Health Technology Co., Ltd. The actual controller significantly affects the company Zhongguancun Meinian Health Industry Research Actual-controller holds office in the institution Institute Beijing Trust&Far Technology Co., Ltd. Actual-controller holds office in the company Tianjin Huiyigu Technology Co., Ltd. Actual-controller holds office in the company Shanghai Jianyi Investment Centre (Limited Controlled by the actual-controller Partnership) Shaoxing Meizhao Outpatient Medical Co., Ltd. Controlled by the actual-controller Xi'an Meizhao Health Management Co., Ltd. Controlled by the actual-controller Wuxi Meizhao Clinic Co., Ltd. Controlled by the actual-controller Zhengzhou Meizhao Health Medical Management Controlled by the actual-controller Co., Ltd. Chengdu Meizhao Health Management Co., Ltd. Controlled by the actual-controller Shanghai Meizhao Zheyuan Clinic Co., Ltd. Controlled by the actual-controller Shanghai Tianyi Hongfang Corporate Controlled by the actual-controller Management Co., Ltd. Shanghai Haozhuo Data Service Co., Ltd. Controlled by the actual-controller Shanghai Elephant Healthcare Technology Co., Controlled by the actual-controller Ltd. Yinchuan Dr. Elephant Internet Hospital Co., Ltd. Controlled by the actual-controller Shenzhen Meizhao Health Management Co., Ltd. Controlled by the actual-controller Shanghai Tianyi Hongfang Property Management Controlled by the actual-controller Co., Ltd. Guangzhou Meizhao Health Management Co., Controlled by the actual-controller Ltd. Chongqing Tianji Pharmaceutical Co., Ltd. Controlled by the actual-controller Shanghai Meiwei Dental Care Management Group Controlled by the actual-controller Co., Ltd. Meizhi Health Management (Beijing) Co., Ltd. Controlled by the actual-controller Foshan Wanda Meizhao Health Management Co., Controlled by the actual-controller Ltd. Wuhan Haozhuo Big Data Technology Co., Ltd. Controlled by the actual-controller Wuhan Qinghua Sunshine Dentistry Co., Ltd. Controlled by the actual-controller Huangshi Meiwei Zhongshan Dental Care Controlled by the actual-controller Management Co., Ltd. Shanghai Sino Incubator Capital Management Controlled by the actual-controller Co., Ltd. Ningbo Henghe Dental Care Management Service Controlled by the actual-controller Co., Ltd. Wuxi Welle Dental Clinic Co., Ltd. Controlled by the actual-controller Hangzhou Haozhuo Youyi Data Technology Co., Controlled by the actual-controller Ltd. Wuxi Meihao Dental Clinic Co., Ltd. Controlled by the actual-controller Wuhan Tianyi Hongfang Investment Management Controlled by the actual-controller Co., Ltd. Shanghai Zhongwei Anjian Venture Capital Controlled by the actual-controller Management Co., Ltd. Meiwei (Guangzhou) Dental Health Medical Controlled by the actual-controller Investment Co., Ltd. Chengdu Aidi Ophthalmic Hospital Co., Ltd. Controlled by the actual-controller
130 Jinjian Technology Service (Beijing) Co., Ltd. Controlled by the actual-controller Beijing Tianyi Hongfang Investment Management Controlled by the actual-controller Co., Ltd. Shanghai Yushen Enterprise Management Co., Controlled by the actual-controller Ltd. Shanghai Bairuisi Corporate Management Co., Controlled by the actual-controller Ltd. Shanghai Jiuyi Information Technology Co., Ltd. Controlled by the actual-controller Nanchang Meiwei Dental Clinic Co., Ltd. Controlled by the actual-controller Chengdu Tiandiwang Information Technology Co., Controlled by the actual-controller Ltd. Bengbu Bao Zhong Tang Traditional Chinese Controlled by the actual-controller Medicine Clinic Co., Ltd. Shenyang Minsheng Otorhinolaryngology Hospital Controlled by the actual-controller Co., Ltd. Wuxi Huishan Welle Dental Clinic Co., Ltd. Controlled by the actual-controller Tianjin Meiweile Health Management Co., Ltd. Controlled by the actual-controller Qingdao Meiweile Medical Management Co., Ltd. Controlled by the actual-controller Nanjing Baozhongtang Medical Technology Co., Controlled by the actual-controller Ltd. Alibaba Group and its subsidiaries Other related parties Hangzhou Aidikang Medical Laboratories Co., Ltd. Other related parties and its subsidiaries Weihai Guoji Meinian Onehealth Checkup Centre Associates Co., Ltd. Yantai Meinian Onehealth Checkup Management Associates Co., Ltd. Yantai Meinian Futian Health Checkup Associates Management Co., Ltd. Yinchuan Meinian Onehealth Hospital Co., Ltd. Associates Foshan Meinian Onehealth Checkup Management Associates Co., Ltd. Dongguan Meinian Onehealth Health Associates Management Co., Ltd. Baoshan Meinian Onehealth Checkup Centre Co., Associates Ltd. Fuyang Meinian Onehealth Health Management Associates Co., Ltd. Wenshan Meinian Onehealth Checkup Centre Co., Associates Ltd. Yixing Meinian Comprehensive Clinic Co., Ltd. Associates Leshan Ciming Health Checkup Service Co., Ltd. Associates Mengcheng Meinian Onehealth Management Co., Associates Ltd. Weihai Meinian Onehealth Checkup Centre Co., Associates Ltd. Wuxi Ciming Oasis Clinic Co., Ltd. Associates Dalian Pulan Meinian Health Comprehensive Associates Clinic Co., Ltd. Huai'an Ciming Huakang Clinic Co., Ltd. Associates Hefei Ciming Oasis Health Management Co., Ltd. Associates Anshun Ciming Health Checkup Management Co., Associates Ltd.
131 Luoyang Meinian Onehealth Medical Technology Associates Co., Ltd. Guangdong Huanyue Healthcare Co., Ltd. Associates Pizhou Ciming Health Checkup Clinic Co., Ltd. Associates Panzhihua Ciming Health Checkup Hospital Co., Associates Ltd. Jiangsu Huakang Occupational Health Consulting Associates Co., Ltd. Zhaoqing Meinian Onehealth Health Management Associates Co., Ltd. Chongqing Meizhao Hospital Management Co., Key manager holds office in the company Ltd. Alipay (China) Network Technology Co., Ltd. Key manager holds office in the company Imeik Technology Development Co., Ltd. Key manager holds office in the company China Europe International Business School Key manager holds office in the company Education Foundation Shanghai Guosheng Asset Management Co., Ltd. Key manager holds office in the company Lianhua Supermarket Holdings Co., Ltd. Key manager holds office in the company Shanghai EGO New Retail network technology Key manager holds office in the company Co., Ltd. Lead Technology Co., Ltd. Key manager holds office in the company Shanghai Yundongli Medical Consulting Co., Ltd. Key manager holds office in the company CIFI Group Key manager holds office in the company Deyang Weile Xinqiao Dental Clinic Co., Ltd. Key manager holds office in the company Suning.Com Co., Ltd. Key manager holds office in the company Shandong Wanshu Trading Co., Ltd. Company controlled by key managers Shanghai Meixin Investment Management Co., Shareholder holding more than 5% of the company's shares Ltd. Shanghai Zunran Hospital Co., Ltd. Shareholder holding more than 5% of the company's shares Beijing Century Changhe Technology Group Co., Shareholder holding more than 5% of the company's shares Ltd. Shanghai Tianyi Industrial Holding Group Co., Ltd. Shareholder holding more than 5% of the company's shares Weifang Century Changhe Economic and Trade Shareholder holding more than 5% of the company's shares Co., Ltd. Associated enterprise from January to June 2020, subsidiary on 30 Harbin Meiming Health Management Co., Ltd. June 2020 Nantong Meizhao Meinian Health Industry M&A Company controlled by the actual-controller from January to May Investment Fund (Limited Partnership) 2020, non-related party in June 2020 Jiaxing Xinwen Yufu Equity Investment Company controlled by the actual-controller from January to May Partnership (Limited Partnership) 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Kunming Meizhao Health Management Co., Ltd. 2020, non-related party in June 2020 Chengdu Meinian Onehealth One Centre Company controlled by the actual-controller from January to May Checkup Clinic Co., Ltd. 2020, non-related party in June 2020 Zhuhai Meinian Onehealth Health Management Company controlled by the actual-controller from January to May Co., Ltd. 2020, non-related party in June 2020 Chengdu Jinniu Meinian Onehealth Management Company controlled by the actual-controller from January to May Consulting Co., Ltd. 2020, non-related party in June 2020 Chengdu Wuhou Meinian Health Checkup Clinic Company controlled by the actual-controller from January to May Co., Ltd. 2020, non-related party in June 2020 Guangzhou Meinian Onehealth Medical Company controlled by the actual-controller from January to May Technology Co., Ltd. 2020, non-related party in June 2020
132 Company controlled by the actual-controller from January to May Maanshan Meinian Onehealth Consulting Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Xiamen Ciming Health Management Co., Ltd. 2020, non-related party in June 2020 Taizhou Meizhao Health Checkup Centre (General Company controlled by the actual-controller from January to May Partnership) 2020, non-related party in June 2020 Guangzhou Zengcheng Meinian Health Company controlled by the actual-controller from January to May Management Co., Ltd. 2020, non-related party in June 2020 Dongguan Humen Meinian Onehealth Clinic Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Guangzhou Huadu Meinian Onehealth Company controlled by the actual-controller from January to May Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Putian Meinian Onehealth Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Qinzhou Meiling Health Checkup Co., Ltd. 2020, non-related party in June 2020 Xiamen Yincheng Meinian Health Management Company controlled by the actual-controller from January to May Co., Ltd. 2020, non-related party in June 2020 Tianjin Heping Meinian Meijia Health Management Company controlled by the actual-controller from January to May Co., Ltd. 2020, non-related party in June 2020 Wuhan Meici Oasis Technology Management Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Yangzhou Meishun Health Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Nan'an Meinian Onehealth Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Nanjing Meikai Clinic Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Nanjing Meiyi Clinic Co., Ltd. 2020, non-related party in June 2020 Huangshan Meinian Onehealth Consulting Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Jinan Meinian Onehealth Technology Co., Ltd. 2020, non-related party in June 2020 Qingdao Meinian Health Technology Health Company controlled by the actual-controller from January to May Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Shanghai Mekai Clinic Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Shaoxing Yuecheng Meinian Clinic Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Shenzhen Oasis Health Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Shenzhen Meiyang Health Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Shenzhen Yierkang Health Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Shenyang Oasis Hospital Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Yunnan Ciming Health Service Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Changchun Meijian Health Technology Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Zhengzhou Meijian Health Management Co., Ltd. 2020, non-related party in June 2020 Chongqing Meiyi Health Management Co., Ltd. Company controlled by the actual-controller from January to May
133 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Anxi Meinian Onehealth Management Co., Ltd. 2020, non-related party in June 2020 Fuzhou Ciming Oasis Health Checkup Centre Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Guangzhou Meinian Onehealth Hospital Company controlled by the actual-controller from January to May Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Harbin Oasis Health Management Co., Ltd. 2020, non-related party in June 2020 Shandong Meiming Oasis Health Consulting Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Houma Meinian Onehealth Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Tonglu Meinian Checkup Centre Co., Ltd. 2020, non-related party in June 2020 Dongguan Songshan Lake Meici Oasis Clinic Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Chongqing Meinian Meiyang Health Management Company controlled by the actual-controller from January to May Co., Ltd. 2020, non-related party in June 2020 Jilin Changyi Meinian Onehealth Technology Company controlled by the actual-controller from January to May Management Co., Ltd. 2020, non-related party in June 2020 Linyi Meiming Health Checkup Management Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Jinjiang Meinian Onehealth Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Tianjin Binhai New Area Ciai Clinic Co., Ltd. 2020, non-related party in June 2020 Tianjin Ciming Oasis Hospital Management Company controlled by the actual-controller from January to May Consulting Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Tianjin Meize Clinic Co., Ltd. 2020, non-related party in June 2020 Jinan Laiwu Meinian Onehealth Checkup Company controlled by the actual-controller from January to May Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Guizhou Jizhong Health Management Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Yongjia Youhao Polyclinic Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Guigang Meiyuankang Health Checkup Co., Ltd. 2020, non-related party in June 2020 Company controlled by the actual-controller from January to May Wuhan Meici Oasis Health Management Co., Ltd. 2020, non-related party in June 2020 Dongguan Chang‘an Meinian Health Management Company controlled by the actual-controller from January to May Co., Ltd. 2020, non-related party in June 2020 Nanping Meinian Onehealth Management Co., Company controlled by the actual-controller from January to May Ltd. 2020, non-related party in June 2020 Shanghai Lubinghua Healthcare Technology Co., Company significantly affected by the actual-controller in 2019, Ltd. non-related party in 2020 Enshi Meinian Onehealth Management Co., Ltd. Associated enterprise in 2019, non-related party in 2020 Xianning Meinian Onehealth Checkup Associated enterprise in 2019, non-related party in 2020 Management Co., Ltd. Bijie Meinian Onehealth Management Co., Ltd. Associated enterprise in 2019, non-related party in 2020 Guyuan Meinian Onehealth Hospital Co., Ltd. Associated enterprise in 2019, non-related party in 2020 Chenzhou Meinian Onehealth Management Co., Associated enterprise in 2019, non-related party in 2020 Ltd.
134 Ningbo Yinzhou Meizhao Comprehensive Clinic Associated enterprise in 2019, non-related party in 2020 Co., Ltd. Shanghai Jiao Tong University Shanghai Company where key manager holds office in 2019, non-related Advanced Institute of Finance party in 2020 Company where key manager holds office from January to Bestore Co., Ltd. November 2019, non-related party in December 2019 Company where key manager holds office from January to Perfect (China) Co., Ltd. November 2019, non-related party in December 2019 Company where key manager holds office from January to Shandong Wohua Pharmaceutical Co., Ltd. November 2019, non-related party in December 2019 Company where key manager holds office from January to Yongyi Furniture Co., Ltd. November 2019, non-related party in December 2019 Zhejiang Shenbo Medical Technology Co., Ltd. Substance over form Other description: N/A
5 Transactions with related parties
(1) Related party transactions including purchase and sale of goods and rendering and receiving of services
Purchase of goods/receiving of services Unit: Renminbi Yuan
Whether Approved Accrued during over Accrued during Related party Related party transactions transaction the period transaction the prior period limit limit Hangzhou Aidikang Medical Laboratories Examination delivery fee 37,985,168.84 29,291,600.17 Co., Ltd. and its subsidiaries Outsourced physical examination Shanghai Meizhao Zheyuan Clinic Co., Ltd. fee, consultation service fee 11,389,537.40 231,022.00 and equipment procurement Outsourced physical examination Shanghai Meikai Clinic Co., Ltd. 4,943,132.56 2,537,571.90 fee Consultation service and software Alibaba Group and its subsidiaries 4,713,297.72 service fees Wuhan Meici Oasis Technology Management Outsourced physical examination 3,954,222.44 1,560,426.06 Co., Ltd. fee Shenzhen Yierkang Health Management Co., Outsourced physical examination 2,957,384.60 4,735,174.11 Ltd. fee Guangzhou Meizhao Health Management Outsourced physical examination 2,724,028.00 23,874.00 Co., Ltd. fee Zhengzhou Meijian Health Management Co., Outsourced physical examination 2,604,886.65 6,982,303.15 Ltd. fee Guangzhou Meinian Onehealth Medical Outsourced physical examination 2,570,296.05 8,884,700.68 Technology Co., Ltd. fee Zhongguancun Meinian Health Industry Consultation service fee 2,500,000.01 750,000.00 Research Institute Procurement of medical Zhejiang Shenbo Medical Technology Co., consumables and procurement 2,407,000.00 Ltd. of equipment Examination delivery fee and Beijing Ciji Network Technology Co., Ltd. 1,819,991.98 11,138,520.88 business cooperation fee Outsourced physical examination Xiamen Ciming Health Management Co., Ltd. fee and examination delivery 1,797,897.17 3,402,090.74 fee Nanjing Meiyi Clinic Co., Ltd. Outsourced physical examination 1,720,587.95 4,871,433.62
135 fee Outsourced physical examination Nanjing Meikai Clinic Co., Ltd. 1,641,084.75 955,994.10 fee Outsourced physical examination Shenyang Oasis Hospital Co., Ltd. 1,327,435.86 fee Fuyang Meinian Onehealth Health Outsourced physical examination 1,189,785.28 2,445,466.92 Management Co., Ltd. fee Examination delivery fee, remote Yinchuan Dr. Elephant Internet Hospital Co., film reading service and 1,002,966.87 2,419,095.65 Ltd. procurement of medical consumables Hefei Ciming Oasis Health Management Co., Outsourced physical examination 824,158.85 Ltd. fee Zhengzhou Meizhao Health Medical Outsourced physical examination 812,560.00 404,244.00 Management Co., Ltd. fee Foshan Meinian Onehealth Checkup Outsourced physical examination 691,295.28 Management Co., Ltd. fee Jinan Meinian Onehealth Technology Co., Outsourced physical examination 577,531.50 2,224,279.34 Ltd. fee Beijing Wandong Medical Technology Co., Equipment maintenance and 548,666.63 26,232,433.30 Ltd. equipment procurement Linyi Meiming Health Checkup Management Outsourced physical examination 509,496.12 Co., Ltd. fee Esaote (Shenzhen) Medical Equipment Co., Outsourced physical examination 380,000.00 3,040,000.00 Ltd. fee Chongqing Meinian Meiyang Health Consultation service fee 332,597.00 Management Co., Ltd. Chengdu Jinniu Meinian Onehealth Outsourced physical examination 321,080.45 2,069,768.24 Management Consulting Co., Ltd. fee Taizhou Meizhao Health Checkup Centre Outsourced physical examination 312,046.45 238,741.79 (General Partnership) fee and consultation service fee Yinchuan Meinian Onehealth Hospital Co., Outsourced physical examination 285,549.83 Ltd. fee Kunming Meizhao Health Management Co., Outsourced physical examination 276,286.00 Ltd. fee Dongguan Humen Meinian Onehealth Clinic Outsourced physical examination 247,830.40 389,504.16 Co., Ltd. fee Jilin Changyi Meinian Onehealth Technology Outsourced physical examination 220,967.95 1,174,076.24 Management Co., Ltd. fee Shanghai Meixin Investment Management Interest expense 190,666.67 Co., Ltd. Guangzhou Huadu Meinian Onehealth Outsourced physical examination 184,344.46 39,229.00 Management Co., Ltd. fee Tianjin Heping Meinian Meijia Health Outsourced physical examination 180,260.00 Management Co., Ltd. fee Outsourced physical examination Zhuhai Meinian Onehealth Health fee and procurement of medical 151,344.91 555,231.33 Management Co., Ltd. consumables Yantai Meinian Onehealth Checkup Outsourced physical examination 148,583.21 427,171.17 Management Co., Ltd. fee Yantai Meinian Futian Health Checkup Outsourced physical examination 137,472.46 Management Co., Ltd. fee Guangzhou Zengcheng Meinian Health Outsourced physical examination 131,612.17 Management Co., Ltd. fee Wuhan Meizhao Health Management Co., Outsourced physical examination 112,594.50 125,911.50 Ltd. fee Maanshan Meinian Onehealth Consulting Outsourced physical examination 111,511.91 163,254.43 Co., Ltd. fee Xiamen Yincheng Meinian Health Outsourced physical examination 110,731.56 Management Co., Ltd. fee Guangzhou Meinian Onehealth Hospital Outsourced physical examination 98,103.98 47,166.55
136 Management Co., Ltd. fee Outsourced physical examination Tonglu Meinian Checkup Centre Co., Ltd. 96,769.00 fee Changchun Meijian Health Technology Co., Outsourced physical examination 93,888.50 231,109.50 Ltd. fee Qingdao Meinian Health Technology Health Outsourced physical examination 88,874.16 7,999,849.75 Management Co., Ltd. fee and consultation service fee Yixing Meinian Comprehensive Clinic Co., Outsourced physical examination 84,285.12 15,371.00 Ltd. fee Yangzhou Meishun Health Management Co., Outsourced physical examination 82,416.70 Ltd. fee Shenzhen Oasis Health Management Co., Outsourced physical examination 76,695.88 9,785,649.86 Ltd. fee Chengdu Wuhou Meinian Health Checkup Outsourced physical examination 75,471.53 79,712.98 Clinic Co., Ltd. fee Harbin Meiming Health Management Co., Outsourced physical examination 73,088.51 Ltd. fee Shenzhen Meiyang Health Management Co., Outsourced physical examination 72,403.22 829,402.95 Ltd. fee Mengcheng Meinian Onehealth Management Outsourced physical examination 69,238.66 145,994.41 Co., Ltd. fee and consultation service fee Outsourced physical examination Xi'an Meizhao Health Management Co., Ltd. 66,554.00 346,000.00 fee Leshan Ciming Health Checkup Service Co., Outsourced physical examination 58,237.83 34,236.00 Ltd. fee Weihai Meinian Onehealth Checkup Centre Outsourced physical examination 56,622.95 Co., Ltd. fee Outsourced physical examination Shaoxing Yuecheng Meinian Clinic Co., Ltd. 50,199.85 fee Dongguan Meinian Onehealth Health Outsourced physical examination 46,659.75 181,708.75 Management Co., Ltd. fee Fuzhou Ciming Oasis Health Checkup Centre Outsourced physical examination 44,011.00 Co., Ltd. fee Procurement of medical Shanghai Zunran Hospital Co., Ltd. 43,898.75 consumables Chongqing Meizhao Hospital Management Outsourced physical examination 42,513.00 38,700.00 Co., Ltd. fee Outsourced physical examination Dongguan Songshan Lake Meici Oasis Clinic fee and examination delivery 41,583.79 454,069.48 Co., Ltd. fee Chengdu Meinian Onehealth Yi Centre Outsourced physical examination 39,880.69 55,954.36 Checkup Clinic Co., Ltd. fee and consultation service fee Outsourced physical examination Wuxi Meizhao Clinic Co., Ltd. 38,659.91 fee Weihai Guoji Meinian Onehealth Checkup Outsourced physical examination 38,500.52 70,382.45 Centre Co., Ltd. fee Procurement of medical Chongqing Tianji Pharmaceutical Co., Ltd. 35,539.08 consumables Outsourced physical examination Yunnan Ciming Health Service Co., Ltd. 19,901.16 fee Chengdu Meizhao Health Management Co., Outsourced physical examination 18,528.40 2,063,041.25 Ltd. fee Outsourced physical examination Wuxi Ciming Oasis Clinic Co., Ltd. 18,404.00 13,054.85 fee Outsourced physical examination Huai'an Ciming Huakang Clinic Co., Ltd. 14,384.55 16,795.50 fee Putian Meinian Onehealth Management Co., Outsourced physical examination 13,482.30 Ltd. fee Shaoxing Meizhao Outpatient Medical Co., Outsourced physical examination 11,984.80 29,922.00 Ltd. fee
137 Wenshan Meinian Onehealth Checkup Outsourced physical examination 11,041.65 Centre Co., Ltd. fee Anshun Ciming Health Checkup Outsourced physical examination 200,203.84 Management Co., Ltd. fee Luoyang Meinian Onehealth Medical Outsourced physical examination 30,732.40 Technology Co., Ltd. fee Jinjiang Meinian Onehealth Management Outsourced physical examination 30,313.50 Co., Ltd. fee Shanghai Lubinghua Healthcare Technology Consultancy fee 30,000.00 Co., Ltd. Beijing Huamei Kangxun Information Meeting affair charge 49,800.00 Technology Co., Ltd. Enshi Meinian Onehealth Management Co., Outsourced physical examination 28,515.95 Ltd. fee Xianning Meinian Onehealth Checkup Outsourced physical examination 43,805.40 Management Co., Ltd. fee Shenzhen Meizhao Health Management Co., Outsourced physical examination 162,273.00 Ltd. fee Outsourced physical examination Shandong Wanshu Trading Co., Ltd. 1,729,600.00 fee Shanghai Meiwei Dental Care Management Outsourced physical examination 709,690.47 Group Co., Ltd. fee Total 98,669,715.68 142,766,174.68 Sale of goods/rendering of services Unit: Renminbi Yuan
Accrued during Accrued during Related party Related party transactions the period the prior period Alibaba Group and its subsidiaries Medical examination income and genetic testing income 8,941,380.66 Beijing Ciji Network Technology Co., Ltd. Medical examination income and TAP subsidy income 10,198,640.54 18,373,863.69 Shanghai Jianyi Investment Centre (Limited Investment consultant income and investment dividends 3,720,911.95 3,707,023.07 Partnership) Guangzhou Meinian Onehealth Medical Medical examination income, finance lease income, consulting 3,227,180.50 5,956,861.15 Technology Co., Ltd. service income and genetic testing income Nantong Meizhao Meinian Health Industry M&A Investment consultant income, investment dividends 1,719,285.77 3,685,498.69 Investment Fund (Limited Partnership) Shenzhen Yierkang Health Management Co., Medical examination income, consulting service income and 1,394,352.77 2,919,039.19 Ltd. genetic testing income Medical examination income, consulting service income, Wuhan Meici Oasis Technology Management professional technical service income and genetic testing 1,279,006.66 7,658,577.06 Co., Ltd. income Tianjin Heping Meinian Meijia Health Medical examination income, consulting service income and 1,053,565.30 144,427.92 Management Co., Ltd. genetic testing income Chengdu Jinniu Meinian Onehealth Management Medical examination income, consulting service income and 1,022,727.13 2,703,700.44 Consulting Co., Ltd. genetic testing income Medical examination income, professional technical service Chengdu Meizhao Health Management Co., Ltd. 966,681.23 4,910,831.10 income and genetic testing income Jiaxing Xinwen Yufu Equity Investment Investment consultant income 825,471.70 1,646,420.27 Partnership (Limited Partnership) Foshan Meinian Onehealth Checkup Medical examination income, consulting service income and 777,948.08 Management Co., Ltd. genetic testing income Medical examination income, consulting service income and Shenyang Oasis Hospital Co., Ltd. 757,472.67 1,249,074.94 genetic testing income Zhengzhou Meizhao Health Medical Medical examination income, professional technical service 673,286.12 243,057.55 Management Co., Ltd. income and genetic testing income Qingdao Meinian Health Technology Health Medical examination income, consulting service income and 638,356.06 1,281,271.21 Management Co., Ltd. genetic testing income Fuyang Meinian Onehealth Health Management Medical examination income, consulting service income and 635,949.55 412,564.20 Co., Ltd. genetic testing income Shenzhen Oasis Health Management Co., Ltd. Medical examination income, consulting service income and 578,286.11 4,179,064.44
138 genetic testing income Chongqing Meizhao Hospital Management Co., Medical examination income, professional technical service 567,718.47 624,764.17 Ltd. income and genetic testing income Meizhi Health Management (Beijing) Co., Ltd. Health consulting income 566,037.72 Consulting service income, interest income and genetic testing Zhengzhou Meijian Health Management Co., Ltd. 545,123.56 466,659.62 income Shenzhen Meizhao Health Management Co., Medical examination income and consulting service income 543,180.53 739,880.37 Ltd. Medical examination income and professional technical service Kunming Meizhao Health Management Co., Ltd. 536,429.94 529,117.45 income Dongguan Humen Meinian Onehealth Clinic Co., Medical examination income, consulting service income and 535,214.21 1,127,461.74 Ltd. genetic testing income Medical examination income, consulting service income, Chengdu Meinian Onehealth Yi Centre Checkup professional technical service income and genetic testing 535,177.64 1,734,736.96 Clinic Co., Ltd. income Wuxi Ciming Oasis Clinic Co., Ltd. Medical examination income and consulting service income 514,128.85 251,328.49 Yantai Meinian Onehealth Checkup Management Medical examination income, consulting service income and 487,869.81 1,539,728.68 Co., Ltd. genetic testing income Medical examination income, consulting service income, Shanghai Meizhao Zheyuan Clinic Co., Ltd. professional technical service income and genetic testing 480,673.61 192,991.40 income Medical examination income, professional technical service Xi'an Meizhao Health Management Co., Ltd. income, genetic testing income and consulting service 462,676.04 388,503.92 income Guangzhou Meizhao Health Management Co., Consulting service income 417,152.83 595,767.13 Ltd. Hefei Ciming Oasis Health Management Co., Medical examination income, genetic testing income and 403,988.80 Ltd. consulting service income Medical examination income, consulting service income, and Yinchuan Meinian Onehealth Hospital Co., Ltd. 400,321.53 genetic testing income Shandong Meiming Oasis Health Consulting Co., Physical examination income, consulting service income and 398,409.68 702,494.66 Ltd. interest income Medical examination income, consulting service income, Chongqing Meiyi Health Management Co., Ltd. 392,644.86 interest income and genetic testing income Medical examination income, consulting service income, and Putian Meinian Onehealth Management Co., Ltd. 382,952.23 718,574.83 genetic testing income Guangzhou Huadu Meinian Onehealth Medical examination income, consulting service income, and 355,205.71 759,834.82 Management Co., Ltd. genetic testing income Wenshan Meinian Onehealth Checkup Centre Medical examination income and consulting service income 353,396.69 577,698.44 Co., Ltd. Shenzhen Meiyang Health Management Co., Medical examination income, consulting service income, and 351,231.06 385,499.83 Ltd. genetic testing income Guangzhou Zengcheng Meinian Health Medical examination income, consulting service income, and 329,457.22 1,016,104.50 Management Co., Ltd. genetic testing income Baoshan Meinian Onehealth Checkup Centre Consulting service income and genetic testing income 319,762.13 511,154.72 Co., Ltd. Medical examination income, professional technical service Shaoxing Meizhao Outpatient Medical Co., Ltd. income, genetic testing income and consulting service 305,389.88 386,094.98 income Jilin Changyi Meinian Onehealth Technology Consulting service income and genetic testing income 297,698.85 542,155.28 Management Co., Ltd. Harbin Meiming Health Management Co., Ltd. Consulting service income and genetic testing income 297,169.27 Medical examination income, consulting service income, and Jinan Meinian Onehealth Technology Co., Ltd. 295,380.77 663,566.99 genetic testing income Jinjiang Meinian Onehealth Management Co., Medical examination income, genetic testing income and 292,619.04 432,471.29 Ltd. consulting service income Dalian Pulan Meinian Health Comprehensive Medical examination income, professional technical service 286,486.52 505,066.22 Clinic Co., Ltd. income and genetic testing income Chengdu Wuhou Meinian Health Checkup Clinic Medical examination income, consulting service income, and 285,254.89 1,305,296.30 Co., Ltd. genetic testing income
139 Hangzhou Aidikang Medical Laboratories Co., Medical examination income 248,100.00 Ltd. and its subsidiaries Changchun Meijian Health Technology Co., Ltd. Consulting service income and genetic testing income 243,467.24 382,210.79 Yunnan Ciming Health Service Co., Ltd. Medical examination income and consulting service income 240,408.78 1,097,546.18 Nan'an Meinian Onehealth Management Co., Medical examination income, professional technical service 237,035.64 342,421.39 Ltd. income and genetic testing income Medical examination income, consulting service income, Xiamen Ciming Health Management Co., Ltd. professional technical service income and genetic testing 231,116.34 908,040.88 income Guangdong Huanyue Healthcare Co., Ltd. Medical examination income and consulting service income 218,924.23 Nanjing Meiyi Clinic Co., Ltd. Consulting service income and genetic testing income 214,933.00 213,722.94 Medical examination income, consulting service income, and Shaoxing Yuecheng Meinian Clinic Co., Ltd. 210,590.45 303,112.33 genetic testing income Anshun Ciming Health Checkup Management Consulting service income and genetic testing income 201,425.47 227,221.15 Co., Ltd. Guangzhou Meinian Onehealth Hospital Physical examination income, consulting service income and 200,964.94 173,135.02 Management Co., Ltd. interest income Nanjing Meikai Clinic Co., Ltd. Consulting service income and genetic testing income 200,131.83 261,665.69 Medical examination income, professional technical service Wuhan Meizhao Health Management Co., Ltd. 198,021.54 613,263.82 income and genetic testing income Xiamen Yincheng Meinian Health Management Medical examination income, consulting service income, and 183,515.05 35,372.82 Co., Ltd. genetic testing income Weihai Guoji Meinian Onehealth Checkup Medical examination income, consulting service income, and 182,128.89 228,515.72 Centre Co., Ltd. genetic testing income Medical examination income, consulting service income, and Yixing Meinian Comprehensive Clinic Co., Ltd. 180,345.62 112,772.26 genetic testing income Fuzhou Ciming Oasis Health Checkup Centre Professional technical service income, genetic testing income 178,735.68 21,972.01 Co., Ltd. and consulting service income Zhuhai Meinian Onehealth Health Management Medical examination income, consulting service income, and 169,565.71 725,805.14 Co., Ltd. genetic testing income Dongguan Meinian Onehealth Health Medical examination income, consulting service income, and 155,533.81 208,443.49 Management Co., Ltd. genetic testing income Medical examination income, professional technical service Wuxi Meizhao Clinic Co., Ltd. 145,094.67 34,578.30 income and genetic testing income Tianjin Binhai New Area Ciai Clinic Co., Ltd. Consulting service income 136,828.30 190,381.02 Taizhou Meizhao Health Checkup Centre Medical examination income, consulting service income, and 135,314.38 889,691.70 (General Partnership) genetic testing income Tianjin Ciming Oasis Hospital Management Consulting service income 134,549.99 16,985.04 Consulting Co., Ltd. Medical examination income, consulting service income, and Qinzhou Meiling Health Checkup Co., Ltd. 114,542.67 genetic testing income Weihai Meinian Onehealth Checkup Centre Co., Medical examination income, consulting service income, and 113,381.19 637,001.17 Ltd. genetic testing income Huai'an Ciming Huakang Clinic Co., Ltd. Medical examination income and genetic testing income 108,387.91 190,970.57 Maanshan Meinian Onehealth Consulting Co., Medical examination income, consulting service income, and 99,053.28 135,585.09 Ltd. genetic testing income Foshan Wanda Meizhao Health Management Consulting service income 98,066.04 156,747.46 Co., Ltd. Yangzhou Meishun Health Management Co., Medical examination income, consulting service income, and 86,420.81 68,160.03 Ltd. genetic testing income Medical examination income, consulting service income, Mengcheng Meinian Onehealth Management professional technical service income and genetic testing 79,045.42 92,697.45 Co., Ltd. income Huangshan Meinian Onehealth Consulting Co., Consulting service income and genetic testing income 78,960.47 12,023.58 Ltd. Chengdu Aidi Ophthalmic Hospital Co., Ltd. Medical examination income 78,418.00 14,702.00 Medical examination income, consulting service income, Leshan Ciming Health Checkup Service Co., Ltd. professional technical service income and genetic testing 77,743.86 153,334.11 income
140 Dongguan Songshan Lake Meici Oasis Clinic Medical examination income and consulting service income 65,357.57 557,108.11 Co., Ltd. Yantai Meinian Futian Health Checkup Medical examination income, consulting service income, and 58,845.20 Management Co., Ltd. genetic testing income Houma Meinian Onehealth Management Co., Medical examination income, consulting service income, and 57,797.26 Ltd. genetic testing income Jinan Laiwu Meinian Onehealth Checkup Medical examination income, consulting service income, and 45,711.27 Management Co., Ltd. genetic testing income Wuhan Haozhuo Big Data Technology Co., Ltd. Medical examination income 40,377.00 Weifang Century Changhe Economic and Trade Medical examination income 35,445.00 Co., Ltd. Medical examination income, consulting service income, and Shanghai Meikai Clinic Co., Ltd. 28,242.36 645,287.81 genetic testing income Tonglu Meinian Checkup Centre Co., Ltd. Medical examination income and genetic testing income 27,498.09 Beijing Trust&Far Technology Co., Ltd. Medical examination income 24,513.50 61,090.70 Medical examination income, consulting service income, Anxi Meinian Onehealth Management Co., Ltd. professional technical service income and genetic testing 19,800.25 income Guizhou Jizhong Health Management Co., Ltd. Consulting service income and genetic testing income 5,099.47 29,520.00 Pizhou Ciming Health Checkup Clinic Co., Ltd. Genetic testing income 4,216.98 59,594.34 Panzhihua Ciming Health Checkup Hospital Co., Genetic testing income 3,323.49 44,009.42 Ltd. Harbin Oasis Health Management Co., Ltd. Consulting service income and genetic testing income 3,052.84 63,705.69 Cixin (Beijing) Medicare Investment Co., Ltd. Medical examination income 1,830.00 12,750.00 Shanghai Elephant Healthcare Technology Co., Medical examination income 1,216.00 15,973.00 Ltd. Xianning Meinian Onehealth Checkup Professional technical service income and consulting service 664,173.76 Management Co., Ltd. income Bijie Meinian Onehealth Management Co., Ltd. Genetic testing income 333,446.90 Professional technical service income and software service Guyuan Meinian Onehealth Hospital Co., Ltd. 121,362.83 income Bestore Co., Ltd. Medical examination income 91,786.50 Yinchuan Dr. Elephant Internet Hospital Co., Ltd. Medical examination income 77,586.80 Esaote (Shenzhen) Medical Equipment Co., Ltd. Medical examination income 50,623.71 Perfect (China) Co., Ltd. Medical examination income 30,794.40 Changsha Meizhao Medical Management Co., Consulting service income 24,547.13 Ltd. Shandong Wohua Pharmaceutical Co., Ltd. Medical examination income 22,531.00 Shanghai Guosheng Asset Management Co., Medical examination income 21,378.00 Ltd. Meiwei (Guangzhou) Dental Health Medical Medical examination income 16,486.00 Investment Co., Ltd. Medical examination income, consulting service income, and Shanghai Haozhuo Data Service Co., Ltd. 2,862,578.25 genetic testing income Total 55,952,332.63 90,022,641.21 Description of related party transactions including purchase and sale of goods and rendering and receiving of services: Not applicable
(2) Related party trusteeship/contracting arrangement and entrusted management/outsourcing
(3) Information on leases
As a lessor: Unit: Renminbi Yuan
141 Lease income Lease income Name of lessee Type of assets leased recognised during the recognised during period the prior period Shenzhen Oasis Health Management Co., Ltd. Equipment 143,460.80 Shenzhen Meiyang Health Management Co., Buildings and equipment 76,073.00 906,705.84 Ltd. Shenzhen Yierkang Health Management Co., Buildings and equipment 318,065.55 Ltd. Shenyang Oasis Hospital Co., Ltd. Buildings and equipment 72,815.55 Jinjian Technology Service (Beijing) Co., Ltd. Buildings and equipment 4,055,792.85 Meizhi Health Management (Beijing) Co., Ltd. Buildings and equipment 989,120.70 Total 5,655,328.45 906,705.84 As a lessee: Unit: Renminbi Yuan Lease expense Lease expense Name of lessor Type of assets leased recognised during recognised during the period the prior period Chongqing Meizhao Hospital Management Buildings 18,000.00 Co., Ltd. Xiamen Ciming Health Management Co., Ltd. Buildings 150,000.00 Shanghai Tianyi Hongfang Corporate Buildings 7,644,731.19 3,982,110.35 Management Co., Ltd. Beijing Tianyi Hongfang Investment Buildings 4,686,885.73 4,944,018.38 Management Co., Ltd. Shanghai Tianyi Hongfang Property Buildings 2,684,052.70 3,753,264.76 Management Co., Ltd. Shanghai Yushen Enterprise Management Co., Buildings 1,906,294.91 Ltd. Shanghai Bairuisi Corporate Management Co., Buildings 2,551,266.00 Ltd. Total 17,089,964.53 15,230,659.49
142 Information on leases As a lessor of finance leases: Finance lease income Finance lease income recognised Name of lessee recognised during the prior during the period period Hefei Ciming Oasis Health Management Co., Ltd. 678,397.34 - Tianjin Ciming Oasis Hospital Management 527,208.85 10,726.55 Consulting Co., Ltd. Foshan Wanda Meizhao Health Management Co., 426,092.22 53,294.63 Ltd. Xi'an Meizhao Health Management Co., Ltd. 396,403.54 143,964.29 Wuhan Meici Oasis Technology Management Co., 381,166.35 279,433.80 Ltd. Chongqing Meiyi Health Management Co., Ltd. 359,310.62 - Harbin Meiming Health Management Co., Ltd. 341,162.83 - Shanghai Meizhao Zheyuan Clinic Co., Ltd. 314,539.04 69,291.25 Yangzhou Meishun Health Management Co., Ltd. 312,123.88 50,219.47 Shenzhen Oasis Health Management Co., Ltd. 234,328.28 83,152.74 Kunming Meizhao Health Management Co., Ltd. 232,710.62 173,690.09 Huangshan Meinian Onehealth Consulting Co., 216,369.03 - Ltd. Shandong Meiming Oasis Health Consulting Co., 212,194.69 264,047.48 Ltd. Weihai Meinian Onehealth Checkup Centre Co., 205,778.75 - Ltd. Chongqing Meizhao Hospital Management Co., 203,923.01 175,089.58 Ltd. Shenyang Oasis Hospital Co., Ltd. 185,198.23 241,284.24 Chengdu Meizhao Health Management Co., Ltd. 146,797.33 203,742.55 Dongguan Humen Meinian Onehealth Clinic Co., 143,935.39 202,288.11 Ltd. Guangzhou Meizhao Health Management Co., Ltd. 139,427.99 178,218.08 Shanghai Meikai Clinic Co., Ltd. 130,400.00 184,578.18 Shenzhen Meizhao Health Management Co., Ltd. 127,398.22 208,604.16 Nanjing Meiyi Clinic Co., Ltd. 125,228.32 44,279.54 Guizhou Jizhong Health Management Co., Ltd. 119,474.33 - Jinjiang Meinian Onehealth Management Co., Ltd. 114,634.53 101,625.69 Nan'an Meinian Onehealth Management Co., Ltd. 114,438.06 99,812.81 Putian Meinian Onehealth Management Co., Ltd. 113,533.63 164,949.97 Jinan Meinian Onehealth Technology Co., Ltd. 112,212.40 149,106.04 Dalian Pulan Meinian Health Comprehensive Clinic 106,577.88 159,899.43 Co., Ltd. Yunnan Ciming Health Service Co., Ltd. 103,116.82 154,521.66 Wenshan Meinian Onehealth Checkup Centre Co., 101,753.98 147,147.56 Ltd. Baoshan Meinian Onehealth Checkup Centre Co., 99,390.27 146,140.55 Ltd. Fuzhou Ciming Oasis Health Checkup Centre Co., 98,430.97 5,038.05 Ltd. Zhengzhou Meijian Health Management Co., Ltd. 93,745.14 128,315.29 Qingdao Meinian Health Technology Health 82,297.37 141,698.89 Management Co., Ltd. Nanjing Meikai Clinic Co., Ltd. 74,835.39 92,755.32 Tianjin Heping Meinian Meijia Health Management 74,684.95 50,392.08 Co., Ltd. Shaoxing Yuecheng Meinian Clinic Co., Ltd. 73,985.83 90,412.32 Shenzhen Yierkang Health Management Co., Ltd. 73,590.25 152,146.39 Guangdong Huanyue Healthcare Co., Ltd. 73,332.75 - Zhengzhou Meizhao Health Medical Management 73,310.38 64,839.62
143 Co., Ltd. Chengdu Meinian Onehealth Yi Centre Checkup 72,307.97 95,890.88 Clinic Co., Ltd. Guangzhou Meinian Onehealth Medical 69,993.95 141,373.54 Technology Co., Ltd. Guangzhou Zengcheng Meinian Health 69,959.29 96,922.44 Management Co., Ltd. Fuyang Meinian Onehealth Health Management 69,533.61 101,894.05 Co., Ltd. Shaoxing Meizhao Outpatient Medical Co., Ltd. 69,127.44 108,519.51 Mengcheng Meinian Onehealth Management Co., 65,030.97 12,777.88 Ltd. Chengdu Jinniu Meinian Onehealth Management 61,380.53 92,171.72 Consulting Co., Ltd. Shenzhen Meiyang Health Management Co., Ltd. 58,007.08 81,162.86 Guangzhou Huadu Meinian Onehealth 57,694.69 81,626.55 Management Co., Ltd. Jilin Changyi Meinian Onehealth Technology 52,836.29 78,837.68 Management Co., Ltd. Xiamen Yincheng Meinian Health Management 50,015.93 22,297.35 Co., Ltd. Anshun Ciming Health Checkup Management Co., 47,682.30 72,998.41 Ltd. Qinzhou Meiling Health Checkup Co., Ltd. 46,692.92 - Changchun Meijian Health Technology Co., Ltd. 46,123.01 67,928.31 Chengdu Wuhou Meinian Health Checkup Clinic 46,031.86 62,962.41 Co., Ltd. Foshan Meinian Onehealth Checkup Management 45,927.06 - Co., Ltd. Wuxi Ciming Oasis Clinic Co., Ltd. 38,893.81 60,641.71 Tianjin Binhai New Area Ciai Clinic Co., Ltd. 37,460.18 53,552.72 Taizhou Meizhao Health Checkup Centre (General 37,310.61 49,343.72 Partnership) Leshan Ciming Health Checkup Service Co., Ltd. 21,888.50 34,899.90 Dongguan Songshan Lake Meici Oasis Clinic Co., 17,274.34 26,988.67 Ltd. Zhuhai Meinian Onehealth Health Management 17,000.00 80,557.47 Co., Ltd. Guangzhou Meinian Onehealth Hospital 14,817.70 23,656.72 Management Co., Ltd. Yinchuan Meinian Onehealth Hospital Co., Ltd. 13,924.79 - Yantai Meinian Futian Health Checkup 12,726.54 - Management Co., Ltd. Dongguan Meinian Onehealth Health Management 12,237.17 51,938.50 Co., Ltd. Weihai Guoji Meinian Onehealth Checkup Centre 3,282.30 14,111.47 Co., Ltd. Huai'an Ciming Huakang Clinic Co., Ltd. 1,460.18 4,042.78 Xianning Meinian Onehealth Checkup - 159,073.39 Management Co., Ltd. Harbin Oasis Health Management Co., Ltd. - 63,150.00 Guyuan Meinian Onehealth Hospital Co., Ltd. - 36,030.98 Wuxi Meizhao Clinic Co., Ltd. - 31,630.19 Wuhan Meizhao Health Management Co., Ltd. - 26,859.43 Changsha Meizhao Medical Management Co., Ltd. - 11,529.20 Maanshan Meinian Onehealth Consulting Co., Ltd. - 5,412.83 Total 8,900,060.48 6,265,489.68
144 (4) Guarantee
The Company as the guarantor Unit: Renminbi Yuan
Amount of Inception date of Maturity date of Guarantee Guarantee holder guarantee guarantee guarantee expired (Y/N) Shanghai Meixin Financial Leasing Co., Ltd. 294,000,000.00 31 August 2016 15 October 2026 N Shanghai Meixin Financial Leasing Co., Ltd. 495,000,000.00 11 November 2016 24 February 2025 N Shanghai Meixin Financial Leasing Co., Ltd. 160,000,000.00 11 May 2017 24 April 2020 Y Shanghai Meixin Financial Leasing Co., Ltd. 150,000,000.00 7 September 2017 25 February 2025 N Shanghai Meixin Financial Leasing Co., Ltd. 200,000,000.00 5 March 2018 17 May 2025 N Shanghai Meixin Financial Leasing Co., Ltd. 200,000,000.00 25 July 2018 29 April 2024 N Shanghai Meixin Financial Leasing Co., Ltd. 100,000,000.00 7 June 2018 25 December 2022 N Shanghai Meixin Financial Leasing Co., Ltd. 30,000,000.00 22 April 2019 22 July 2022 N Meinian Onehealth 470,000,000.00 26 May 2017 6 August 2024 N Meinian Onehealth 47,500,000.00 22 June 2017 23 June 2022 N Meinian Onehealth 1,200,000,000.00 22 September 2017 5 March 2025 N Meinian Onehealth 188,000,000.00 30 October 2017 30 October 2022 N Meinian Onehealth 100,000,000.00 9 January 2018 22 December 2022 N Meinian Onehealth 300,000,000.00 9 January 2018 22 December 2022 N Meinian Onehealth 390,000,000.00 8 May 2018 25 May 2023 N Meinian Onehealth 80,000,000.00 17 October 2018 16 October 2023 N Meinian Onehealth 200,000,000.00 18 March 2019 17 March 2020 Y Meinian Onehealth 10,000,000.00 19 April 2019 18 April 2020 Y Meinian Onehealth 100,000,000.00 30 April 2019 29 April 2020 Y Meinian Onehealth 500,000,000.00 6 March 2020 12 March 2023 N Meinian Onehealth 450,000,000.00 13 September 2020 12 September 2022 N Meinian Onehealth 150,000,000.00 20 January 2021 19 January 2023 N Meinian Onehealth 88,000,000.00 10 April 2021 9 April 2023 N Meinian Onehealth 30,000,000.00 7 May 2021 6 May 2023 N Meinian Onehealth 210,000,000.00 26 May 2021 25 November 2021 N Meinian Onehealth 260,000,000.00 15 January 2022 14 January 2024 N Meinian Onehealth 150,000,000.00 26 January 2022 25 January 2024 N Meinian Onehealth 7,000,000.00 7 March 2024 6 March 2026 N Meinian Onehealth 15,000,000.00 16 January 2025 15 January 2027 N Meinian Onehealth 14,000,000.00 19 January 2025 18 January 2027 N Meinian Onehealth 14,000,000.00 19 February 2025 18 February 2027 N MeiNianInvestmentLimited 1,415,900,000.00 3 April 2019 2 April 2021 N
145 The Company as the guarantee holder Unit: Renminbi Yuan Amount of Inception date of Maturity date of Guarantee expired Name of guarantor guarantee guarantee guarantee (Y/N) Meinian Onehealth 80,000,000.00 17 October 2018 16 October 2023 N Xu Yongjun 2,140,000.00 8 March 2017 7 March 2020 Y Xu Yongjun 5,000,000.00 26 September 2020 25 September 2022 N Wu Minhua 5,000,000.00 26 September 2020 25 September 2022 N Hainan Meinian Onehealth Hospital 1,500,000.00 27 September 2017 22 April 2020 Y Co., Ltd. Sha Qibin 1,500,000.00 27 September 2017 22 April 2020 Y Liu Xiaofeng 1,500,000.00 27 September 2017 22 April 2020 Y Hainan Meinian Onehealth Hospital 1,200,000.00 27 September 2017 22 April 2020 Y Co., Ltd. Sha Qibin 1,200,000.00 27 September 2017 22 April 2020 Y Liu Xiaofeng 1,200,000.00 27 September 2017 22 April 2020 Y Sha Qibin 19,000,000.00 12 April 2018 16 August 2023 N Liu Xiaofeng 19,000,000.00 12 April 2018 16 August 2023 N Haikou Ciming Health Checkup 19,000,000.00 12 April 2018 16 August 2023 N Clinic (General Partnership) Sha Qibin 4,200,000.00 27 April 2023 26 April 2025 N Liu Xiaofeng 4,200,000.00 27 April 2023 26 April 2025 N Wang Chaoting 1,500,000.00 20 December 2019 19 December 2023 N Xiao Yu 1,500,000.00 20 December 2019 19 December 2023 N Xu Zhaorong 5,500,000.00 30 October 2020 29 October 2022 N Ren Liping 5,500,000.00 30 October 2020 29 October 2022 N Li Lin 6,000,000.00 9 January 2021 8 January 2023 N Li Ruihong 6,000,000.00 9 January 2021 8 January 2023 N Li Lin 30,000,000.00 24 March 2021 23 March 2023 N Li Ruihong 30,000,000.00 24 March 2021 23 March 2023 N Bai Huifang 1,800,000.00 21 April 2021 20 April 2023 N Wu Xueying 1,800,000.00 21 April 2021 20 April 2023 N Cao Kejian 2,800,000.00 4 June 2021 3 June 2023 N
146 (5) Funding from related party
Unit: Renminbi Yuan Related party Amount of funding Inception date Maturity date Note Funds from Yunnan Ciming Health Service Co., Ltd. 6,030,000.00 Chongqing Meiyi Health Management Co., Ltd. 1,969,365.26 Funds to Yunnan Ciming Health Service Co., Ltd. 6,030,000.00 Chongqing Meiyi Health Management Co., Ltd. 1,969,365.26
(6) Transfer of assets and debt restructuring
(7) Remuneration of key management personnel
Unit: Renminbi Yuan Item Accrued during the period Accrued during the prior period Remuneration of key management 3,825,000.00 7,340,000.00 personnel
(8) Other related party transactions
6 Receivables from and payables to related parties
(1) Receivables
Unit: Renminbi Yuan
Balance at the beginning of the Balance at the end of the period period Item Related party Provision for bad Provision for Book value and doubtful Book value bad and debts doubtful debts Accounts
receivable Beijing Ciji Network Technology Co., Ltd. 120,926,019.87 10,479,269.06 110,766,311.08 8,610,521.02 Shanghai Haozhuo Data Service Co., Ltd. 8,521,322.98 53,730.55 Alibaba Group and its subsidiaries 2,955,184.88 8,065.03 20,394,912.89 83,150.08 Chengdu Meizhao Health Management Co., Ltd. 4,237,107.58 6,942.72 3,743,831.21 6,009.70 Shanghai Jianyi Investment Centre (Limited Partnership) 3,750,000.00 377,500.00 2,500,000.00 Jiaxing Xinwen Yufu Equity Investment Partnership 1,754,794.52 (Limited Partnership) Jinjian Technology Service (Beijing) Co., Ltd. 4,568,000.00 4,568.00 7,512,000.00 7,512.00 Meizhi Health Management (Beijing) Co., Ltd. 1,710,000.00 1,710.00 285,000.00 285.00 Yantai Meinian Onehealth Checkup Management Co., 1,859,338.49 60,697.65 2,364,684.30 264,658.13 Ltd. Foshan Meinian Onehealth Checkup Management Co., 1,054,270.74 22,153.77 1,116,861.45 132,417.25 Ltd. Fuyang Meinian Onehealth Health Management Co., 430,835.48 12.67 Ltd. Zhengzhou Meizhao Health Medical Management Co., 166,319.12 1,033.87
147 Ltd. Yixing Meinian Comprehensive Clinic Co., Ltd. 865,528.94 6.51 1,224,336.94 299,550.36 Leshan Ciming Health Checkup Service Co., Ltd. 186,235.37 3,267.89 113,726.55 392.62 Hangzhou Aidikang Medical Laboratories Co., Ltd. and 336,690.00 306.40 194,439.00 204.53 its subsidiaries Luoyang Meinian Onehealth Medical Technology Co., 296,439.65 88,931.90 300,000.00 90,000.00 Ltd. Wuhan Meizhao Health Management Co., Ltd. 45,309.98 11,750.84 Beijing Trust&Far Technology Co., Ltd. 188,607.40 664.82 175,646.50 561.38 Yinchuan Dr. Elephant Internet Hospital Co., Ltd. 146,875.80 2,180.86 147,100.80 5,837.12 China Europe International Business School Education 82,353.00 23,509.90 101,983.00 868.25 Foundation Imeik Technology Development Co., Ltd. 58,760.00 447.00 45,788.00 386.96 Shanghai Elephant Healthcare Technology Co., Ltd. 67,716.50 67.72 57,795.20 22.70 Shanghai Zhongwei Anjian Venture Capital Management 30,588.00 7,674.03 30,588.00 420.68 Co., Ltd. Shanghai Jiuyi Information Technology Co., Ltd. 23,107.00 9,660.21 21,207.00 5,800.21 Shanghai EGO New Retail network technology Co., Ltd. 22,710.00 22.71 63,430.00 63.43 Lianhua Supermarket Holdings Co., Ltd. 12,683.00 3,683.81 Huai'an Ciming Huakang Clinic Co., Ltd. 252,498.87 46.45 263,126.74 52.54 Wuxi Meizhao Clinic Co., Ltd. 215,313.91 207.38 106,019.00 106.02 Lead Technology Co., Ltd. 4,295.00 4.48 4,295.00 4.48 Panzhihua Ciming Health Checkup Hospital Co., Ltd. 9,304.40 9.30 18,241.50 18.24 Wuhan Meici Oasis Technology Management Co., Ltd. 15,009,163.65 252,765.32 Harbin Meiming Health Management Co., Ltd. 4,240,369.96 2,161.91 Xiamen Ciming Health Management Co., Ltd. 4,206,775.77 553,993.76 Jilin Changyi Meinian Onehealth Technology 3,536,245.66 4,845.63 Management Co., Ltd. Shanghai Meizhao Zheyuan Clinic Co., Ltd. 1,712,302.92 1,888.92 Chengdu Jinniu Meinian Onehealth Management 1,276,445.82 86,756.85 Consulting Co., Ltd. Chengdu Meinian Onehealth Yi Centre Checkup Clinic 1,245,804.06 2,291.95 Co., Ltd. Guigang Meiyuankang Health Checkup Co., Ltd. 1,030,000.00 309,000.00 Wuhan Meici Oasis Health Management Co., Ltd. 1,000,000.00 1,000.00 Guangzhou Huadu Meinian Onehealth Management Co., 965,630.09 14,190.12 Ltd. Chongqing Meinian Meiyang Health Management Co., 801,293.16 206,473.57 Ltd. Xiamen Yincheng Meinian Health Management Co., Ltd. 776,010.77 219,157.26 Jinan Laiwu Meinian Onehealth Checkup Management 755,857.00 210,055.86 Co., Ltd. Tonglu Meinian Checkup Centre Co., Ltd. 741,546.25 210,092.67 Jinan Meinian Onehealth Technology Co., Ltd. 733,931.27 1,293.95 Anxi Meinian Onehealth Management Co., Ltd. 706,851.71 210,032.39 Guangzhou Zengcheng Meinian Health Management 701,490.08 18,810.00 Co., Ltd. Dongguan Chang’an Meinian Health Management Co., 700,000.00 210,000.00 Ltd. Nanping Meinian Onehealth Management Co., Ltd. 700,000.00 700.00 Zhuhai Meinian Onehealth Health Management Co., Ltd. 652,437.39 211,354.45 Yongjia Youhao Polyclinic Co., Ltd. 576,497.50 576.50 Fuzhou Ciming Oasis Health Checkup Centre Co., Ltd. 535,398.45 149,620.33 Taizhou Meizhao Health Checkup Centre (General 482,626.10 183,256.05 Partnership)
148 Harbin Oasis Health Management Co., Ltd. 377,910.00 99,047.91 Tianjin Meize Clinic Co., Ltd. 271,500.96 120,000.00 Yinchuan Meinian Onehealth Hospital Co., Ltd. 202,822.43 704.60 Qinzhou Meiling Health Checkup Co., Ltd. 187,547.17 56,276.35 Shenzhen Yierkang Health Management Co., Ltd. 162,829.12 197,722.02 Dongguan Songshan Lake Meici Oasis Clinic Co., Ltd. 128,506.48 8.80 CIFI Group 123,378.00 126.88 Perfect (China) Co., Ltd. 118,945.90 80,373.76 Shaoxing Yuecheng Meinian Clinic Co., Ltd. 95,783.44 28,821.38 Maanshan Meinian Onehealth Consulting Co., Ltd. 84,826.75 1,655.91 Tianjin Heping Meinian Meijia Health Management Co., 78,441.28 7.94 Ltd. Yantai Meinian Futian Health Checkup Management Co., 76,084.30 1,178.43 Ltd. Guangzhou Meinian Onehealth Medical Technology Co., 74,192.00 44,328.23 Ltd. Shanghai Jiao Tong University Shanghai Advanced 51,000.00 25,140.00 Institute of Finance Guyuan Meinian Onehealth Hospital Co., Ltd. 44,249.24 13,274.77 Yongyi Furniture Co., Ltd. 34,260.00 34.26 Beijing Century Changhe Technology Group Co., Ltd. 17,200.00 8,417.90 Total 153,023,415.96 11,168,125.53 198,522,273.36 13,246,279.33 Prepayments Beijing Wandong Medical Technology Co., Ltd. 77,113.05 Alibaba Group and its subsidiaries 31,742.01 Alipay (China) Network Technology Co., Ltd. 331,626.63 Shanghai Elephant Healthcare Technology Co., Ltd. 2,877,575.20 2,749,284.20 Qingdao Meinian Health Technology Health Management 1,015,880.22 Co., Ltd. Shenzhen Meiyang Health Management Co., Ltd. 853,866.00 Dongguan Humen Meinian Onehealth Clinic Co., Ltd. 824,638.72 Zhongguancun Meinian Health Industry Research 500,000.01 Institute Shenzhen Yierkang Health Management Co., Ltd. 482,779.15 Nanjing Meiyi Clinic Co., Ltd. 358,554.00 Shaoxing Yuecheng Meinian Clinic Co., Ltd. 232,065.55 Total 2,986,430.26 7,348,694.48 Other
receivables Wuxi Ciming Oasis Clinic Co., Ltd. 8,592,296.00 8,593.50 1,264,365.00 1,265.00 Yantai Meinian Onehealth Checkup Management Co., 4,841,154.12 484.10 5,115,031.02 5,240.41 Ltd. Alibaba Group and its subsidiaries 3,771,920.29 377.20 Jiangsu Huakang Occupational Health Consulting Co., 3,000,000.00 3,000,000.00 Ltd. Zhengzhou Meizhao Health Medical Management Co., 2,028,542.58 2,028.54 Ltd. Chongqing Meizhao Hospital Management Co., Ltd. 2,004,062.85 23.89 1,989,175.00 Shanghai Tianyi Hongfang Property Management Co., 1,589,769.28 1,774,795.90 Ltd. Shanghai Tianyi Hongfang Corporate Management Co., 996,444.37 817,923.37 Ltd. Guangzhou Meizhao Health Management Co., Ltd. 560,000.00 560.00 Yantai Meinian Futian Health Checkup Management Co., 544,646.72 674.36 871,055.08 954.94 Ltd.
149 Shanghai Yushen Enterprise Management Co., Ltd. 414,250.00 Alipay (China) Network Technology Co., Ltd. 305,237.81 Beijing Tianyi Hongfang Investment Management Co., 356,155.00 1,530,671.00 Ltd. Shanghai Bairuisi Corporate Management Co., Ltd. 775,492.78 232,940.00 Dalian Pulan Meinian Health Comprehensive Clinic Co., 223,207.03 226.00 200,000.00 200.00 Ltd. Shaoxing Meizhao Outpatient Medical Co., Ltd. 209,603.61 209.60 160,143.87 160.14 Hefei Ciming Oasis Health Management Co., Ltd. 149,789.08 149.79 Shanghai Meizhao Zheyuan Clinic Co., Ltd. 143,442.03 109,165.77 Xi'an Meizhao Health Management Co., Ltd. 49,986.91 49.99 Wuxi Meizhao Clinic Co., Ltd. 33,669.52 33.67 Wuhan Meizhao Health Management Co., Ltd. 31,712.77 31.71 Shanghai Zunran Hospital Co., Ltd. 10,000.00 10,000.00 Chengdu Meizhao Health Management Co., Ltd. 5,737.20 53.07 2,216,915.23 560,481.77 Wang Shifang 1,188,070.00 1,188,070.00 Shanghai Meikai Clinic Co., Ltd. 10,000,000.00 Yunnan Ciming Health Service Co., Ltd. 6,279,220.00 6,280.00 Harbin Meiming Health Management Co., Ltd. 4,829,278.98 4,829.28 Wuhan Meici Oasis Technology Management Co., Ltd. 4,582,058.69 4,611.89 Leshan Ciming Health Checkup Service Co., Ltd. 2,647,270.96 2,648.01 Chongqing Meiyi Health Management Co., Ltd. 2,208,991.51 156,781.56 Wuhan Meici Oasis Health Management Co., Ltd. 1,516,231.75 1,516.23 Dongguan Songshan Lake Meici Oasis Clinic Co., Ltd. 1,000,000.00 Fuzhou Ciming Oasis Health Checkup Centre Co., Ltd. 698,650.00 700.00 Yongjia Youhao Polyclinic Co., Ltd. 600,000.00 600.00 Chenzhou Meinian Onehealth Management Co., Ltd. 454,694.39 454.69 Ningbo Yinzhou Meizhao Comprehensive Clinic Co., Ltd. 434,982.04 434.98 Xiamen Ciming Health Management Co., Ltd. 39,784.00 11,935.20 Shenzhen Oasis Health Management Co., Ltd. 16,435.00 30.00 Total 31,519,952.14 1,201,565.42 54,905,016.37 759,124.10 Long-term
receivables Hefei Ciming Oasis Health Management Co., Ltd. 13,315,537.00 11,376.04 16,964,427.00 34,236.21 Shanghai Meizhao Zheyuan Clinic Co., Ltd. 13,217,298.00 11,997.77 5,666,175.00 11,476.11 Chongqing Meizhao Hospital Management Co., Ltd. 13,099,354.00 11,295.80 15,657,281.00 29,480.95 Shenzhen Meizhao Health Management Co., Ltd. 13,018,448.00 978,375.46 12,874,488.00 1,555,112.32 Guangzhou Meizhao Health Management Co., Ltd. 12,009,265.00 329,194.99 11,852,728.00 509,084.95 Xi'an Meizhao Health Management Co., Ltd. 10,922,845.00 9,620.07 14,974,123.00 28,974.57 Chengdu Meizhao Health Management Co., Ltd. 10,155,204.00 8,738.29 12,434,527.00 23,367.38 Foshan Wanda Meizhao Health Management Co., Ltd. 10,053,492.09 942,073.14 9,613,139.00 1,302,159.97 Shaoxing Meizhao Outpatient Medical Co., Ltd. 6,657,182.00 572,977.07 6,849,027.00 829,108.30 Dalian Pulan Meinian Health Comprehensive Clinic Co., 5,487,173.00 4,753.23 6,828,430.00 12,947.42 Ltd. Wenshan Meinian Onehealth Checkup Centre Co., Ltd. 5,206,105.00 4,502.73 6,569,067.00 12,432.78 Baoshan Meinian Onehealth Checkup Centre Co., Ltd. 5,033,524.00 4,336.32 6,458,443.00 12,178.09 Weihai Meinian Onehealth Checkup Centre Co., Ltd. 4,326,319.00 4,322.20 4,829,737.00 10,706.85 Guangdong Huanyue Healthcare Co., Ltd. 4,002,361.00 3,508.45 Fuyang Meinian Onehealth Health Management Co., 3,370,651.00 2,868.60 4,533,358.00 8,459.51 Ltd. Foshan Meinian Onehealth Checkup Management Co., 3,287,766.00 2,365.10 4,342,405.00 8,003.47 Ltd.
150 Zhengzhou Meizhao Health Medical Management Co., 3,032,987.00 408,421.01 4,702,160.00 729,323.24 Ltd. Wuxi Ciming Oasis Clinic Co., Ltd. 2,587,115.00 2,203.36 3,449,963.00 6,413.90 Anshun Ciming Health Checkup Management Co., Ltd. 2,260,860.00 1,926.68 3,036,977.00 5,675.14 Leshan Ciming Health Checkup Service Co., Ltd. 1,339,127.00 905.11 1,451,017.00 2,701.92 Mengcheng Meinian Onehealth Management Co., Ltd. 1,269,458.00 1,162.53 1,561,013.00 3,180.19 Yinchuan Meinian Onehealth Hospital Co., Ltd. 816,000.00 687.15 1,224,000.00 2,254.66 Yantai Meinian Onehealth Checkup Management Co., 311,647.00 258.07 Ltd. Dongguan Meinian Onehealth Health Management Co., 133,071.00 110.20 917,669.00 1,674.69 Ltd. Weihai Guoji Meinian Onehealth Checkup Centre Co., 69,958.00 57.93 485,997.00 880.42 Ltd. Huai'an Ciming Huakang Clinic Co., Ltd. 67,089.00 55.77 166,461.00 302.70 Wuhan Meici Oasis Technology Management Co., Ltd. 25,624,829.00 49,033.24 Shenzhen Oasis Health Management Co., Ltd. 15,703,505.00 842,255.86 Shenyang Oasis Hospital Co., Ltd. 14,996,470.00 28,294.70 Kunming Meizhao Health Management Co., Ltd. 14,921,079.00 28,009.89 Shandong Meiming Oasis Health Consulting Co., Ltd. 13,124,363.00 25,363.18 Tianjin Ciming Oasis Hospital Management Consulting 12,797,339.00 27,822.93 Co., Ltd. Harbin Meiming Health Management Co., Ltd. 10,358,229.00 21,965.15 Shanghai Meikai Clinic Co., Ltd. 10,152,927.00 18,915.58 Putian Meinian Onehealth Management Co., Ltd. 9,296,284.00 17,410.44 Dongguan Humen Meinian Onehealth Clinic Co., Ltd. 9,224,267.00 17,461.52 Chongqing Meiyi Health Management Co., Ltd. 8,481,360.00 17,977.90 Guangzhou Meinian Onehealth Medical Technology Co., 8,400,063.00 1,293,860.56 Ltd. Qingdao Meinian Health Technology Health Management 7,867,707.79 14,636.55 Co., Ltd. Yangzhou Meishun Health Management Co., Ltd. 7,779,352.00 16,508.27 Jinjiang Meinian Onehealth Management Co., Ltd. 7,269,169.00 13,935.14 Nan'an Meinian Onehealth Management Co., Ltd. 7,268,090.00 13,931.17 Xianning Meinian Onehealth Checkup Management Co., 7,031,370.00 13,392.41 Ltd. Shenzhen Yierkang Health Management Co., Ltd. 6,910,431.00 12,780.50 Yunnan Ciming Health Service Co., Ltd. 6,731,173.00 12,669.07 Zhengzhou Meijian Health Management Co., Ltd. 6,674,815.00 12,417.38 Chengdu Meinian Onehealth Yi Centre Checkup Clinic 6,158,260.00 11,543.25 Co., Ltd. Fuzhou Ciming Oasis Health Checkup Centre Co., Ltd. 6,065,530.00 10,919.00 Chenzhou Meinian Onehealth Management Co., Ltd. 6,031,641.00 13,137.80 Guangzhou Zengcheng Meinian Health Management 5,962,768.00 11,155.13 Co., Ltd. Shaoxing Yuecheng Meinian Clinic Co., Ltd. 5,880,085.00 11,044.85 Chengdu Jinniu Meinian Onehealth Management 5,347,820.00 9,972.85 Consulting Co., Ltd. Huangshan Meinian Onehealth Consulting Co., Ltd. 5,100,622.00 11,149.37 Jinan Meinian Onehealth Technology Co., Ltd. 5,039,649.00 9,887.40 Shenzhen Meiyang Health Management Co., Ltd. 4,926,593.00 9,237.02 Guangzhou Huadu Meinian Onehealth Management Co., 4,906,664.00 9,198.08 Ltd. Enshi Meinian Onehealth Management Co., Ltd. 4,868,602.00 9,255.35 Guyuan Meinian Onehealth Hospital Co., Ltd. 4,736,809.00 8,907.16
151 Nanjing Meikai Clinic Co., Ltd. 4,736,735.00 9,047.52 Nanjing Meiyi Clinic Co., Ltd. 4,726,183.00 9,217.16 Jilin Changyi Meinian Onehealth Technology 4,583,204.00 8,569.47 Management Co., Ltd. Changchun Meijian Health Technology Co., Ltd. 3,986,494.00 7,453.61 Chengdu Wuhou Meinian Health Checkup Clinic Co., 3,867,937.00 7,285.06 Ltd. Tianjin Binhai New Area Ciai Clinic Co., Ltd. 3,204,694.00 6,001.83 Taizhou Meizhao Health Checkup Centre (General 3,111,950.00 5,868.84 Partnership) Qinzhou Meiling Health Checkup Co., Ltd. 3,101,878.00 5,774.00 Tianjin Heping Meinian Meijia Health Management Co., 2,896,172.00 5,412.05 Ltd. Tianjin Meize Clinic Co., Ltd. 2,118,921.00 3,809.50 Zhuhai Meinian Onehealth Health Management Co., Ltd. 1,562,211.47 2,880.03 Guangzhou Meinian Onehealth Hospital Management 1,302,809.00 2,405.89 Co., Ltd. Xiamen Yincheng Meinian Health Management Co., Ltd. 1,205,002.00 2,443.59 Dongguan Songshan Lake Meici Oasis Clinic Co., Ltd. 1,135,840.00 2,118.55 Yantai Meinian Futian Health Checkup Management Co., 967,268.01 1,764.85 Ltd. Ningbo Yinzhou Meizhao Comprehensive Clinic Co., Ltd. 257,516.00 480.51 Total 145,049,836.09 3,318,093.07 475,845,292.27 7,844,716.90
(2) Payables
Unit: Renminbi Yuan Carrying amount at the Carrying amount at the Item Related party end of the period beginning of the period Accounts
payable Hangzhou Aidikang Medical Laboratories Co., Ltd. 69,077,348.57 47,920,419.25 and its subsidiaries Shanghai Tianyi Hongfang Corporate Management 7,169,479.99 2,004,407.87 Co., Ltd. Beijing Ciji Network Technology Co., Ltd. 3,400,818.87 5,053,174.40 Fuyang Meinian Onehealth Health Management Co., 2,963,062.87 3,534,961.96 Ltd. Beijing Tianyi Hongfang Investment Management Co., 2,354,138.80 1,839,860.24 Ltd. Chengdu Meizhao Health Management Co., Ltd. 1,175,795.43 1,159,634.33 Shanghai Tianyi Hongfang Property Management Co., 1,385,808.14 668,222.33 Ltd. Esaote (Shenzhen) Medical Equipment Co., Ltd. 1,140,000.00 1,500,000.00 Foshan Meinian Onehealth Checkup Management 864,386.14 2,196,731.36 Co., Ltd. Yinchuan Dr. Elephant Internet Hospital Co., Ltd. 201,110.84 1,466,980.47 Shenzhen Meizhao Health Management Co., Ltd. 637,774.69 451,538.00 Yinchuan Meinian Onehealth Hospital Co., Ltd. 452,413.09 1,842,040.74 Mengcheng Meinian Onehealth Management Co., Ltd. 382,253.46 335,280.30 Shanghai Yushen Enterprise Management Co., Ltd. 368,508.00 1,105,524.00 Alibaba Group and its subsidiaries 1,050,841.42
152 Anshun Ciming Health Checkup Management Co., 328,510.35 328,691.85 Ltd. Shanghai Meizhao Zheyuan Clinic Co., Ltd. 303,599.40 250,172.80 Wuxi Meizhao Clinic Co., Ltd. 259,666.00 228,058.00 Yantai Meinian Futian Health Checkup Management 250,037.25 706,375.45 Co., Ltd. Yantai Meinian Onehealth Checkup Management Co., 211,155.20 941,513.39 Ltd. Harbin Meiming Health Management Co., Ltd. 205,545.00 4,517,619.10 Zhengzhou Meizhao Health Medical Management 180,338.00 615,199.60 Co., Ltd. Weihai Guoji Meinian Onehealth Checkup Centre Co., 176,153.25 498,443.01 Ltd. Shandong Wanshu Trading Co., Ltd. 62,187.50 62,187.50 Wuhan Meizhao Health Management Co., Ltd. 124,696.50 37,932.00 Guangzhou Meizhao Health Management Co., Ltd. 85,054.00 106,347.00 Weihai Meinian Onehealth Checkup Centre Co., Ltd. 84,339.29 49,344.99 Shanghai Haozhuo Data Service Co., Ltd. 77,666.59 77,666.59 Luoyang Meinian Onehealth Medical Technology Co., 54,398.45 57,958.80 Ltd. Yixing Meinian Comprehensive Clinic Co., Ltd. 49,761.75 193,861.53 Leshan Ciming Health Checkup Service Co., Ltd. 43,170.00 43,170.00 Xi'an Meizhao Health Management Co., Ltd. 39,464.00 154,557.00 Wenshan Meinian Onehealth Checkup Centre Co., 13,973.60 Ltd. Shaoxing Meizhao Outpatient Medical Co., Ltd. 11,500.00 133,579.20 Chongqing Meizhao Hospital Management Co., Ltd. 11,194.00 Huai'an Ciming Huakang Clinic Co., Ltd. 11,573.10 16,980.20 Baoshan Meinian Onehealth Checkup Centre Co., 10,733.75 176,207.15 Ltd. Bengbu Bao Zhong Tang Traditional Chinese 14,256.00 Medicine Clinic Co., Ltd. Dongguan Meinian Onehealth Health Management 3,429.00 162,080.50 Co., Ltd. Wuhan Meici Oasis Technology Management Co., Ltd. 8,422,841.09 Zhengzhou Meijian Health Management Co., Ltd. 2,104,333.20 Zhuhai Meinian Onehealth Health Management Co., 1,530,104.00 Ltd. Xiamen Ciming Health Management Co., Ltd. 1,519,611.52 Chengdu Jinniu Meinian Onehealth Management 1,428,313.48 Consulting Co., Ltd. Beijing Wandong Medical Technology Co., Ltd. 1,379,420.32 Kunming Meizhao Health Management Co., Ltd. 981,763.00 Maanshan Meinian Onehealth Consulting Co., Ltd. 896,323.07 Guangzhou Meinian Onehealth Medical Technology 701,520.25 Co., Ltd. Chengdu Meinian Onehealth Yi Centre Checkup Clinic 609,936.77 Co., Ltd. Yunnan Ciming Health Service Co., Ltd. 540,642.20 Tonglu Meinian Checkup Centre Co., Ltd. 402,725.75 Guangzhou Zengcheng Meinian Health Management 360,771.85
153 Co., Ltd. Dongguan Songshan Lake Meici Oasis Clinic Co., Ltd. 326,682.41 Hefei Ciming Oasis Health Management Co., Ltd. 295,105.85 Shenzhen Oasis Health Management Co., Ltd. 272,682.20 Chongqing Meiyi Health Management Co., Ltd. 271,250.89 Shandong Meiming Oasis Health Consulting Co., Ltd. 262,458.35 Xianning Meinian Onehealth Checkup Management 216,980.50 Co., Ltd. Tianjin Heping Meinian Meijia Health Management 212,227.40 Co., Ltd. Chengdu Wuhou Meinian Health Checkup Clinic Co., 206,246.68 Ltd. Deyang Weile Xinqiao Dental Clinic Co., Ltd. 193,629.63 Taizhou Meizhao Health Checkup Centre (General 193,187.95 Partnership) Jinan Meinian Onehealth Technology Co., Ltd. 191,257.57 Guangzhou Huadu Meinian Onehealth Management 163,069.19 Co., Ltd. Yangzhou Meishun Health Management Co., Ltd. 142,068.45 Changchun Meijian Health Technology Co., Ltd. 131,623.00 Qinzhou Meiling Health Checkup Co., Ltd. 121,957.25 Jinjiang Meinian Onehealth Management Co., Ltd. 97,690.09 Putian Meinian Onehealth Management Co., Ltd. 82,541.06 Xiamen Yincheng Meinian Health Management Co., 53,234.26 Ltd. Enshi Meinian Onehealth Management Co., Ltd. 41,745.66 Guangzhou Meinian Onehealth Hospital Management 35,759.86 Co., Ltd. Jilin Changyi Meinian Onehealth Technology 35,286.93 Management Co., Ltd. Nanjing Meikai Clinic Co., Ltd. 31,286.60 Wuxi Ciming Oasis Clinic Co., Ltd. 25,724.51 Huangshan Meinian Onehealth Consulting Co., Ltd. 23,263.05 Shenyang Oasis Hospital Co., Ltd. 22,450.33 Total 94,171,044.87 106,029,534.50 Advance payments received Shanghai Meizhao Zheyuan Clinic Co., Ltd. 660,538.77 Hefei Ciming Oasis Health Management Co., Ltd. 2,361,633.97 2,649,294.30 Wuxi Ciming Oasis Clinic Co., Ltd. 109,280.74 537,806.64 Guangdong Huanyue Healthcare Co., Ltd. 1,015,720.65 Xi'an Meizhao Health Management Co., Ltd. 2,586,692.12 3,098,941.71 Guangzhou Meizhao Health Management Co., Ltd. 2,550,955.99 2,987,284.82 Wenshan Meinian Onehealth Checkup Centre Co., 1,079,776.11 1,419,951.69 Ltd. Anshun Ciming Health Checkup Management Co., 283,175.95 473,701.67 Ltd. Beijing Wandong Medical Technology Co., Ltd. 74,781.00 88,068.00 Shenzhen Meizhao Health Management Co., Ltd. 1,548,017.58 2,281,413.30
154 Chongqing Meizhao Hospital Management Co., Ltd. 3,133,943.55 3,691,274.97 Dalian Pulan Meinian Health Comprehensive Clinic 1,431,120.45 1,689,563.22 Co., Ltd. Shaoxing Meizhao Outpatient Medical Co., Ltd. 894,919.24 1,152,218.82 Foshan Wanda Meizhao Health Management Co., 314,019.41 409,022.45 Ltd. Esaote (Shenzhen) Medical Equipment Co., Ltd. 10,950.00 10,950.00 Baoshan Meinian Onehealth Checkup Centre Co., 977,035.59 1,280,033.01 Ltd. Weihai Meinian Onehealth Checkup Centre Co., Ltd. 892,988.39 943,754.20 Wuhan Qinghua Sunshine Dentistry Co., Ltd. 14,800.00 Shanghai Bao Zhong Tang Eshan Traditional Chinese 23,268.00 Medicine Clinic Co., Ltd. Qingdao Meiweile Medical Management Co., Ltd. 34,174.00 34,174.00 Cixin (Beijing) Medicare Investment Co., Ltd. 45,369.00 47,199.00 Dongguan Meinian Onehealth Health Management 194,129.89 221,074.59 Co., Ltd. Weihai Guoji Meinian Onehealth Checkup Centre Co., 266,792.75 69,310.63 Ltd. Nanjing Baozhongtang Medical Technology Co., Ltd. 299,612.00 299,612.00 Yantai Meinian Futian Health Checkup Management 503,604.18 Co., Ltd. Yinchuan Meinian Onehealth Hospital Co., Ltd. 1,077,868.39 Mengcheng Meinian Onehealth Management Co., Ltd. 156,970.69 213,784.91 Weifang Century Changhe Economic and Trade Co., 25,545.00 Ltd. Chengdu Aidi Ophthalmic Hospital Co., Ltd. 11,250.00 Shenyang Oasis Hospital Co., Ltd. 3,371,295.92 Kunming Meizhao Health Management Co., Ltd. 2,779,968.74 Tianjin Ciming Oasis Hospital Management 2,738,072.63 Consulting Co., Ltd. Shandong Meiming Oasis Health Consulting Co., Ltd. 2,352,995.47 Shanghai Haozhuo Data Service Co., Ltd. 2,087,967.58 Putian Meinian Onehealth Management Co., Ltd. 1,979,543.32 Shenzhen Oasis Health Management Co., Ltd. 1,650,315.13 Changchun Meijian Health Technology Co., Ltd. 1,433,796.41 Chengdu Wuhou Meinian Health Checkup Clinic Co., 1,410,711.97 Ltd. Nanjing Meiyi Clinic Co., Ltd. 1,345,456.83 Chenzhou Meinian Onehealth Management Co., Ltd. 1,173,441.87 Nan'an Meinian Onehealth Management Co., Ltd. 1,129,914.84 Nanjing Meikai Clinic Co., Ltd. 1,079,619.11 Zhengzhou Meijian Health Management Co., Ltd. 1,074,873.04 Yangzhou Meishun Health Management Co., Ltd. 1,059,544.39 Huangshan Meinian Onehealth Consulting Co., Ltd. 1,015,289.47 Enshi Meinian Onehealth Management Co., Ltd. 1,001,865.24 Shenzhen Meiyang Health Management Co., Ltd. 938,624.99 Xianning Meinian Onehealth Checkup Management 916,859.92 Co., Ltd. Qingdao Meinian Health Technology Health 898,698.11
155 Management Co., Ltd. Tianjin Binhai New Area Ciai Clinic Co., Ltd. 821,689.90 Chongqing Meiyi Health Management Co., Ltd. 791,875.96 Zhengzhou Meizhao Health Medical Management 587,446.04 Co., Ltd. Dongguan Humen Meinian Onehealth Clinic Co., Ltd. 455,518.12 Yunnan Ciming Health Service Co., Ltd. 340,569.19 Shanghai Meikai Clinic Co., Ltd. 327,426.85 Jinjiang Meinian Onehealth Management Co., Ltd. 270,534.31 Wuhan Meizhao Health Management Co., Ltd. 118,160.02 Guangzhou Meinian Onehealth Hospital Management 117,802.95 Co., Ltd. Bestore Co., Ltd. 98,487.50 Ningbo Yinzhou Meizhao Comprehensive Clinic Co., 71,143.96 Ltd. Houma Meinian Onehealth Management Co., Ltd. 47,064.80 Fuyang Meinian Onehealth Health Management Co., 28,581.12 Ltd. Total 22,578,933.41 59,113,589.63 Other
payables Hangzhou Aidikang Medical Laboratories Co., Ltd. 892,137.19 733,368.35 and its subsidiaries Tianjin Meiweile Health Management Co., Ltd. 8,800.80 8,800.80 Yinchuan Dr. Elephant Internet Hospital Co., Ltd. 11,163.00 12,280.30 Weihai Meinian Onehealth Checkup Centre Co., Ltd. 13,441.80 Yixing Meinian Comprehensive Clinic Co., Ltd. 23,889.60 11,334.00 Weihai Guoji Meinian Onehealth Checkup Centre Co., 71,473.30 80,200.00 Ltd. Shanghai Meiwei Dental Care Management Group 100,000.00 100,000.00 Co., Ltd. Yinchuan Meinian Onehealth Hospital Co., Ltd. 395,078.60 349,593.00 Tianjin Huiyigu Technology Co., Ltd. 588,500.00 588,500.00 Leshan Ciming Health Checkup Service Co., Ltd. 658,977.83 Esaote (Shenzhen) Medical Equipment Co., Ltd. 740,000.00 740,000.00 Shanghai Tianyi Industrial Holding Group Co., Ltd. 1,000,000.00 1,000,000.00 Shanghai Haozhuo Data Service Co., Ltd. 1,075,827.20 1,075,827.20 Shanghai Elephant Healthcare Technology Co., Ltd. 1,253,513.81 1,233,513.81 Fuyang Meinian Onehealth Health Management Co., 3,037,010.00 Ltd. Shanghai Meixin Investment Management Co., Ltd. 13,840,666.67 Foshan Meinian Onehealth Checkup Management 18,752,397.60 4,493,489.00 Co., Ltd. Zhaoqing Meinian Onehealth Health Management 151,272.50 Co., Ltd. Zhejiang Shenbo Medical Technology Co., Ltd. 60,000.00 Zhuhai Meinian Onehealth Health Management Co., 958,872.87 Ltd. Taizhou Meizhao Health Checkup Centre (General 610,645.00 Partnership) Beijing Ciji Network Technology Co., Ltd. 300,000.00
156 Guangzhou Meinian Onehealth Medical Technology 137,116.00 Co., Ltd. Maanshan Meinian Onehealth Consulting Co., Ltd. 88,068.00 Chengdu Jinniu Meinian Onehealth Management 40,890.00 Consulting Co., Ltd. Chengdu Wuhou Meinian Health Checkup Clinic Co., 35,446.00 Ltd. Xiamen Yincheng Meinian Health Management Co., 33,128.00 Ltd. Tianjin Heping Meinian Meijia Health Management 30,813.00 Co., Ltd. Dongguan Humen Meinian Onehealth Clinic Co., Ltd. 19,362.00 Chengdu Meinian Onehealth Yi Centre Checkup Clinic 14,312.00 Co., Ltd. Guangzhou Zengcheng Meinian Health Management 10,687.00 Co., Ltd. Total 42,674,149.90 12,706,246.33
7 Commitments of the related parties
8 Others
XIII. Share-based payments
1 Information about share-based payments
□Applicable √ Not applicable
2 Equity-settled share-based payments
□Applicable √ Not applicable
3 Cash-settled share-based payments
□Applicable √ Not applicable
4 Modification and termination of share-based payments
157 5 Others
XIV. Commitments and contingencies
1 Significant commitments
Significant commitments as at the balance sheet date (1) Capital commitments Balance at the Balance at the end of the Item beginning of the period period Signed but not recognised in the financial statements — External investment commitments 135,103,100.00 189,595,900.00 Total 135,103,100.00 189,595,900.00 (2) Operating lease commitments As at 30 June, the total future minimum lease payments under non-cancellable operating leases of properties and fixed assets were payable as follows: Balance at the Balance at the end of the Operating lease commitments beginning of the period period Minimum lease payments under non-cancellable operating leases: Within the first year after the balance sheet date 734,349,982.13 722,443,211.22 Within the second year after the balance sheet date 665,771,664.34 632,168,834.42 Within the third year after the balance sheet date 602,335,763.46 576,309,056.37 After 3 years 1,968,680,491.93 2,041,997,977.63 Total 3,971,137,901.86 3,972,919,079.64 2 Contingencies
(1) Significant contingencies as at the balance sheet date
① Contingent liabilities arising from providing debt guarantee for other organisations and their financial impacts The Company provided guarantees for the finance lease agreements signed between the following companies and De Lage Landen Financial Leasing (China) Co., Ltd. As at the reporting date, there has been no default events in respect of this matter: Name of guaranteed company Amount of guarantee Term of guarantee (RMB ‘0,000) Baotou Meinian Onehealth Aiputuo Polyclinic Co., 30 60 months Ltd. Linhai Meinian Risheng Hospital Co., Ltd. 36 60 months
(2) If there are no significant contingencies which should be disclosed by the Company, disclose this fact.
There are no significant contingencies which should be disclosed by the Company.
158 3 Others
XV. Subsequent events
1 Material non-adjusting events
2 Profit appropriations
3 Sales returns
4 Other post balance sheet date events
XVI. Other significant items
1 Corrections of prior year accounting errors
2 Debt restructuring
3 Exchange of assets
(1) Exchange of non-monetary assets
(2) Exchange of other assets
4 Annuity plan
5 Discontinued operations
6 Information on segments
(1) Basis for determining the reportable segments and related accounting policies
(2) Financial information of reportable segments
Expressed in Renminbi Yuan
Elimination Northeast Northern Central Northwest Southwest Southern Item Eastern China among Total China China South Area China China China segments Operating income from 12,527.53 67,352.40 35,907.72 44,931.20 12,454.64 18,478.77 20,254.50 -30,461.67 181,445.09 principal activities Operating cost of principal 13,240.44 62,639.91 34,875.99 41,151.30 9,921.71 19,905.76 20,466.42 -28,904.06 173,297.47 activities Total assets 181,595.58 2,820,391.18 334,545.75 274,611.02 59,349.48 172,424.84 166,176.38 -2,324,779.43 1,684,314.80 Total liabilities 136,610.45 1,327,207.47 175,924.54 220,140.78 47,230.59 150,670.35 120,628.30 -1,237,339.04 941,073.44
(3) If there is no reportable segments for the Company or the total assets and total liabilities of each reportable segment cannot be disclosed, the reasons should be stated.
(4) Other description
159 7 Other significant transactions and matters that have an impact on the investment decisions of investors
8 Others
XVII. Notes to the Company’s financial statements
1 Accounts receivable
(1) Accounts receivable by category:
Expressed in Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period Provision for bad and Provision for bad and Category Book value Carrying amount Book value Carrying amount doubtful debts doubtful debts Amount Percentage Amount Percentage Amount Percentage Amount Percentage Including: Accounts receivable for 10,100,000.00 100.00% 10,100,000.00 41,100,000.00 100.00% 41,100,000.00 collective assessment Including: Accounts receivables that are collectively assessed for impairment 10,100,000.00 100.00% 10,100,000.00 41,100,000.00 100.00% 41,100,000.00 based on credit risk characteristics Total 10,100,000.00 100.00% 10,100,000.00 41,100,000.00 100.00% 41,100,000.00 Individual assessment: None Collective assessment: None Description of the basis of determining the group: None If the provision for bad and doubtful debts of accounts receivable is made in accordance with the general expected credit loss model, please disclose the relevant information of the provision for bad and doubtful debts with reference to the disclosure methods adopted for other receivables: □Applicable √ Not applicable By ageing Expressed in Renminbi Yuan Ageing Balance at the end of the period Within 1 year (inclusive) 10,100,000.00 Total 10,100,000.00
(2) Additions, recoveries or reversals of provision for bad and doubtful debts during the period
(3) Accounts receivable written off during the period
(4) Five largest accounts receivable by debtor at the end of the period:
Expressed in Renminbi Yuan Balance of accounts Percentage of the total ending Ending balance of Debtor receivable at the end of the balance of accounts receivable provision for bad and
160 period doubtful debts No.1 5,000,000.00 49.50% No.2 3,000,000.00 29.70% No.3 2,000,000.00 19.80% No.4 100,000.00 1.00% Total 10,100,000.00 100.00%
(5) Derecognition of accounts receivable due to transfer of financial assets
(6) Assets and liabilities recognised due to the continuing involvement of accounts receivable transferred
Other description: The five largest accounts receivable of the Company amounted to RMB10,100,000.00, accounting for 100% of the total accounts receivable at the end of the year.
2 Other receivables
Expressed in Renminbi Yuan Item Balance at the end of the period Balance at the beginning of the period Dividends receivable 39,725,570.73 125,339,452.03 Other receivables 385,696,529.08 154,836,663.46 Total 425,422,099.81 280,176,115.49
(1) Interest receivable
1) Interest receivable by category
2) Significant overdue interest
3) Additions of provisions for bad and doubtful debts
□Applicable √ Not applicable
161 (2) Dividends receivable
1) Dividends receivable by category
Expressed in Renminbi Yuan Balance at the Balance at the end of Item (or investee) beginning of the the period period Meinian Onehealth Healthcare (Group) Co., Ltd. 100,000,000.00 Nantong Meifu Health Industry Investment Partnership (Limited 29,766,666.65 17,859,999.99 Partnership) Nantong Meizhao Meinian Health Industry M&A Investment Fund (Limited 9,958,904.08 7,479,452.04 Partnership) Total 39,725,570.73 125,339,452.03
2) Significant dividends receivable ageing over one year
3) Additions of provisions for bad and doubtful debts
□Applicable √ Not applicable Other description: N/A
(3) Other receivables
1) Other receivables categorised by nature
Expressed in Renminbi Yuan Book value at the beginning of the Nature of other receivables Book value at the end of the period period Balances of inter-company 384,696,037.92 153,206,866.09 transactions Security deposits 814,080.00 Deposits 698,604.37 698,604.37 Amounts due from other entities 301,886.79 117,113.00 Total 385,696,529.08 154,836,663.46
2) Movements of provision for bad and doubtful debts
By ageing Expressed in Renminbi Yuan Ageing Balance at the end of the period Within 1 year (inclusive) 384,980,911.71 Over 1 year but within 2 years 331,752.00 Over 3 years 383,865.37 Over 4 year but within 5 years 383,865.37 Total 385,696,529.08
162 3) Additions, recoveries or reversals of provision for bad and doubtful debts during the period
4) Other receivables written off during the period
5) Five largest other receivables by debtor at the end of the period:
Expressed in Renminbi Yuan
Ending balance of Nature of other Balance at the Percentage of the total ending balance of Debtor Ageing provision for bad receivable end of the period other receivables and doubtful debts Balances of No.1 inter-company 289,726,363.86 Within 1 year 75.12% transactions Balances of No.2 inter-company 65,290,000.00 Within 1 year 16.93% transactions Balances of No.3 inter-company 15,747,494.90 Within 1 year 4.08% transactions Balances of No.4 inter-company 11,165,000.00 Within 1 year 2.89% transactions Balances of No.5 inter-company 1,719,091.00 Within 1 year 0.45% transactions Total -- 383,647,949.76 -- 99.47%
6) Receivables relating to government grant
7) Derecognition of other receivables due to transfer of financial assets
8) Assets and liabilities recognised due to the continuing involvement of other receivables transferred
3 Long-term equity investments
Expressed in Renminbi Yuan
Balance at the end of the period Balance at the beginning of the period Item Provision for Provision for Book value Carrying amount Book value Carrying amount impairment impairment Investments in subsidiaries 9,699,224,346.03 18,055,000.00 9,681,169,346.03 9,698,324,346.03 18,055,000.00 9,680,269,346.03 Investments in joint 493,002.54 0.00 493,002.54 633,365.86 0.00 633,365.86 ventures and associates Total 9,699,717,348.57 18,055,000.00 9,681,662,348.57 9,698,957,711.89 18,055,000.00 9,680,902,711.89
163 (1) Investments in subsidiaries:
Expressed in Renminbi Yuan
Movements during the period
Balance of Balance (carrying
Balance (carrying provision for amount) at the Investee amount) at the end impairment at beginning of the Increase in Provision for of the period the end of the period investments impairment
Others period
Decreasein investments
Meinian Onehealth Healthcare (Group) 6,682,699,415.39 6,682,699,415.39 Co., Ltd. Ciming Health Checkup Management 2,774,560,149.83 2,774,560,149.83 18,055,000.00 Group Co., Ltd. Shanghai Meizhao Health 50,000,000.00 50,000,000.00 Management Co., Ltd. Shanghai Meijian Oasis Health 61,905,000.00 900,000.00 62,805,000.00 Management Co., Ltd. Beijing Meinian Insurance Broker Co., 50,000,000.00 50,000,000.00 Ltd. Zhoushan Meici Investment 1,000,000.00 1,000,000.00 Management Co., Ltd. Mega Genomics Health Technology 55,004,780.81 55,004,780.81 (Beijing) Co., Ltd. Shanghai Elephant Medical 5,100,000.00 5,100,000.00 Technology Co., Ltd. Total 9,680,269,346.03 900,000.00 9,681,169,346.03 18,055,000.00
(2) Investments in joint ventures and associates
Expressed in Renminbi Yuan
Movements during the period
Balance
Balance
Investment
(carrying Declared
(carrying amount) at income or Name of investee distribution amount) at the losses of cash the end of period
beginning of recognised
Others Balanceof
to to other dividends
the period provisionfor impairment at
under equity end the ofthe
ve incomeve
Increasein impairment
the period movements
investments Decreasein investments
Otherequity
Adjustments Provision for
comprehensi or profits method I. Joint ventures II. Associates Beijing Langmei 633,365.86 -140,363.32 493,002.54 Communication Co., Ltd. Shanghai Haozhuo Data Service Co., Ltd. (Note IX.3(3)) Sub-total 633,365.86 -140,363.32 493,002.54 Total 633,365.86 -140,363.32 493,002.54 0.00
(3) Other description
164 4 Operating income and operating costs
Expressed in Renminbi Yuan Current period Prior period Item Income Cost Income Cost Principal activities 0.00 2,365,431.52 38,915,094.34 4,000,000.00 Other operating 0.00 activities Total 0.00 2,365,431.52 38,915,094.34 4,000,000.00 Information about performance obligations: Revenue from the Company’s checkup business is recognised when checkup business is completed (i.e. when the Company satisfies the performance obligation in the contract).
5 Investment income
Expressed in Renminbi Yuan Item Current period Prior period Income from long-term equity investments accounted 100,000,000.00 for using cost method Income from long-term equity investments accounted -140,363.32 -153,746.32 for using equity method Investment income from other non-current financial assets 16,927,785.37 16,968,795.12 during the holding period Total 16,787,422.05 116,815,048.80
6 Others
XVIII. Supplementary information
1 Extraordinary gains and losses for the period
√Applicable □Not applicable Expressed in Renminbi Yuan Item Amount Note Disposal of non-current assets -5,071,535.18 Government grants recognised through profit or loss (excluding those having close relationships with 12,760,934.20 the Group’s operation and enjoyed in fixed amount or quantity according to uniform national standard) Other non-operating income and expenses besides -16,703,835.40 items above Mainly due to the impact of the changes in fair Other items qualified as extraordinary gain and loss 23,494,165.24 value of other non-current financial assets on gain and loss during the current period Less: Tax effect 131,402.07 Effect on non-controlling interests 2,855,568.69 Total 11,492,758.10 --
165 For the items defined by the Company as extraordinary gain and loss items in accordance with Interpretive Pronouncement on the Preparation of Information Disclosures of Companies Issuing Public Shares No. 1 – Extraordinary Gain and Loss, the reasons for defining these items should be stated. Besides, disclose the reason for redefining any extraordinary gain or loss item listed in Interpretive Pronouncement on the Preparation of Information Disclosures of Companies Issuing Public Shares No. 1 – Extraordinary Gain and Loss as an ordinary gain and loss item. □Applicable √ Not applicable
2 Return on net assets and earnings per share
Weighted Earnings per share average Profit for the reporting period return on net Basic earnings per Diluted earnings per assets share (RMB/share) share (RMB/share) Net profit attributable to the Company’s ordinary equity -11.28% -0.22 -0.22 shareholders Net profit excluding extraordinary gain and loss attributable to the Company’s ordinary equity -11.45% -0.22 -0.22 shareholders
3 Differences between financial statements prepared under domestic and overseas accounting standards
(1) The differences between the financial statements prepared under the International Accounting Standards and the PRC accounting standards (PRC GAAP) on net profit and net assets are as follows:
□Applicable √ Not applicable
(2) The differences between the financial statements prepared under the overseas accounting standards and the PRC accounting standards (PRC GAAP) on net profit and net assets are as follows:
□Applicable √ Not applicable
(2) Information on the reasons for the differences between financial statements prepared under domestic and overseas accounting standards. For the financial statements audited by an overseas auditor, if the differences in the financial statements have been reconciled, the name of the overseas auditor should be indicated.
4 Others
166